<?xml version="1.0" encoding="UTF-8"?>
<root id="root" uuid="16a03a26-b4d5-4fe5-a000-84e9ed7b6149-lbl">
   <Additions id="adds" size="1017">
      <Effectual id="effadds" size="815">
         <Strengthening id="st" size="33">
            <Change id="1">
               <Axiom>Stage I Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage I)</Axiom>
               <Source>
                  <Axiom>Stage I Thyroid Gland Follicular Carcinoma SubClassOf Disease_is_Stage only Stage I</Axiom>
               </Source>
            </Change>
            <Change id="2">
               <Axiom>Thyroid Gland Nodule EquivalentTo Thyroid Gland Disorder and (Disease_Has_Finding only Nodular Lesion)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Nodule SubClassOf Thyroid Gland Disorder</Axiom>
               </Source>
            </Change>
            <Change id="3">
               <Axiom>Thyroid Gland Neoplasm EquivalentTo Neck Neoplasm and Thyroid Gland Disorder</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Neoplasm SubClassOf Neck Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="4">
               <Axiom>Sporadic Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_May_Have_Molecular_Abnormality some RET Gene Mutation)</Axiom>
               <Source>
                  <Axiom>Sporadic Thyroid Gland Medullary Carcinoma SubClassOf Thyroid Gland Medullary Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="5">
               <Axiom>Stage IV Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage IV)</Axiom>
               <Source>
                  <Axiom>Stage IV Thyroid Gland Medullary Carcinoma SubClassOf Disease_is_Stage only Stage IV</Axiom>
               </Source>
            </Change>
            <Change id="6">
               <Axiom>Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia EquivalentTo Thyroid Gland Mucoepidermoid Carcinoma and (Disease_May_Have_Associated_Disease some Chronic Lymphocytic Thyroiditis) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia SubClassOf Thyroid Gland Mucoepidermoid Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="7">
               <Axiom>Thyroid Gland Lipoadenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Normal_Cell_Origin only Adipocyte)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Lipoadenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
               </Source>
            </Change>
            <Change id="8">
               <Axiom>Multicentric Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_Has_Finding only Multifocal Lesion)</Axiom>
               <Source>
                  <Axiom>Multicentric Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="9">
               <Axiom>Sporadic Thyroid Gland Micromedullary Carcinoma EquivalentTo Sporadic Thyroid Gland Medullary Carcinoma and (Disease_Has_Finding only Lesion with Diameter of 10mm or Less)</Axiom>
               <Source>
                  <Axiom>Sporadic Thyroid Gland Micromedullary Carcinoma SubClassOf Disease_Has_Finding only Lesion with Diameter of 10mm or Less</Axiom>
               </Source>
            </Change>
            <Change id="10">
               <Axiom>Thyroid Gland Paraganglioma EquivalentTo Head and Neck Paraganglioma and Thyroid Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Paraganglioma SubClassOf Thyroid Gland Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="11">
               <Axiom>Stage III Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage III)</Axiom>
               <Source>
                  <Axiom>Stage III Thyroid Gland Medullary Carcinoma SubClassOf Thyroid Gland Medullary Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="12">
               <Axiom>Benign Thyroid Gland Neoplasm EquivalentTo Benign Neck Neoplasm and Thyroid Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
               <Source>
                  <Axiom>Benign Thyroid Gland Neoplasm SubClassOf Benign Neck Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="13">
               <Axiom>Stage II Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage II)</Axiom>
               <Source>
                  <Axiom>Stage II Thyroid Gland Follicular Carcinoma SubClassOf Thyroid Gland Follicular Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="14">
               <Axiom>Tall Cell Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Finding only Trabecular Pattern)</Axiom>
               <Source>
                  <Axiom>Tall Cell Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="15">
               <Axiom>Thyroid Gland Sarcoma EquivalentTo Malignant Thyroid Gland Neoplasm and Soft Tissue Sarcoma</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Sarcoma SubClassOf Soft Tissue Sarcoma</Axiom>
               </Source>
            </Change>
            <Change id="16">
               <Axiom>Stage IV Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage IV)</Axiom>
               <Source>
                  <Axiom>Stage IV Thyroid Gland Papillary Carcinoma SubClassOf Disease_is_Stage only Stage IV</Axiom>
               </Source>
            </Change>
            <Change id="17">
               <Axiom>Thyroid Gland Follicular Adenoma with Papillary Hyperplasia EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_May_Have_Finding some Multifocal Lesion) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Follicular Adenoma with Papillary Hyperplasia SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
               </Source>
            </Change>
            <Change id="18">
               <Axiom>Thyroid Gland Toxic (Hyperfunctioning) Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Associated_Disease only Hyperthyroidism) and (Disease_Has_Finding only Hot Nodule)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Toxic (Hyperfunctioning) Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
               </Source>
            </Change>
            <Change id="19">
               <Axiom>Hereditary Thyroid Gland Medullary Carcinoma EquivalentTo Hereditary Malignant Neoplasm and Thyroid Gland Medullary Carcinoma and (Disease_Has_Associated_Disease only Neoplastic C-Cell Hyperplasia) and (Disease_Has_Finding only Bilateral Mass) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
               <Source>
                  <Axiom>Hereditary Thyroid Gland Medullary Carcinoma SubClassOf Disease_Has_Molecular_Abnormality only RET Gene Mutation</Axiom>
               </Source>
            </Change>
            <Change id="20">
               <Axiom>Malignant Thyroid Gland Neoplasm EquivalentTo Malignant Neck Neoplasm and Thyroid Gland Neoplasm</Axiom>
               <Source>
                  <Axiom>Malignant Thyroid Gland Neoplasm SubClassOf Malignant Neck Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="21">
               <Axiom>Stage II Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage II)</Axiom>
               <Source>
                  <Axiom>Stage II Thyroid Gland Medullary Carcinoma SubClassOf Disease_is_Stage only Stage II</Axiom>
               </Source>
            </Change>
            <Change id="22">
               <Axiom>Stage I Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage I)</Axiom>
               <Source>
                  <Axiom>Stage I Thyroid Gland Medullary Carcinoma SubClassOf Thyroid Gland Medullary Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="23">
               <Axiom>Solid Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_Has_Finding only Solid Pattern)</Axiom>
               <Source>
                  <Axiom>Solid Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="24">
               <Axiom>C-Cell Hyperplasia EquivalentTo Hyperplasia and Non-Neoplastic Endocrine Disorder and Thyroid Gland Disorder and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
               <Source>
                  <Axiom>C-Cell Hyperplasia SubClassOf Thyroid Gland Disorder</Axiom>
               </Source>
            </Change>
            <Change id="25">
               <Axiom>Stage III Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage III)</Axiom>
               <Source>
                  <Axiom>Stage III Thyroid Gland Follicular Carcinoma SubClassOf Disease_is_Stage only Stage III</Axiom>
               </Source>
            </Change>
            <Change id="26">
               <Axiom>Thyroid Gland Mucoepidermoid Carcinoma EquivalentTo Mucoepidermoid Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Circumscribed Lesion) and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Indolent Clinical Course)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Mucoepidermoid Carcinoma SubClassOf Mucoepidermoid Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="27">
               <Axiom>Stage III Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage III)</Axiom>
               <Source>
                  <Axiom>Stage III Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="28">
               <Axiom>Stage IV Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage IV)</Axiom>
               <Source>
                  <Axiom>Stage IV Thyroid Gland Follicular Carcinoma SubClassOf Disease_is_Stage only Stage IV</Axiom>
               </Source>
            </Change>
            <Change id="29">
               <Axiom>Stage I Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage I)</Axiom>
               <Source>
                  <Axiom>Stage I Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="30">
               <Axiom>Thyroid Gland Angiosarcoma EquivalentTo Angiosarcoma and Thyroid Gland Sarcoma and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Angiosarcoma SubClassOf Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue</Axiom>
               </Source>
            </Change>
            <Change id="31">
               <Axiom>Recurrent Thyroid Gland Carcinoma EquivalentTo Recurrent Head and Neck Cancer and Thyroid Gland Carcinoma</Axiom>
               <Source>
                  <Axiom>Recurrent Thyroid Gland Carcinoma SubClassOf Recurrent Head and Neck Cancer</Axiom>
               </Source>
            </Change>
            <Change id="32">
               <Axiom>Thyroid Gland Medullary Carcinoma with Amyloid Stroma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_Has_Finding only Amyloid Deposition)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Medullary Carcinoma with Amyloid Stroma SubClassOf Thyroid Gland Medullary Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="33">
               <Axiom>Stage II Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage II)</Axiom>
               <Source>
                  <Axiom>Stage II Thyroid Gland Papillary Carcinoma SubClassOf Disease_is_Stage only Stage II</Axiom>
               </Source>
            </Change>
         </Strengthening>
         <StrengtheningWithNewTerms id="stnt" size="33">
            <Change id="34">
               <Axiom>Clear Cell Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Papillary Pattern) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Clear Cell)</Axiom>
               <Source>
                  <Axiom>Clear Cell Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
               <New_Terms>Follicular Structures Present, Malignant Thyroid Gland Follicular Clear Cell</New_Terms>
            </Change>
            <Change id="35">
               <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Epithelial Spindle Cell) and (Disease_May_Have_Finding some Biphasic Pattern) and (Disease_May_Have_Finding some Monophasic Pattern) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell) and (Disease_Has_Finding only Slow Growing Mass)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation SubClassOf Thyroid Gland Carcinoma</Axiom>
               </Source>
               <New_Terms>Calcitonin Positive Neoplastic Cells Present, Thyroglobulin Positive Neoplastic Cells Present</New_Terms>
            </Change>
            <Change id="36">
               <Axiom>Thyroid Gland Mucinous Follicular Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_May_Have_Abnormal_Cell some Neoplastic Thyroid Gland Follicular Signet Ring Cell) and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Honeycomb Pattern) and (Disease_Has_Finding only Mucoid Stroma Formation)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Mucinous Follicular Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
               </Source>
               <New_Terms>Neoplastic Thyroid Gland Follicular Signet Ring Cell</New_Terms>
            </Change>
            <Change id="37">
               <Axiom>Poorly Differentiated Thyroid Gland Carcinoma EquivalentTo Thyroid Gland Adenocarcinoma and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Follicular Structures Present) and (Disease_Excludes_Finding only Papillary Pattern)</Axiom>
               <Source>
                  <Axiom>Poorly Differentiated Thyroid Gland Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation</Axiom>
               </Source>
               <New_Terms>Follicular Structures Present</New_Terms>
            </Change>
            <Change id="38">
               <Axiom>Thyroid Gland Follicular Carcinoma EquivalentTo Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PPAR-gamma Rearrangement) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Follicular Carcinoma SubClassOf Differentiated Thyroid Gland Carcinoma</Axiom>
               </Source>
               <New_Terms>Nuclear Clearing, Nuclear Grooves, Nuclear Pseudoinclusion, Follicular Structures Present</New_Terms>
            </Change>
            <Change id="39">
               <Axiom>Thyroid Gland Undifferentiated (Anaplastic) Carcinoma EquivalentTo Thyroid Gland Carcinoma and Undifferentiated Carcinoma and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_May_Have_Finding some Coagulative Necrosis) and (Disease_May_Have_Finding some Dysphagia) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Hoarseness) and (Disease_May_Have_Finding some Vocal Cord Paralysis) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Abnormal_Cell only Anaplastic Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Giant Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelioid Cell) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Rapidly Enlarging Mass)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Undifferentiated (Anaplastic) Carcinoma SubClassOf Undifferentiated Carcinoma</Axiom>
               </Source>
               <New_Terms>Hoarseness, Vocal Cord Paralysis</New_Terms>
            </Change>
            <Change id="40">
               <Axiom>Thyroid Gland Macrofollicular Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Finding only Macrofollicular Structures Present)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Macrofollicular Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
               </Source>
               <New_Terms>Macrofollicular Structures Present</New_Terms>
            </Change>
            <Change id="41">
               <Axiom>Thyroid Gland Follicular Adenoma with Bizarre Nuclei EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell with Large and Hyperchromatic Nucleus) and (Disease_Has_Finding only Nuclear Atypia)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Follicular Adenoma with Bizarre Nuclei SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
               </Source>
               <New_Terms>Neoplastic Thyroid Gland Follicular Cell with Large and Hyperchromatic Nucleus</New_Terms>
            </Change>
            <Change id="42">
               <Axiom>Thyroid Gland Diffuse Sclerosing Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_Has_Finding only Diffuse Lesion) and (Disease_Has_Finding only Fibrotic Stroma Formation) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Finding only Squamous Metaplasia)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Diffuse Sclerosing Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
               <New_Terms>Diffuse Lesion</New_Terms>
            </Change>
            <Change id="43">
               <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7</Axiom>
               </Source>
               <New_Terms>Nuclear Clearing, Nuclear Grooves, Nuclear Pseudoinclusion, Follicular Structures Present, Thyroglobulin Positive Neoplastic Cells Present</New_Terms>
            </Change>
            <Change id="44">
               <Axiom>Thyroid Gland Fetal Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_May_Have_Cytogenetic_Abnormality some Aneuploidy) and (Disease_Has_Finding only Edematous Stroma Formation) and (Disease_Has_Finding only Microfollicular Structures Present) and (Disease_Has_Finding only Trabecular Pattern)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Fetal Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
               </Source>
               <New_Terms>Microfollicular Structures Present</New_Terms>
            </Change>
            <Change id="45">
               <Axiom>Thyroid Gland Mixed Medullary and Follicular Cell Carcinoma EquivalentTo Malignant Endocrine Neoplasm and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Metastatic Neoplasm to the Lymph Node) and (Disease_May_Have_Molecular_Abnormality some RET Gene Mutation) and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Mixed Medullary and Follicular Cell Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some RET Gene Mutation</Axiom>
               </Source>
               <New_Terms>Calcitonin Positive Neoplastic Cells Present, Thyroglobulin Positive Neoplastic Cells Present</New_Terms>
            </Change>
            <Change id="46">
               <Axiom>Neoplastic C-Cell Hyperplasia EquivalentTo Atypical Hyperplasia and C-Cell Hyperplasia and Thyroid Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic C-Cell) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
               <Source>
                  <Axiom>Neoplastic C-Cell Hyperplasia SubClassOf Atypical Hyperplasia</Axiom>
               </Source>
               <New_Terms>Neoplastic C-Cell</New_Terms>
            </Change>
            <Change id="47">
               <Axiom>Thyroid Gland Medullary Carcinoma EquivalentTo Medullary Carcinoma and Neuroendocrine Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Polygonal Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Round Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Spindle Cell) and (Disease_May_Have_Associated_Disease some Paraneoplastic Syndrome) and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Metastatic Neoplasm to the Lymph Node) and (Disease_May_Have_Finding some Organoid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Serum Calcitonin Level Increased) and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Medullary Carcinoma SubClassOf Thyroid Gland Carcinoma</Axiom>
               </Source>
               <New_Terms>Malignant Neuroendocrine Round Cell, Calcitonin Positive Neoplastic Cells Present, Serum Calcitonin Level Increased</New_Terms>
            </Change>
            <Change id="48">
               <Axiom>Thyroid Gland Papillary Microcarcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Papillary Pattern) and (Disease_Has_Finding only Lesion with Diameter of 10mm or Less)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Papillary Microcarcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
               <New_Terms>Follicular Structures Present</New_Terms>
            </Change>
            <Change id="49">
               <Axiom>Thyroid Gland Atypical Follicular Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Excludes_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell with Large and Hyperchromatic Nucleus) and (Disease_Has_Finding only Nuclear Atypia)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Atypical Follicular Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
               </Source>
               <New_Terms>Neoplastic Thyroid Gland Follicular Cell with Large and Hyperchromatic Nucleus</New_Terms>
            </Change>
            <Change id="50">
               <Axiom>Oncocytic Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Papillary Pattern) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Oxyphil Cell)</Axiom>
               <Source>
                  <Axiom>Oncocytic Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
               <New_Terms>Follicular Structures Present</New_Terms>
            </Change>
            <Change id="51">
               <Axiom>Thyroid Gland Papillary Carcinoma EquivalentTo Papillary Adenocarcinoma and Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_May_Have_Molecular_Abnormality some TRK Rearrangement) and (Disease_Has_Finding only Ground Glass Nuclear Inclusion) and (Disease_Has_Finding only Nuclear Grooves) and (Disease_Has_Finding only Nuclear Pseudoinclusion)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Papillary Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement</Axiom>
               </Source>
               <New_Terms>Nuclear Grooves, Nuclear Pseudoinclusion</New_Terms>
            </Change>
            <Change id="52">
               <Axiom>Follicular Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Papillary Pattern) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Nuclear Clearing)</Axiom>
               <Source>
                  <Axiom>Follicular Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
               <New_Terms>Nuclear Clearing, Follicular Structures Present</New_Terms>
            </Change>
            <Change id="53">
               <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor EquivalentTo Thyroid Gland Neoplasm and (Disease_May_Have_Associated_Disease some Thyroid Gland Papillary Carcinoma) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Finding only Hyalinized Stroma Formation) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Trabecular Pattern) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor SubClassOf Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell</Axiom>
               </Source>
               <New_Terms>Thyroglobulin Positive Neoplastic Cells Present</New_Terms>
            </Change>
            <Change id="54">
               <Axiom>Reactive C-Cell Hyperplasia EquivalentTo C-Cell Hyperplasia and Non-Neoplastic Endocrine Disorder and Non-Neoplastic Thyroid Gland Disorder and (Disease_Excludes_Abnormal_Cell only Neoplastic C-Cell)</Axiom>
               <Source>
                  <Axiom>Reactive C-Cell Hyperplasia SubClassOf Non-Neoplastic Thyroid Gland Disorder</Axiom>
               </Source>
               <New_Terms>Neoplastic C-Cell</New_Terms>
            </Change>
            <Change id="55">
               <Axiom>Clear Cell Variant Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Clear Cell)</Axiom>
               <Source>
                  <Axiom>Clear Cell Variant Thyroid Gland Follicular Carcinoma SubClassOf Thyroid Gland Follicular Carcinoma</Axiom>
               </Source>
               <New_Terms>Malignant Thyroid Gland Follicular Clear Cell</New_Terms>
            </Change>
            <Change id="56">
               <Axiom>Macrofollicular Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_Excludes_Finding only Papillary Pattern) and (Disease_Has_Finding only Macrofollicular Structures Present) and (Disease_Has_Finding only Nuclear Clearing)</Axiom>
               <Source>
                  <Axiom>Macrofollicular Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
               <New_Terms>Nuclear Clearing, Macrofollicular Structures Present</New_Terms>
            </Change>
            <Change id="57">
               <Axiom>Thyroid Gland Teratoma EquivalentTo Teratoma and Thyroid Gland Neoplasm and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Hoarseness) and (Disease_Has_Finding only Multicystic Lesion) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Teratoma SubClassOf Teratoma</Axiom>
               </Source>
               <New_Terms>Hoarseness</New_Terms>
            </Change>
            <Change id="58">
               <Axiom>Thyroid Gland Adenocarcinoma EquivalentTo Adenocarcinoma and Common Carcinoma and Malignant Endocrine Neoplasm and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cold Nodule) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Adenocarcinoma SubClassOf Thyroid Gland Carcinoma</Axiom>
               </Source>
               <New_Terms>Thyroglobulin Positive Neoplastic Cells Present</New_Terms>
            </Change>
            <Change id="59">
               <Axiom>Differentiated Thyroid Gland Carcinoma EquivalentTo Thyroid Gland Adenocarcinoma and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Has_Finding only Follicular Cell Differentiation)</Axiom>
               <Source>
                  <Axiom>Differentiated Thyroid Gland Carcinoma SubClassOf Thyroid Gland Adenocarcinoma</Axiom>
               </Source>
               <New_Terms>Follicular Cell Differentiation</New_Terms>
            </Change>
            <Change id="60">
               <Axiom>Thyroid Gland Carcinoma Showing Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Epithelial Spindle Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Squamoid Cell) and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Metastatic Neoplasm to the Lymph Node) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Desmoplastic Stroma Formation)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Carcinoma Showing Thymus-Like Differentiation SubClassOf Thyroid Gland Carcinoma</Axiom>
               </Source>
               <New_Terms>Calcitonin Positive Neoplastic Cells Present, Malignant Squamoid Cell, Thyroglobulin Positive Neoplastic Cells Present</New_Terms>
            </Change>
            <Change id="61">
               <Axiom>Columnar Cell Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Papillary Pattern) and (Disease_Has_Finding only Pseudostratified Columnar Tumor Cells Present)</Axiom>
               <Source>
                  <Axiom>Columnar Cell Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
               </Source>
               <New_Terms>Follicular Structures Present, Pseudostratified Columnar Tumor Cells Present</New_Terms>
            </Change>
            <Change id="62">
               <Axiom>Thyroid Gland Squamous Cell Carcinoma EquivalentTo Squamous Cell Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Squamous Cell Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation</Axiom>
               </Source>
               <New_Terms>Calcitonin Positive Neoplastic Cells Present, Thyroglobulin Positive Neoplastic Cells Present</New_Terms>
            </Change>
            <Change id="63">
               <Axiom>Thyroid Gland Undifferentiated Carcinoma, Osteoclastic Variant EquivalentTo Thyroid Gland Undifferentiated (Anaplastic) Carcinoma and (Disease_Has_Abnormal_Cell only Non-Neoplastic Osteoclast-Like Giant Cell)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Undifferentiated Carcinoma, Osteoclastic Variant SubClassOf Thyroid Gland Undifferentiated (Anaplastic) Carcinoma</Axiom>
               </Source>
               <New_Terms>Non-Neoplastic Osteoclast-Like Giant Cell</New_Terms>
            </Change>
            <Change id="64">
               <Axiom>Thyroid Gland Carcinoma EquivalentTo Malignant Thyroid Gland Neoplasm and Neck Carcinoma and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Epithelial Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Carcinoma SubClassOf Disease_Has_Primary_Anatomic_Site only Thyroid Gland</Axiom>
               </Source>
               <New_Terms>Thyroid Gland Epithelial Tissue</New_Terms>
            </Change>
            <Change id="65">
               <Axiom>Thyroid Gland Signet Ring Cell Follicular Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Signet Ring Cell)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Signet Ring Cell Follicular Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
               </Source>
               <New_Terms>Neoplastic Thyroid Gland Follicular Signet Ring Cell</New_Terms>
            </Change>
            <Change id="66">
               <Axiom>Thyroid Gland Clear Cell Follicular Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Clear Cell)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Clear Cell Follicular Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
               </Source>
               <New_Terms>Neoplastic Thyroid Gland Follicular Clear Cell</New_Terms>
            </Change>
         </StrengtheningWithNewTerms>
         <NewDescription id="newdesc" size="399">
            <Change id="67">
               <Axiom>Km SubClassOf Physical Phenomenon or Property</Axiom>
               <New_Terms>Km</New_Terms>
            </Change>
            <Change id="68">
               <Axiom>Complex SubClassOf General Qualifier</Axiom>
               <New_Terms>Complex</New_Terms>
            </Change>
            <Change id="69">
               <Axiom>Embed SubClassOf Techniques</Axiom>
               <New_Terms>Embed</New_Terms>
            </Change>
            <Change id="70">
               <Axiom>Neoplastic Thyroid Gland Follicular Signet Ring Cell SubClassOf Neoplastic Thyroid Gland Follicular Cell</Axiom>
               <New_Terms>Neoplastic Thyroid Gland Follicular Signet Ring Cell</New_Terms>
            </Change>
            <Change id="71">
               <Axiom>Metropolitan France SubClassOf Geographic Area</Axiom>
               <New_Terms>Metropolitan France</New_Terms>
            </Change>
            <Change id="72">
               <Axiom>Centroid SubClassOf General Qualifier</Axiom>
               <New_Terms>Centroid</New_Terms>
            </Change>
            <Change id="73">
               <Axiom>Poultice Dosage Form SubClassOf Solid Dosage Form</Axiom>
               <New_Terms>Poultice Dosage Form</New_Terms>
            </Change>
            <Change id="74">
               <Axiom>Norepinephrine Bitartrate SubClassOf Adrenal Hormone</Axiom>
               <New_Terms>Norepinephrine Bitartrate</New_Terms>
            </Change>
            <Change id="75">
               <Axiom>Protein Turn SubClassOf Secondary Protein Structure</Axiom>
               <New_Terms>Protein Turn</New_Terms>
            </Change>
            <Change id="76">
               <Axiom>Betamethasone Valerate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Betamethasone Valerate</New_Terms>
            </Change>
            <Change id="77">
               <Axiom>Aminosalicylate Sodium SubClassOf Antitubercular Agent</Axiom>
               <New_Terms>Aminosalicylate Sodium</New_Terms>
            </Change>
            <Change id="78">
               <Axiom>Paget's Disease of the Breast SubClassOf Paget's Disease</Axiom>
               <New_Terms>Paget's Disease of the Breast</New_Terms>
            </Change>
            <Change id="79">
               <Axiom>Malignant Cuboidal Mucous Cell SubClassOf Mucin-Producing Neoplastic Epithelial Cell</Axiom>
               <New_Terms>Malignant Cuboidal Mucous Cell</New_Terms>
            </Change>
            <Change id="80">
               <Axiom>Neoplastic Thyroid Gland Follicular Cell with Large and Hyperchromatic Nucleus SubClassOf Neoplastic Thyroid Gland Follicular Cell</Axiom>
               <New_Terms>Neoplastic Thyroid Gland Follicular Cell with Large and Hyperchromatic Nucleus</New_Terms>
            </Change>
            <Change id="81">
               <Axiom>Tamoxifen Citrate SubClassOf Protein Kinase C Inhibitor</Axiom>
               <New_Terms>Tamoxifen Citrate</New_Terms>
            </Change>
            <Change id="82">
               <Axiom>Magnesium Acetate Tetrahydrate SubClassOf Nutritional Supplement</Axiom>
               <New_Terms>Magnesium Acetate Tetrahydrate</New_Terms>
            </Change>
            <Change id="83">
               <Axiom>Chloramphenicol Sodium Succinate SubClassOf Antibiotic</Axiom>
               <New_Terms>Chloramphenicol Sodium Succinate</New_Terms>
            </Change>
            <Change id="84">
               <Axiom>Postcondition SubClassOf Logical Condition</Axiom>
               <New_Terms>Postcondition, Logical Condition</New_Terms>
            </Change>
            <Change id="85">
               <Axiom>Breast Carcinoma with Osseous Metaplasia SubClassOf Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma</Axiom>
               <New_Terms>Breast Carcinoma with Osseous Metaplasia</New_Terms>
            </Change>
            <Change id="86">
               <Axiom>Ordinal Scale SubClassOf Scale</Axiom>
               <New_Terms>Ordinal Scale</New_Terms>
            </Change>
            <Change id="87">
               <Axiom>Thyroid Gland Epithelial Tissue SubClassOf Epithelial Tissue</Axiom>
               <New_Terms>Thyroid Gland Epithelial Tissue</New_Terms>
            </Change>
            <Change id="88">
               <Axiom>Cefazolin Sodium SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cefazolin Sodium</New_Terms>
            </Change>
            <Change id="89">
               <Axiom>Imatinib Mesylate SubClassOf Tyrosine Kinase Inhibitor</Axiom>
               <New_Terms>Imatinib Mesylate</New_Terms>
            </Change>
            <Change id="90">
               <Axiom>Atazanavir Sulfate SubClassOf Protease Inhibitor</Axiom>
               <New_Terms>Atazanavir Sulfate</New_Terms>
            </Change>
            <Change id="91">
               <Axiom>Three Dimensional Size SubClassOf Size</Axiom>
               <New_Terms>Three Dimensional Size</New_Terms>
            </Change>
            <Change id="92">
               <Axiom>Epirubicin Hydrochloride SubClassOf Anthracycline Antibiotic</Axiom>
               <New_Terms>Epirubicin Hydrochloride</New_Terms>
            </Change>
            <Change id="93">
               <Axiom>Levothyroxine Sodium SubClassOf Thyroid Agent</Axiom>
               <New_Terms>Levothyroxine Sodium</New_Terms>
            </Change>
            <Change id="94">
               <Axiom>Run SubClassOf Clinical or Research Activity</Axiom>
               <New_Terms>Run</New_Terms>
            </Change>
            <Change id="95">
               <Axiom>Mexiletine Hydrochloride SubClassOf Adjuvant Analgesic</Axiom>
               <New_Terms>Mexiletine Hydrochloride</New_Terms>
            </Change>
            <Change id="96">
               <Axiom>Vacuum-Assisted Biopsy SubClassOf Needle Biopsy</Axiom>
               <New_Terms>Vacuum-Assisted Biopsy</New_Terms>
            </Change>
            <Change id="97">
               <Axiom>Proprotein SubClassOf Miscellaneous Molecular Biology Terms</Axiom>
               <New_Terms>Proprotein</New_Terms>
            </Change>
            <Change id="98">
               <Axiom>Chlorhexidine Gluconate SubClassOf Miscellaneous Antibiotic</Axiom>
               <New_Terms>Chlorhexidine Gluconate</New_Terms>
            </Change>
            <Change id="99">
               <Axiom>Microcalcification Present in Neoplastic and Non-Neoplastic Tissue SubClassOf Microcalcification</Axiom>
               <New_Terms>Microcalcification Present in Neoplastic and Non-Neoplastic Tissue</New_Terms>
            </Change>
            <Change id="100">
               <Axiom>Minute SubClassOf Unit of Time</Axiom>
               <New_Terms>Minute</New_Terms>
            </Change>
            <Change id="101">
               <Axiom>Hydrocodone Bitartrate SubClassOf Opioid</Axiom>
               <New_Terms>Hydrocodone Bitartrate</New_Terms>
            </Change>
            <Change id="102">
               <Axiom>Routine Signature SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Routine Signature</New_Terms>
            </Change>
            <Change id="103">
               <Axiom>Sponge Dosage Form SubClassOf Solid Dosage Form</Axiom>
               <New_Terms>Sponge Dosage Form</New_Terms>
            </Change>
            <Change id="104">
               <Axiom>Daunorubicin Hydrochloride SubClassOf Anthracycline Antibiotic</Axiom>
               <New_Terms>Daunorubicin Hydrochloride</New_Terms>
            </Change>
            <Change id="105">
               <Axiom>Riboflavin Phosphate Sodium SubClassOf B Vitamin</Axiom>
               <New_Terms>Riboflavin Phosphate Sodium</New_Terms>
            </Change>
            <Change id="106">
               <Axiom>Serum Calcitonin Level Increased SubClassOf Abnormal Blood and Hematology Test Result</Axiom>
               <New_Terms>Serum Calcitonin Level Increased</New_Terms>
            </Change>
            <Change id="107">
               <Axiom>Web Service Definition Language SubClassOf Extensible Markup Language</Axiom>
               <New_Terms>Web Service Definition Language</New_Terms>
            </Change>
            <Change id="108">
               <Axiom>Calcitonin Positive Neoplastic Cells Present SubClassOf Positive Immunophenotypic Test Result</Axiom>
               <New_Terms>Calcitonin Positive Neoplastic Cells Present</New_Terms>
            </Change>
            <Change id="109">
               <Axiom>Azathioprine Sodium SubClassOf Immunosuppressant</Axiom>
               <New_Terms>Azathioprine Sodium</New_Terms>
            </Change>
            <Change id="110">
               <Axiom>Adefovir Dipivoxil SubClassOf Reverse Transcriptase Inhibitor</Axiom>
               <New_Terms>Adefovir Dipivoxil</New_Terms>
            </Change>
            <Change id="111">
               <Axiom>Cefamandole Nafate SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cefamandole Nafate</New_Terms>
            </Change>
            <Change id="112">
               <Axiom>Ceftazidime Sodium SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Ceftazidime Sodium</New_Terms>
            </Change>
            <Change id="113">
               <Axiom>Scalar SubClassOf Data Type</Axiom>
               <New_Terms>Scalar</New_Terms>
            </Change>
            <Change id="114">
               <Axiom>Cephradine Monohydrate SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cephradine Monohydrate</New_Terms>
            </Change>
            <Change id="115">
               <Axiom>Default SubClassOf General Qualifier</Axiom>
               <New_Terms>Default</New_Terms>
            </Change>
            <Change id="116">
               <Axiom>Mitotic Count SubClassOf General Qualifier</Axiom>
               <New_Terms>Mitotic Count</New_Terms>
            </Change>
            <Change id="117">
               <Axiom>Base SubClassOf General Qualifier</Axiom>
               <New_Terms>Base</New_Terms>
            </Change>
            <Change id="118">
               <Axiom>Clindamycin Phosphate SubClassOf Miscellaneous Antibiotic</Axiom>
               <New_Terms>Clindamycin Phosphate</New_Terms>
            </Change>
            <Change id="119">
               <Axiom>Patch SubClassOf Drug Delivery System</Axiom>
               <New_Terms>Patch</New_Terms>
            </Change>
            <Change id="120">
               <Axiom>FASTA Format SubClassOf Format</Axiom>
               <New_Terms>FASTA Format</New_Terms>
            </Change>
            <Change id="121">
               <Axiom>Neoplastic Thyroid Gland Follicular Clear Cell SubClassOf Neoplastic Endocrine Clear Cell</Axiom>
               <New_Terms>Neoplastic Thyroid Gland Follicular Clear Cell</New_Terms>
            </Change>
            <Change id="122">
               <Axiom>Contract SubClassOf Document</Axiom>
               <New_Terms>Contract</New_Terms>
            </Change>
            <Change id="123">
               <Axiom>Transit Peptide SubClassOf Protein Sequence</Axiom>
               <New_Terms>Transit Peptide</New_Terms>
            </Change>
            <Change id="124">
               <Axiom>Ampicillin Trihydrate SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Ampicillin Trihydrate</New_Terms>
            </Change>
            <Change id="125">
               <Axiom>10q23.33 SubClassOf Chromosome Band</Axiom>
               <New_Terms>10q23.33</New_Terms>
            </Change>
            <Change id="126">
               <Axiom>Vacuum-Assisted Biopsy SubClassOf Image Guided Biopsy</Axiom>
               <New_Terms>Vacuum-Assisted Biopsy</New_Terms>
            </Change>
            <Change id="127">
               <Axiom>Norethindrone Acetate SubClassOf Therapeutic Progestin</Axiom>
               <New_Terms>Norethindrone Acetate</New_Terms>
            </Change>
            <Change id="128">
               <Axiom>Granisetron Hydrochloride SubClassOf Antiemetic Agent</Axiom>
               <New_Terms>Granisetron Hydrochloride</New_Terms>
            </Change>
            <Change id="129">
               <Axiom>Hydrocortisone Butyrate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Hydrocortisone Butyrate</New_Terms>
            </Change>
            <Change id="130">
               <Axiom>Nortriptyline Hydrochloride SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Nortriptyline Hydrochloride</New_Terms>
            </Change>
            <Change id="131">
               <Axiom>Estradiol Acetate SubClassOf Estrogen</Axiom>
               <New_Terms>Estradiol Acetate</New_Terms>
            </Change>
            <Change id="132">
               <Axiom>Acebutolol Hydrochloride SubClassOf Beta-Adrenergic Antagonist</Axiom>
               <New_Terms>Acebutolol Hydrochloride</New_Terms>
            </Change>
            <Change id="133">
               <Axiom>Cevimeline Hydrochloride SubClassOf Miscellaneous Chemoprotective Agent</Axiom>
               <New_Terms>Cevimeline Hydrochloride</New_Terms>
            </Change>
            <Change id="134">
               <Axiom>Base 64 SubClassOf Format</Axiom>
               <New_Terms>Base 64</New_Terms>
            </Change>
            <Change id="135">
               <Axiom>Donepezil Hydrochloride SubClassOf Miscellaneous Adjuvant</Axiom>
               <New_Terms>Donepezil Hydrochloride</New_Terms>
            </Change>
            <Change id="136">
               <Axiom>Microcalcification Present in Non-Neoplastic Tissue SubClassOf Microcalcification</Axiom>
               <New_Terms>Microcalcification Present in Non-Neoplastic Tissue</New_Terms>
            </Change>
            <Change id="137">
               <Axiom>Malignant Goblet-Like Mucous Cell SubClassOf Mucin-Producing Neoplastic Epithelial Cell</Axiom>
               <New_Terms>Malignant Goblet-Like Mucous Cell</New_Terms>
            </Change>
            <Change id="138">
               <Axiom>Betamethasone Dipropionate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Betamethasone Dipropionate</New_Terms>
            </Change>
            <Change id="139">
               <Axiom>Nafcillin Sodium SubClassOf Beta-Lactam Antibiotic</Axiom>
               <New_Terms>Nafcillin Sodium</New_Terms>
            </Change>
            <Change id="140">
               <Axiom>Mechlorethamine Hydrochloride SubClassOf Nitrogen Mustard Compound</Axiom>
               <New_Terms>Mechlorethamine Hydrochloride</New_Terms>
            </Change>
            <Change id="141">
               <Axiom>Gemcitabine Hydrochloride SubClassOf Pyrimidine Antagonist</Axiom>
               <New_Terms>Gemcitabine Hydrochloride</New_Terms>
            </Change>
            <Change id="142">
               <Axiom>Collision SubClassOf Physical Phenomenon or Property</Axiom>
               <New_Terms>Collision</New_Terms>
            </Change>
            <Change id="143">
               <Axiom>Diclofenac Sodium SubClassOf Cyclooxygenase Inhibitor</Axiom>
               <New_Terms>Diclofenac Sodium</New_Terms>
            </Change>
            <Change id="144">
               <Axiom>Terbinafine SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Terbinafine</New_Terms>
            </Change>
            <Change id="145">
               <Axiom>Sodium Acetate, Anhydrous SubClassOf Drug Vehicle</Axiom>
               <New_Terms>Sodium Acetate, Anhydrous</New_Terms>
            </Change>
            <Change id="146">
               <Axiom>Tetracycline Hydrochloride SubClassOf Tetracycline Antibiotic</Axiom>
               <New_Terms>Tetracycline Hydrochloride</New_Terms>
            </Change>
            <Change id="147">
               <Axiom>Follicular Structures Present SubClassOf Morphologic Finding</Axiom>
               <New_Terms>Follicular Structures Present</New_Terms>
            </Change>
            <Change id="148">
               <Axiom>Generation SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Generation</New_Terms>
            </Change>
            <Change id="149">
               <Axiom>Output SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Output</New_Terms>
            </Change>
            <Change id="150">
               <Axiom>Force SubClassOf Physical Phenomenon or Property</Axiom>
               <New_Terms>Force</New_Terms>
            </Change>
            <Change id="151">
               <Axiom>Hydrocortisone Probutate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Hydrocortisone Probutate</New_Terms>
            </Change>
            <Change id="152">
               <Axiom>Amikacin Sulfate SubClassOf Aminoglycoside Antibiotic</Axiom>
               <New_Terms>Amikacin Sulfate</New_Terms>
            </Change>
            <Change id="153">
               <Axiom>Malignant Endothelial Cell SubClassOf Neoplastic Endothelial Cell</Axiom>
               <New_Terms>Malignant Endothelial Cell</New_Terms>
            </Change>
            <Change id="154">
               <Axiom>Intrauterine Device Dosage Form SubClassOf Solid Dosage Form</Axiom>
               <New_Terms>Intrauterine Device Dosage Form</New_Terms>
            </Change>
            <Change id="155">
               <Axiom>Valproate Sodium SubClassOf Anticonvulsant Agent</Axiom>
               <New_Terms>Valproate Sodium</New_Terms>
            </Change>
            <Change id="156">
               <Axiom>Melphalan Hydrochloride SubClassOf Nitrogen Mustard Compound</Axiom>
               <New_Terms>Melphalan Hydrochloride</New_Terms>
            </Change>
            <Change id="157">
               <Axiom>Ampicillin Sodium SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Ampicillin Sodium</New_Terms>
            </Change>
            <Change id="158">
               <Axiom>Life Sciences Identifier SubClassOf Identifier</Axiom>
               <New_Terms>Life Sciences Identifier</New_Terms>
            </Change>
            <Change id="159">
               <Axiom>Flurbiprofen Sodium SubClassOf Cyclooxygenase Inhibitor</Axiom>
               <New_Terms>Flurbiprofen Sodium</New_Terms>
            </Change>
            <Change id="160">
               <Axiom>Mitoxantrone Hydrochloride SubClassOf Anthraquinone Compound</Axiom>
               <New_Terms>Mitoxantrone Hydrochloride</New_Terms>
            </Change>
            <Change id="161">
               <Axiom>Clonidine Hydrochloride SubClassOf Adjuvant Analgesic</Axiom>
               <New_Terms>Clonidine Hydrochloride</New_Terms>
            </Change>
            <Change id="162">
               <Axiom>Neoplastic C-Cell SubClassOf Neoplastic Neuroendocrine Cell</Axiom>
               <New_Terms>Neoplastic C-Cell</New_Terms>
            </Change>
            <Change id="163">
               <Axiom>Pravastatin Sodium SubClassOf HMG-CoA Reductase Inhibitor</Axiom>
               <New_Terms>Pravastatin Sodium</New_Terms>
            </Change>
            <Change id="164">
               <Axiom>Mass Analyzer SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
               <New_Terms>Mass Analyzer</New_Terms>
            </Change>
            <Change id="165">
               <Axiom>Charge SubClassOf Characteristic</Axiom>
               <New_Terms>Charge</New_Terms>
            </Change>
            <Change id="166">
               <Axiom>Morphine Sulfate SubClassOf Opiate</Axiom>
               <New_Terms>Morphine Sulfate</New_Terms>
            </Change>
            <Change id="167">
               <Axiom>7q21-q22.1 SubClassOf Chromosome Band</Axiom>
               <New_Terms>7q21-q22.1</New_Terms>
            </Change>
            <Change id="168">
               <Axiom>Chlordiazepoxide Hydrochloride SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Chlordiazepoxide Hydrochloride</New_Terms>
            </Change>
            <Change id="169">
               <Axiom>Pilocarpine Hydrochloride SubClassOf Miscellaneous Chemoprotective Agent</Axiom>
               <New_Terms>Pilocarpine Hydrochloride</New_Terms>
            </Change>
            <Change id="170">
               <Axiom>Pseudostratified Columnar Tumor Cells Present SubClassOf Morphologic Finding</Axiom>
               <New_Terms>Pseudostratified Columnar Tumor Cells Present</New_Terms>
            </Change>
            <Change id="171">
               <Axiom>Metronidazole Hydrochloride SubClassOf Protein Synthesis Inhibitor</Axiom>
               <New_Terms>Metronidazole Hydrochloride</New_Terms>
            </Change>
            <Change id="172">
               <Axiom>Paget's Disease of the Breast without Invasive Carcinoma SubClassOf Paget's Disease of the Breast</Axiom>
               <New_Terms>Paget's Disease of the Breast, Paget's Disease of the Breast without Invasive Carcinoma</New_Terms>
            </Change>
            <Change id="173">
               <Axiom>Swab Dosage Form SubClassOf Solid Dosage Form</Axiom>
               <New_Terms>Swab Dosage Form</New_Terms>
            </Change>
            <Change id="174">
               <Axiom>Pyridoxine Hydrochloride SubClassOf Miscellaneous Chemoprotective Agent</Axiom>
               <New_Terms>Pyridoxine Hydrochloride</New_Terms>
            </Change>
            <Change id="175">
               <Axiom>Resolution SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Resolution</New_Terms>
            </Change>
            <Change id="176">
               <Axiom>Prochlorperazine Edisylate SubClassOf Phenothiazine</Axiom>
               <New_Terms>Prochlorperazine Edisylate</New_Terms>
            </Change>
            <Change id="177">
               <Axiom>Epinephrine Bitartrate SubClassOf Adrenal Agent</Axiom>
               <New_Terms>Epinephrine Bitartrate</New_Terms>
            </Change>
            <Change id="178">
               <Axiom>Naproxen Sodium SubClassOf Cyclooxygenase Inhibitor</Axiom>
               <New_Terms>Naproxen Sodium</New_Terms>
            </Change>
            <Change id="179">
               <Axiom>Ciprofloxacin Hydrochloride SubClassOf Quinolone Antibiotic</Axiom>
               <New_Terms>Ciprofloxacin Hydrochloride</New_Terms>
            </Change>
            <Change id="180">
               <Axiom>QS Wave SubClassOf Electrocardiographic Finding</Axiom>
               <New_Terms>QS Wave</New_Terms>
            </Change>
            <Change id="181">
               <Axiom>Sentinel Lymph Node Biopsy with Axillary Lymph Node Dissection SubClassOf Axillary Lymph Node Dissection</Axiom>
               <New_Terms>Sentinel Lymph Node Biopsy with Axillary Lymph Node Dissection</New_Terms>
            </Change>
            <Change id="182">
               <Axiom>Precondition SubClassOf Logical Condition</Axiom>
               <New_Terms>Logical Condition, Precondition</New_Terms>
            </Change>
            <Change id="183">
               <Axiom>Mass-to-Charge Ratio SubClassOf Physical Phenomenon or Property</Axiom>
               <New_Terms>Mass-to-Charge Ratio</New_Terms>
            </Change>
            <Change id="184">
               <Axiom>Test SubClassOf Techniques</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="185">
               <Axiom>Sodium Phenylbutyrate SubClassOf Histone Deacetylase Inhibitor</Axiom>
               <New_Terms>Sodium Phenylbutyrate</New_Terms>
            </Change>
            <Change id="186">
               <Axiom>Precision SubClassOf Characteristic</Axiom>
               <New_Terms>Precision</New_Terms>
            </Change>
            <Change id="187">
               <Axiom>Build SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Build</New_Terms>
            </Change>
            <Change id="188">
               <Axiom>Packing Dosage Form SubClassOf Solid Dosage Form</Axiom>
               <New_Terms>Packing Dosage Form</New_Terms>
            </Change>
            <Change id="189">
               <Axiom>Betamethasone Sodium Phosphate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Betamethasone Sodium Phosphate</New_Terms>
            </Change>
            <Change id="190">
               <Axiom>Means SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Means</New_Terms>
            </Change>
            <Change id="191">
               <Axiom>Acid SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
               <New_Terms>Acid</New_Terms>
            </Change>
            <Change id="192">
               <Axiom>Communication Contact SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Communication Contact</New_Terms>
            </Change>
            <Change id="193">
               <Axiom>Thyroid Gland Epithelial Tissue SubClassOf Thyroid Gland Tissue</Axiom>
               <New_Terms>Thyroid Gland Epithelial Tissue</New_Terms>
            </Change>
            <Change id="194">
               <Axiom>Penicillin V Potassium SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Penicillin V Potassium</New_Terms>
            </Change>
            <Change id="195">
               <Axiom>Ratio Scale SubClassOf Scale</Axiom>
               <New_Terms>Ratio Scale</New_Terms>
            </Change>
            <Change id="196">
               <Axiom>Cephalexin Hydrochloride SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cephalexin Hydrochloride</New_Terms>
            </Change>
            <Change id="197">
               <Axiom>Primaquine Phosphate SubClassOf Antimalarial Agent</Axiom>
               <New_Terms>Primaquine Phosphate</New_Terms>
            </Change>
            <Change id="198">
               <Axiom>Erythromycin Estolate SubClassOf Macrolide Antibiotic</Axiom>
               <New_Terms>Erythromycin Estolate</New_Terms>
            </Change>
            <Change id="199">
               <Axiom>Routine SubClassOf Clinical or Research Activity</Axiom>
               <New_Terms>Routine</New_Terms>
            </Change>
            <Change id="200">
               <Axiom>Cancer Research Group SubClassOf Professional Organization or Group</Axiom>
               <New_Terms>Cancer Research Group</New_Terms>
            </Change>
            <Change id="201">
               <Axiom>Female-to-Male Transsexual Phenotype SubClassOf General Qualifier</Axiom>
               <New_Terms>Female-to-Male Transsexual Phenotype</New_Terms>
            </Change>
            <Change id="202">
               <Axiom>Tobramycin Sulfate SubClassOf Aminoglycoside Antibiotic</Axiom>
               <New_Terms>Tobramycin Sulfate</New_Terms>
            </Change>
            <Change id="203">
               <Axiom>Synoptic Surgical Pathology Report SubClassOf Surgical Pathology Report</Axiom>
               <New_Terms>Synoptic Surgical Pathology Report</New_Terms>
            </Change>
            <Change id="204">
               <Axiom>Phosphorus SubClassOf Element</Axiom>
               <New_Terms>Phosphorus</New_Terms>
            </Change>
            <Change id="205">
               <Axiom>Warning SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Warning</New_Terms>
            </Change>
            <Change id="206">
               <Axiom>Embed SubClassOf Techniques</Axiom>
               <New_Terms>Embed</New_Terms>
            </Change>
            <Change id="207">
               <Axiom>Non-Negative Integer SubClassOf Integer</Axiom>
               <New_Terms>Non-Negative Integer</New_Terms>
            </Change>
            <Change id="208">
               <Axiom>Blood Chemistry Study SubClassOf Test</Axiom>
               <New_Terms>Test, Blood Chemistry Study</New_Terms>
            </Change>
            <Change id="209">
               <Axiom>Lidocaine Hydrochloride SubClassOf Anesthetic Agent</Axiom>
               <New_Terms>Lidocaine Hydrochloride</New_Terms>
            </Change>
            <Change id="210">
               <Axiom>Repeat SubClassOf Clinical or Research Activity</Axiom>
               <New_Terms>Repeat</New_Terms>
            </Change>
            <Change id="211">
               <Axiom>Hydrocortisone Valerate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Hydrocortisone Valerate</New_Terms>
            </Change>
            <Change id="212">
               <Axiom>Abacavir Sulfate SubClassOf Reverse Transcriptase Inhibitor</Axiom>
               <New_Terms>Abacavir Sulfate</New_Terms>
            </Change>
            <Change id="213">
               <Axiom>Estradiol Cypionate SubClassOf Estrogen</Axiom>
               <New_Terms>Estradiol Cypionate</New_Terms>
            </Change>
            <Change id="214">
               <Axiom>Mammotome Clip SubClassOf Medical Device</Axiom>
               <New_Terms>Mammotome Clip</New_Terms>
            </Change>
            <Change id="215">
               <Axiom>Scope SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Scope</New_Terms>
            </Change>
            <Change id="216">
               <Axiom>Haloperidol Decanoate SubClassOf Butyrophenone</Axiom>
               <New_Terms>Haloperidol Decanoate</New_Terms>
            </Change>
            <Change id="217">
               <Axiom>Pair SubClassOf General Qualifier</Axiom>
               <New_Terms>Pair</New_Terms>
            </Change>
            <Change id="218">
               <Axiom>Diffuse Lesion SubClassOf Lesion</Axiom>
               <New_Terms>Diffuse Lesion</New_Terms>
            </Change>
            <Change id="219">
               <Axiom>Hyoscyamine Sulfate SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Hyoscyamine Sulfate</New_Terms>
            </Change>
            <Change id="220">
               <Axiom>Repeat SubClassOf Clinical or Research Activity</Axiom>
               <New_Terms>Repeat</New_Terms>
            </Change>
            <Change id="221">
               <Axiom>Trifluoperazine Hydrochloride SubClassOf Multidrug Resistance Modulator</Axiom>
               <New_Terms>Trifluoperazine Hydrochloride</New_Terms>
            </Change>
            <Change id="222">
               <Axiom>Diatrizoate Meglumine SubClassOf Contrast Agent</Axiom>
               <New_Terms>Diatrizoate Meglumine</New_Terms>
            </Change>
            <Change id="223">
               <Axiom>Pyridoxine Hydrochloride SubClassOf B Vitamin</Axiom>
               <New_Terms>Pyridoxine Hydrochloride</New_Terms>
            </Change>
            <Change id="224">
               <Axiom>Imatinib Mesylate SubClassOf Signal Transduction Inhibitor</Axiom>
               <New_Terms>Imatinib Mesylate</New_Terms>
            </Change>
            <Change id="225">
               <Axiom>Polarity SubClassOf Characteristic</Axiom>
               <New_Terms>Polarity</New_Terms>
            </Change>
            <Change id="226">
               <Axiom>Nuclear Grooves SubClassOf Morphologic Finding</Axiom>
               <New_Terms>Nuclear Grooves</New_Terms>
            </Change>
            <Change id="227">
               <Axiom>Mass Spectrometer SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
               <New_Terms>Mass Spectrometer</New_Terms>
            </Change>
            <Change id="228">
               <Axiom>Offset SubClassOf Characteristic</Axiom>
               <New_Terms>Offset</New_Terms>
            </Change>
            <Change id="229">
               <Axiom>Procarbazine Hydrochloride SubClassOf Triazene Compound</Axiom>
               <New_Terms>Procarbazine Hydrochloride</New_Terms>
            </Change>
            <Change id="230">
               <Axiom>Hydromorphone Hydrochloride SubClassOf Opioid</Axiom>
               <New_Terms>Hydromorphone Hydrochloride</New_Terms>
            </Change>
            <Change id="231">
               <Axiom>Spotting SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Spotting</New_Terms>
            </Change>
            <Change id="232">
               <Axiom>Paget's Disease of the Breast SubClassOf Breast Adenocarcinoma</Axiom>
               <New_Terms>Paget's Disease of the Breast</New_Terms>
            </Change>
            <Change id="233">
               <Axiom>Spot SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Spot</New_Terms>
            </Change>
            <Change id="234">
               <Axiom>Fentanyl Citrate SubClassOf Opioid</Axiom>
               <New_Terms>Fentanyl Citrate</New_Terms>
            </Change>
            <Change id="235">
               <Axiom>Female-to-Male Transsexual Animal SubClassOf Laboratory Animal</Axiom>
               <New_Terms>Female-to-Male Transsexual Animal</New_Terms>
            </Change>
            <Change id="236">
               <Axiom>Estradiol Hemihydrate SubClassOf Estrogen</Axiom>
               <New_Terms>Estradiol Hemihydrate</New_Terms>
            </Change>
            <Change id="237">
               <Axiom>Programming Language SubClassOf Language</Axiom>
               <New_Terms>Programming Language</New_Terms>
            </Change>
            <Change id="238">
               <Axiom>Ethacrynate Sodium SubClassOf Multidrug Resistance Modulator</Axiom>
               <New_Terms>Ethacrynate Sodium</New_Terms>
            </Change>
            <Change id="239">
               <Axiom>Ionization SubClassOf Physical Phenomenon or Property</Axiom>
               <New_Terms>Ionization</New_Terms>
            </Change>
            <Change id="240">
               <Axiom>Malignant Thyroid Gland Follicular Clear Cell SubClassOf Malignant Thyroid Gland Follicular Cell</Axiom>
               <New_Terms>Malignant Thyroid Gland Follicular Clear Cell</New_Terms>
            </Change>
            <Change id="241">
               <Axiom>Dorzolamide Hydrochloride SubClassOf Carbonic Anhydrase Inhibitor</Axiom>
               <New_Terms>Dorzolamide Hydrochloride</New_Terms>
            </Change>
            <Change id="242">
               <Axiom>Statistical Markup Language SubClassOf Extensible Markup Language</Axiom>
               <New_Terms>Statistical Markup Language</New_Terms>
            </Change>
            <Change id="243">
               <Axiom>Sodium Phenylbutyrate SubClassOf Differentiation Inducer</Axiom>
               <New_Terms>Sodium Phenylbutyrate</New_Terms>
            </Change>
            <Change id="244">
               <Axiom>Diatrizoate Sodium SubClassOf Contrast Agent</Axiom>
               <New_Terms>Diatrizoate Sodium</New_Terms>
            </Change>
            <Change id="245">
               <Axiom>Nicardipine Hydrochloride SubClassOf Calcium Channel Blocker</Axiom>
               <New_Terms>Nicardipine Hydrochloride</New_Terms>
            </Change>
            <Change id="246">
               <Axiom>Project SubClassOf Clinical or Research Activity</Axiom>
               <New_Terms>Project</New_Terms>
            </Change>
            <Change id="247">
               <Axiom>Oxycodone Hydrochloride SubClassOf Opioid</Axiom>
               <New_Terms>Oxycodone Hydrochloride</New_Terms>
            </Change>
            <Change id="248">
               <Axiom>Interval Scale SubClassOf Scale</Axiom>
               <New_Terms>Interval Scale</New_Terms>
            </Change>
            <Change id="249">
               <Axiom>Operator SubClassOf Person</Axiom>
               <New_Terms>Operator</New_Terms>
            </Change>
            <Change id="250">
               <Axiom>Imipramine Hydrochloride SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Imipramine Hydrochloride</New_Terms>
            </Change>
            <Change id="251">
               <Axiom>Implementation SubClassOf Clinical or Research Activity</Axiom>
               <New_Terms>Implementation</New_Terms>
            </Change>
            <Change id="252">
               <Axiom>Fluphenazine Hydrochloride SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Fluphenazine Hydrochloride</New_Terms>
            </Change>
            <Change id="253">
               <Axiom>Precursor SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Precursor</New_Terms>
            </Change>
            <Change id="254">
               <Axiom>Ceftriaxone Sodium SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Ceftriaxone Sodium</New_Terms>
            </Change>
            <Change id="255">
               <Axiom>Methadone Hydrochloride SubClassOf Opioid</Axiom>
               <New_Terms>Methadone Hydrochloride</New_Terms>
            </Change>
            <Change id="256">
               <Axiom>Operating System SubClassOf Computer Program</Axiom>
               <New_Terms>Operating System</New_Terms>
            </Change>
            <Change id="257">
               <Axiom>Leuprolide Acetate SubClassOf Gonadotropin-Releasing Hormone Analog</Axiom>
               <New_Terms>Leuprolide Acetate</New_Terms>
            </Change>
            <Change id="258">
               <Axiom>Gemcitabine Hydrochloride SubClassOf Ribonucleotide Reductase Inhibitor</Axiom>
               <New_Terms>Gemcitabine Hydrochloride</New_Terms>
            </Change>
            <Change id="259">
               <Axiom>Dead Volume SubClassOf Volume</Axiom>
               <New_Terms>Dead Volume</New_Terms>
            </Change>
            <Change id="260">
               <Axiom>Blood Chemistry Study SubClassOf Lab Test</Axiom>
               <New_Terms>Blood Chemistry Study</New_Terms>
            </Change>
            <Change id="261">
               <Axiom>Malignant Thyroid Gland Follicular Clear Cell SubClassOf Adenocarcinoma Clear Cell</Axiom>
               <New_Terms>Malignant Thyroid Gland Follicular Clear Cell</New_Terms>
            </Change>
            <Change id="262">
               <Axiom>Malignant Neuroendocrine Round Cell SubClassOf Malignant Neuroendocrine Cell</Axiom>
               <New_Terms>Malignant Neuroendocrine Round Cell</New_Terms>
            </Change>
            <Change id="263">
               <Axiom>Thiethylperazine Maleate SubClassOf Antiemetic Agent</Axiom>
               <New_Terms>Thiethylperazine Maleate</New_Terms>
            </Change>
            <Change id="264">
               <Axiom>Dicloxacillin Sodium SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Dicloxacillin Sodium</New_Terms>
            </Change>
            <Change id="265">
               <Axiom>Methylprednisolone Acetate SubClassOf Antiemetic Agent</Axiom>
               <New_Terms>Methylprednisolone Acetate</New_Terms>
            </Change>
            <Change id="266">
               <Axiom>Kit Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
               <New_Terms>Kit Dosage Form</New_Terms>
            </Change>
            <Change id="267">
               <Axiom>Compiler SubClassOf Computer Program</Axiom>
               <New_Terms>Compiler</New_Terms>
            </Change>
            <Change id="268">
               <Axiom>Indomethacin Sodium SubClassOf Cyclooxygenase Inhibitor</Axiom>
               <New_Terms>Indomethacin Sodium</New_Terms>
            </Change>
            <Change id="269">
               <Axiom>Oxaprozin Potassium SubClassOf Cyclooxygenase Inhibitor</Axiom>
               <New_Terms>Oxaprozin Potassium</New_Terms>
            </Change>
            <Change id="270">
               <Axiom>Name-Value Pair SubClassOf UML Entity</Axiom>
               <New_Terms>Name-Value Pair</New_Terms>
            </Change>
            <Change id="271">
               <Axiom>Clindamycin Hydrochloride SubClassOf Miscellaneous Antibiotic</Axiom>
               <New_Terms>Clindamycin Hydrochloride</New_Terms>
            </Change>
            <Change id="272">
               <Axiom>Fludrocortisone Acetate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Fludrocortisone Acetate</New_Terms>
            </Change>
            <Change id="273">
               <Axiom>Vmax SubClassOf Physical Phenomenon or Property</Axiom>
               <New_Terms>Vmax</New_Terms>
            </Change>
            <Change id="274">
               <Axiom>Piperacillin Sodium SubClassOf Extended Spectrum Penicillin Antibiotic</Axiom>
               <New_Terms>Piperacillin Sodium</New_Terms>
            </Change>
            <Change id="275">
               <Axiom>Erythromycin Ethylsuccinate SubClassOf Macrolide Antibiotic</Axiom>
               <New_Terms>Erythromycin Ethylsuccinate</New_Terms>
            </Change>
            <Change id="276">
               <Axiom>Base SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
               <New_Terms>Base</New_Terms>
            </Change>
            <Change id="277">
               <Axiom>Buspirone Hydrochloride SubClassOf Adjuvant Analgesic</Axiom>
               <New_Terms>Buspirone Hydrochloride</New_Terms>
            </Change>
            <Change id="278">
               <Axiom>Norepinephrine Bitartrate SubClassOf Neurotransmitter</Axiom>
               <New_Terms>Norepinephrine Bitartrate</New_Terms>
            </Change>
            <Change id="279">
               <Axiom>Mass Spectrometry Markup Language SubClassOf Extensible Markup Language</Axiom>
               <New_Terms>Mass Spectrometry Markup Language</New_Terms>
            </Change>
            <Change id="280">
               <Axiom>Vocal Cord Paralysis SubClassOf Motor Manifestations</Axiom>
               <New_Terms>Vocal Cord Paralysis</New_Terms>
            </Change>
            <Change id="281">
               <Axiom>Genomic Molecule Entity SubClassOf Miscellaneous Molecular Biology Terms</Axiom>
               <New_Terms>Genomic Molecule Entity</New_Terms>
            </Change>
            <Change id="282">
               <Axiom>Initiation SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Initiation</New_Terms>
            </Change>
            <Change id="283">
               <Axiom>Diclofenac Potassium SubClassOf Cyclooxygenase Inhibitor</Axiom>
               <New_Terms>Diclofenac Potassium</New_Terms>
            </Change>
            <Change id="284">
               <Axiom>Quinidine Gluconate SubClassOf Multidrug Resistance Modulator</Axiom>
               <New_Terms>Quinidine Gluconate</New_Terms>
            </Change>
            <Change id="285">
               <Axiom>Cutoff SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Cutoff</New_Terms>
            </Change>
            <Change id="286">
               <Axiom>Arginine Hydrochloride SubClassOf Non-Essential Amino Acid</Axiom>
               <New_Terms>Arginine Hydrochloride</New_Terms>
            </Change>
            <Change id="287">
               <Axiom>Increment SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Increment</New_Terms>
            </Change>
            <Change id="288">
               <Axiom>Freezing SubClassOf Techniques</Axiom>
               <New_Terms>Freezing</New_Terms>
            </Change>
            <Change id="289">
               <Axiom>Follicular Cell Differentiation SubClassOf Epithelial Differentiation</Axiom>
               <New_Terms>Follicular Cell Differentiation</New_Terms>
            </Change>
            <Change id="290">
               <Axiom>Tape Dosage Form SubClassOf Solid Dosage Form</Axiom>
               <New_Terms>Tape Dosage Form</New_Terms>
            </Change>
            <Change id="291">
               <Axiom>Microfollicular Structures Present SubClassOf Follicular Structures Present</Axiom>
               <New_Terms>Microfollicular Structures Present, Follicular Structures Present</New_Terms>
            </Change>
            <Change id="292">
               <Axiom>Diphenoxylate Hydrochloride SubClassOf Antidiarrheal Agent</Axiom>
               <New_Terms>Diphenoxylate Hydrochloride</New_Terms>
            </Change>
            <Change id="293">
               <Axiom>Plate SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
               <New_Terms>Plate</New_Terms>
            </Change>
            <Change id="294">
               <Axiom>Methylprednisolone Sodium Succinate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Methylprednisolone Sodium Succinate</New_Terms>
            </Change>
            <Change id="295">
               <Axiom>Simple SubClassOf General Qualifier</Axiom>
               <New_Terms>Simple</New_Terms>
            </Change>
            <Change id="296">
               <Axiom>Erythromycin Lactobionate SubClassOf Macrolide Antibiotic</Axiom>
               <New_Terms>Erythromycin Lactobionate</New_Terms>
            </Change>
            <Change id="297">
               <Axiom>Neoplastic Thyroid Gland Follicular Clear Cell SubClassOf Neoplastic Thyroid Gland Follicular Cell</Axiom>
               <New_Terms>Neoplastic Thyroid Gland Follicular Clear Cell</New_Terms>
            </Change>
            <Change id="298">
               <Axiom>Metoclopramide Hydrochloride SubClassOf Antiemetic Agent</Axiom>
               <New_Terms>Metoclopramide Hydrochloride</New_Terms>
            </Change>
            <Change id="299">
               <Axiom>Codeine Phosphate SubClassOf Opiate</Axiom>
               <New_Terms>Codeine Phosphate</New_Terms>
            </Change>
            <Change id="300">
               <Axiom>Marriage SubClassOf Social Concepts</Axiom>
               <New_Terms>Marriage</New_Terms>
            </Change>
            <Change id="301">
               <Axiom>Ciprofloxacin Hydrochloride SubClassOf Topoisomerase-II Inhibitor</Axiom>
               <New_Terms>Ciprofloxacin Hydrochloride</New_Terms>
            </Change>
            <Change id="302">
               <Axiom>Bupivacaine Hydrochloride SubClassOf Anesthetic Agent</Axiom>
               <New_Terms>Bupivacaine Hydrochloride</New_Terms>
            </Change>
            <Change id="303">
               <Axiom>Naloxone Hydrochloride SubClassOf Opiate Antagonist</Axiom>
               <New_Terms>Naloxone Hydrochloride</New_Terms>
            </Change>
            <Change id="304">
               <Axiom>Separation Column SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
               <New_Terms>Separation Column</New_Terms>
            </Change>
            <Change id="305">
               <Axiom>Isozyme SubClassOf Miscellaneous Molecular Biology Terms</Axiom>
               <New_Terms>Isozyme</New_Terms>
            </Change>
            <Change id="306">
               <Axiom>Meperidine Hydrochloride SubClassOf Opioid</Axiom>
               <New_Terms>Meperidine Hydrochloride</New_Terms>
            </Change>
            <Change id="307">
               <Axiom>Azathioprine Sodium SubClassOf Purine Antagonist</Axiom>
               <New_Terms>Azathioprine Sodium</New_Terms>
            </Change>
            <Change id="308">
               <Axiom>Article SubClassOf Document</Axiom>
               <New_Terms>Article</New_Terms>
            </Change>
            <Change id="309">
               <Axiom>Source Code SubClassOf Code</Axiom>
               <New_Terms>Source Code</New_Terms>
            </Change>
            <Change id="310">
               <Axiom>Midazolam Hydrochloride SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Midazolam Hydrochloride</New_Terms>
            </Change>
            <Change id="311">
               <Axiom>Deconvolution SubClassOf Data Processing</Axiom>
               <New_Terms>Deconvolution, Data Processing</New_Terms>
            </Change>
            <Change id="312">
               <Axiom>American Diabetes Association SubClassOf Professional Organization or Group</Axiom>
               <New_Terms>American Diabetes Association</New_Terms>
            </Change>
            <Change id="313">
               <Axiom>Methylphenidate Hydrochloride SubClassOf Miscellaneous Adjuvant</Axiom>
               <New_Terms>Methylphenidate Hydrochloride</New_Terms>
            </Change>
            <Change id="314">
               <Axiom>Cephradine Dihydrate SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cephradine Dihydrate</New_Terms>
            </Change>
            <Change id="315">
               <Axiom>Methylprednisolone Sodium Succinate SubClassOf Antiemetic Agent</Axiom>
               <New_Terms>Methylprednisolone Sodium Succinate</New_Terms>
            </Change>
            <Change id="316">
               <Axiom>Moxifloxacin Hydrochloride SubClassOf Quinolone Antibiotic</Axiom>
               <New_Terms>Moxifloxacin Hydrochloride</New_Terms>
            </Change>
            <Change id="317">
               <Axiom>Unit of Linear Acceleration SubClassOf Unit by Category</Axiom>
               <New_Terms>Unit of Linear Acceleration</New_Terms>
            </Change>
            <Change id="318">
               <Axiom>G_Force SubClassOf Force</Axiom>
               <New_Terms>G_Force, Force</New_Terms>
            </Change>
            <Change id="319">
               <Axiom>Collision-Induced Dissociation SubClassOf Physical Chemical Technique</Axiom>
               <New_Terms>Collision-Induced Dissociation</New_Terms>
            </Change>
            <Change id="320">
               <Axiom>Matrix-Assisted Laser Desorption Ionization Mass Spectrometry SubClassOf Mass Spectrometry</Axiom>
               <New_Terms>Matrix-Assisted Laser Desorption Ionization Mass Spectrometry</New_Terms>
            </Change>
            <Change id="321">
               <Axiom>Unifocal SubClassOf General Qualifier</Axiom>
               <New_Terms>Unifocal</New_Terms>
            </Change>
            <Change id="322">
               <Axiom>10q23.33 SubClassOf Anatomic_Structure_is_Physical_Part_of some 10q</Axiom>
               <New_Terms>10q23.33</New_Terms>
            </Change>
            <Change id="323">
               <Axiom>7q21-q22.1 SubClassOf Anatomic_Structure_is_Physical_Part_of some 7q</Axiom>
               <New_Terms>7q21-q22.1</New_Terms>
            </Change>
            <Change id="324">
               <Axiom>Tampon Dosage Form SubClassOf Solid Dosage Form</Axiom>
               <New_Terms>Tampon Dosage Form</New_Terms>
            </Change>
            <Change id="325">
               <Axiom>Metronidazole Hydrochloride SubClassOf Trichomonacide Agent</Axiom>
               <New_Terms>Metronidazole Hydrochloride</New_Terms>
            </Change>
            <Change id="326">
               <Axiom>Phentolamine Mesylate SubClassOf Alpha-adrenergic Antagonist</Axiom>
               <New_Terms>Phentolamine Mesylate</New_Terms>
            </Change>
            <Change id="327">
               <Axiom>Isotope SubClassOf Inorganic Chemical</Axiom>
               <New_Terms>Isotope</New_Terms>
            </Change>
            <Change id="328">
               <Axiom>Tamoxifen Citrate SubClassOf Selective Estrogen Receptor Modulator</Axiom>
               <New_Terms>Tamoxifen Citrate</New_Terms>
            </Change>
            <Change id="329">
               <Axiom>Transfer SubClassOf Techniques</Axiom>
               <New_Terms>Transfer</New_Terms>
            </Change>
            <Change id="330">
               <Axiom>Uncertain SubClassOf General Qualifier</Axiom>
               <New_Terms>Uncertain</New_Terms>
            </Change>
            <Change id="331">
               <Axiom>Rosiglitazone Maleate SubClassOf Differentiation Inducer</Axiom>
               <New_Terms>Rosiglitazone Maleate</New_Terms>
            </Change>
            <Change id="332">
               <Axiom>Terminal SubClassOf General Qualifier</Axiom>
               <New_Terms>Terminal</New_Terms>
            </Change>
            <Change id="333">
               <Axiom>Male-to-Female Transsexual Phenotype SubClassOf General Qualifier</Axiom>
               <New_Terms>Male-to-Female Transsexual Phenotype</New_Terms>
            </Change>
            <Change id="334">
               <Axiom>Ziprasidone Hydrochloride SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Ziprasidone Hydrochloride</New_Terms>
            </Change>
            <Change id="335">
               <Axiom>Phenylephrine Hydrochloride SubClassOf Alpha-adrenergic Agonist</Axiom>
               <New_Terms>Phenylephrine Hydrochloride</New_Terms>
            </Change>
            <Change id="336">
               <Axiom>Shoot SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Shoot</New_Terms>
            </Change>
            <Change id="337">
               <Axiom>Venous Invasion SubClassOf Angioinvasion</Axiom>
               <New_Terms>Venous Invasion</New_Terms>
            </Change>
            <Change id="338">
               <Axiom>Phase V Trial SubClassOf Clinical Trial</Axiom>
               <New_Terms>Phase V Trial</New_Terms>
            </Change>
            <Change id="339">
               <Axiom>Miconazole Nitrate SubClassOf Antifungal Agent</Axiom>
               <New_Terms>Miconazole Nitrate</New_Terms>
            </Change>
            <Change id="340">
               <Axiom>Gram SubClassOf Unit of Mass</Axiom>
               <New_Terms>Gram</New_Terms>
            </Change>
            <Change id="341">
               <Axiom>Set SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Set</New_Terms>
            </Change>
            <Change id="342">
               <Axiom>Amitriptyline Hydrochloride SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Amitriptyline Hydrochloride</New_Terms>
            </Change>
            <Change id="343">
               <Axiom>Chloramphenicol Sodium Succinate SubClassOf Protein Synthesis Inhibitor</Axiom>
               <New_Terms>Chloramphenicol Sodium Succinate</New_Terms>
            </Change>
            <Change id="344">
               <Axiom>Quinidine Sulfate SubClassOf Multidrug Resistance Modulator</Axiom>
               <New_Terms>Quinidine Sulfate</New_Terms>
            </Change>
            <Change id="345">
               <Axiom>Nesting (Zellballen) Growth Pattern SubClassOf Nested Proliferation</Axiom>
               <New_Terms>Nesting (Zellballen) Growth Pattern</New_Terms>
            </Change>
            <Change id="346">
               <Axiom>Right Breast SubClassOf Breast</Axiom>
               <New_Terms>Right Breast</New_Terms>
            </Change>
            <Change id="347">
               <Axiom>Hyperlink SubClassOf List</Axiom>
               <New_Terms>Hyperlink</New_Terms>
            </Change>
            <Change id="348">
               <Axiom>Demeclocycline SubClassOf Tetracycline Antibiotic</Axiom>
               <New_Terms>Demeclocycline</New_Terms>
            </Change>
            <Change id="349">
               <Axiom>Nominal Scale SubClassOf Scale</Axiom>
               <New_Terms>Nominal Scale</New_Terms>
            </Change>
            <Change id="350">
               <Axiom>Oseltamivir Phosphate SubClassOf Miscellaneous Antiviral Agent</Axiom>
               <New_Terms>Oseltamivir Phosphate</New_Terms>
            </Change>
            <Change id="351">
               <Axiom>Service SubClassOf Clinical or Research Activity</Axiom>
               <New_Terms>Service</New_Terms>
            </Change>
            <Change id="352">
               <Axiom>Sulfacetamide Sodium SubClassOf Sulfonamide Anti-infective Agent</Axiom>
               <New_Terms>Sulfacetamide Sodium</New_Terms>
            </Change>
            <Change id="353">
               <Axiom>Ciprofloxacin Hydrochloride SubClassOf Antitubercular Agent</Axiom>
               <New_Terms>Ciprofloxacin Hydrochloride</New_Terms>
            </Change>
            <Change id="354">
               <Axiom>Malignant Squamoid Cell SubClassOf Malignant Epithelial Cell</Axiom>
               <New_Terms>Malignant Squamoid Cell</New_Terms>
            </Change>
            <Change id="355">
               <Axiom>Azathioprine Sodium SubClassOf Inosine 5'-Phosphate Dehydrogenase Inhibitor</Axiom>
               <New_Terms>Azathioprine Sodium</New_Terms>
            </Change>
            <Change id="356">
               <Axiom>Data Set SubClassOf Information Resources</Axiom>
               <New_Terms>Data Set</New_Terms>
            </Change>
            <Change id="357">
               <Axiom>Flurbiprofen Sodium SubClassOf Carbonic Anhydrase Inhibitor</Axiom>
               <New_Terms>Flurbiprofen Sodium</New_Terms>
            </Change>
            <Change id="358">
               <Axiom>Strip Dosage Form SubClassOf Solid Dosage Form</Axiom>
               <New_Terms>Strip Dosage Form</New_Terms>
            </Change>
            <Change id="359">
               <Axiom>Ziprasidone Mesylate SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Ziprasidone Mesylate</New_Terms>
            </Change>
            <Change id="360">
               <Axiom>Dextromethorphan Hydrobromide SubClassOf Adjuvant Analgesic</Axiom>
               <New_Terms>Dextromethorphan Hydrobromide</New_Terms>
            </Change>
            <Change id="361">
               <Axiom>Amphetamine Sulfate SubClassOf Substance of Abuse</Axiom>
               <New_Terms>Amphetamine Sulfate</New_Terms>
            </Change>
            <Change id="362">
               <Axiom>Quinapril Hydrochloride SubClassOf ACE Inhibitor</Axiom>
               <New_Terms>Quinapril Hydrochloride</New_Terms>
            </Change>
            <Change id="363">
               <Axiom>Triamcinolone Acetonide SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Triamcinolone Acetonide</New_Terms>
            </Change>
            <Change id="364">
               <Axiom>Enalapril Maleate SubClassOf ACE Inhibitor</Axiom>
               <New_Terms>Enalapril Maleate</New_Terms>
            </Change>
            <Change id="365">
               <Axiom>Hydralazine Hydrochloride SubClassOf Antihypertensive Agent</Axiom>
               <New_Terms>Hydralazine Hydrochloride</New_Terms>
            </Change>
            <Change id="366">
               <Axiom>Tazobactam Sodium SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Tazobactam Sodium</New_Terms>
            </Change>
            <Change id="367">
               <Axiom>Ionization Source SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
               <New_Terms>Ionization Source</New_Terms>
            </Change>
            <Change id="368">
               <Axiom>Float SubClassOf Data Type</Axiom>
               <New_Terms>Float</New_Terms>
            </Change>
            <Change id="369">
               <Axiom>Oxycodone Terephthalate SubClassOf Opioid</Axiom>
               <New_Terms>Oxycodone Terephthalate</New_Terms>
            </Change>
            <Change id="370">
               <Axiom>Cefamandole Sodium SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cefamandole Sodium</New_Terms>
            </Change>
            <Change id="371">
               <Axiom>Non-Neoplastic Osteoclast-Like Giant Cell SubClassOf Osteoclast-Like Giant Cell</Axiom>
               <New_Terms>Non-Neoplastic Osteoclast-Like Giant Cell</New_Terms>
            </Change>
            <Change id="372">
               <Axiom>Ondansetron Hydrochloride SubClassOf Antiemetic Agent</Axiom>
               <New_Terms>Ondansetron Hydrochloride</New_Terms>
            </Change>
            <Change id="373">
               <Axiom>Neoplastic Osteoclast-Like Giant Cell SubClassOf Neoplastic Multinucleated Giant Cell</Axiom>
               <New_Terms>Neoplastic Osteoclast-Like Giant Cell</New_Terms>
            </Change>
            <Change id="374">
               <Axiom>Nuclear Clearing SubClassOf Morphologic Finding</Axiom>
               <New_Terms>Nuclear Clearing</New_Terms>
            </Change>
            <Change id="375">
               <Axiom>Suture Dosage Form SubClassOf Solid Dosage Form</Axiom>
               <New_Terms>Suture Dosage Form</New_Terms>
            </Change>
            <Change id="376">
               <Axiom>Byte SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Byte</New_Terms>
            </Change>
            <Change id="377">
               <Axiom>Wavelength SubClassOf Characteristic</Axiom>
               <New_Terms>Wavelength</New_Terms>
            </Change>
            <Change id="378">
               <Axiom>Cefadroxil Hemihydrate SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cefadroxil Hemihydrate</New_Terms>
            </Change>
            <Change id="379">
               <Axiom>Beta-adrenergic Agonist SubClassOf Adrenergic Agent</Axiom>
               <New_Terms>Beta-adrenergic Agonist</New_Terms>
            </Change>
            <Change id="380">
               <Axiom>Amiodarone Hydrochloride SubClassOf Multidrug Resistance Modulator</Axiom>
               <New_Terms>Amiodarone Hydrochloride</New_Terms>
            </Change>
            <Change id="381">
               <Axiom>Triamcinolone Hexacetonide SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Triamcinolone Hexacetonide</New_Terms>
            </Change>
            <Change id="382">
               <Axiom>Irinotecan Hydrochloride SubClassOf Camptothecin Analogue</Axiom>
               <New_Terms>Irinotecan Hydrochloride</New_Terms>
            </Change>
            <Change id="383">
               <Axiom>Sodium Sulfate, Anhydrous SubClassOf Electrolyte Replacement Agent</Axiom>
               <New_Terms>Sodium Sulfate, Anhydrous</New_Terms>
            </Change>
            <Change id="384">
               <Axiom>Benchmark SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Benchmark</New_Terms>
            </Change>
            <Change id="385">
               <Axiom>Peak SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Peak</New_Terms>
            </Change>
            <Change id="386">
               <Axiom>Flurazepam Hydrochloride SubClassOf Benzodiazepine</Axiom>
               <New_Terms>Flurazepam Hydrochloride</New_Terms>
            </Change>
            <Change id="387">
               <Axiom>Dopamine Hydrochloride SubClassOf Adrenergic Agent</Axiom>
               <New_Terms>Dopamine Hydrochloride</New_Terms>
            </Change>
            <Change id="388">
               <Axiom>Logical Condition SubClassOf Property or Attribute</Axiom>
               <New_Terms>Logical Condition</New_Terms>
            </Change>
            <Change id="389">
               <Axiom>Amrubicin Hydrochloride SubClassOf Anthracycline Antibiotic</Axiom>
               <New_Terms>Amrubicin Hydrochloride</New_Terms>
            </Change>
            <Change id="390">
               <Axiom>Beta Sheet SubClassOf Secondary Protein Structure</Axiom>
               <New_Terms>Beta Sheet</New_Terms>
            </Change>
            <Change id="391">
               <Axiom>Rosiglitazone Maleate SubClassOf Anti-diabetic Agent</Axiom>
               <New_Terms>Rosiglitazone Maleate</New_Terms>
            </Change>
            <Change id="392">
               <Axiom>Lymphatic Invasion SubClassOf Angioinvasion</Axiom>
               <New_Terms>Lymphatic Invasion</New_Terms>
            </Change>
            <Change id="393">
               <Axiom>Data Processing SubClassOf Computer Sciences</Axiom>
               <New_Terms>Data Processing</New_Terms>
            </Change>
            <Change id="394">
               <Axiom>Consecutive SubClassOf General Qualifier</Axiom>
               <New_Terms>Consecutive</New_Terms>
            </Change>
            <Change id="395">
               <Axiom>Macrofollicular Structures Present SubClassOf Follicular Structures Present</Axiom>
               <New_Terms>Follicular Structures Present, Macrofollicular Structures Present</New_Terms>
            </Change>
            <Change id="396">
               <Axiom>Sequence Feature SubClassOf Sequence</Axiom>
               <New_Terms>Sequence Feature</New_Terms>
            </Change>
            <Change id="397">
               <Axiom>Tamoxifen Citrate SubClassOf DNA Adduct Forming Agent</Axiom>
               <New_Terms>Tamoxifen Citrate</New_Terms>
            </Change>
            <Change id="398">
               <Axiom>Malignant Thyroid Gland Follicular Clear Cell SubClassOf Neoplastic Thyroid Gland Follicular Clear Cell</Axiom>
               <New_Terms>Neoplastic Thyroid Gland Follicular Clear Cell, Malignant Thyroid Gland Follicular Clear Cell</New_Terms>
            </Change>
            <Change id="399">
               <Axiom>Oxacillin Sodium SubClassOf Penicillin Antibiotic</Axiom>
               <New_Terms>Oxacillin Sodium</New_Terms>
            </Change>
            <Change id="400">
               <Axiom>Window SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Window</New_Terms>
            </Change>
            <Change id="401">
               <Axiom>Male-to-Female Transsexual Animal SubClassOf Laboratory Animal</Axiom>
               <New_Terms>Male-to-Female Transsexual Animal</New_Terms>
            </Change>
            <Change id="402">
               <Axiom>Erythromycin Stearate SubClassOf Macrolide Antibiotic</Axiom>
               <New_Terms>Erythromycin Stearate</New_Terms>
            </Change>
            <Change id="403">
               <Axiom>Chlorpromazine Hydrochloride SubClassOf Multidrug Resistance Modulator</Axiom>
               <New_Terms>Chlorpromazine Hydrochloride</New_Terms>
            </Change>
            <Change id="404">
               <Axiom>Unit of Area SubClassOf Unit by Category</Axiom>
               <New_Terms>Unit of Area</New_Terms>
            </Change>
            <Change id="405">
               <Axiom>Breast Carcinoma with Chondroid Metaplasia SubClassOf Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma</Axiom>
               <New_Terms>Breast Carcinoma with Chondroid Metaplasia</New_Terms>
            </Change>
            <Change id="406">
               <Axiom>Glutathione Disulfide SubClassOf Peptide</Axiom>
               <New_Terms>Glutathione Disulfide</New_Terms>
            </Change>
            <Change id="407">
               <Axiom>Prilocaine Hydrochloride SubClassOf Anesthetic Agent</Axiom>
               <New_Terms>Prilocaine Hydrochloride</New_Terms>
            </Change>
            <Change id="408">
               <Axiom>Medium SubClassOf Substance</Axiom>
               <New_Terms>Medium</New_Terms>
            </Change>
            <Change id="409">
               <Axiom>Foscarnet Sodium SubClassOf Anti-HIV Agent</Axiom>
               <New_Terms>Foscarnet Sodium</New_Terms>
            </Change>
            <Change id="410">
               <Axiom>Input SubClassOf Conceptual Entity</Axiom>
               <New_Terms>Input</New_Terms>
            </Change>
            <Change id="411">
               <Axiom>Cross Link SubClassOf Macromolecular Structure</Axiom>
               <New_Terms>Cross Link</New_Terms>
            </Change>
            <Change id="412">
               <Axiom>Knowledge Base SubClassOf Database</Axiom>
               <New_Terms>Knowledge Base</New_Terms>
            </Change>
            <Change id="413">
               <Axiom>Indinavir Sulfate SubClassOf Protease Inhibitor</Axiom>
               <New_Terms>Indinavir Sulfate</New_Terms>
            </Change>
            <Change id="414">
               <Axiom>Trifluoperazine Hydrochloride SubClassOf Phenothiazine</Axiom>
               <New_Terms>Trifluoperazine Hydrochloride</New_Terms>
            </Change>
            <Change id="415">
               <Axiom>Tolterodine Tartrate SubClassOf Antimuscarinic Agent</Axiom>
               <New_Terms>Tolterodine Tartrate</New_Terms>
            </Change>
            <Change id="416">
               <Axiom>Methylprednisolone Acetate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Methylprednisolone Acetate</New_Terms>
            </Change>
            <Change id="417">
               <Axiom>Beclomethasone Dipropionate SubClassOf Therapeutic Glucocorticoid</Axiom>
               <New_Terms>Beclomethasone Dipropionate</New_Terms>
            </Change>
            <Change id="418">
               <Axiom>Microgram SubClassOf Unit of Mass</Axiom>
               <New_Terms>Microgram</New_Terms>
            </Change>
            <Change id="419">
               <Axiom>Flecainide Acetate SubClassOf Adjuvant Analgesic</Axiom>
               <New_Terms>Flecainide Acetate</New_Terms>
            </Change>
            <Change id="420">
               <Axiom>Pioglitazone Hydrochloride SubClassOf Anti-diabetic Agent</Axiom>
               <New_Terms>Pioglitazone Hydrochloride</New_Terms>
            </Change>
            <Change id="421">
               <Axiom>Metropolitan France SubClassOf Conceptual_Part_Of some France</Axiom>
               <New_Terms>Metropolitan France</New_Terms>
            </Change>
            <Change id="422">
               <Axiom>Foscarnet Sodium SubClassOf Reverse Transcriptase Inhibitor</Axiom>
               <New_Terms>Foscarnet Sodium</New_Terms>
            </Change>
            <Change id="423">
               <Axiom>UniProtKB SubClassOf Knowledge Base</Axiom>
               <New_Terms>Knowledge Base, UniProtKB</New_Terms>
            </Change>
            <Change id="424">
               <Axiom>Thiamine Hydrochloride SubClassOf B Vitamin</Axiom>
               <New_Terms>Thiamine Hydrochloride</New_Terms>
            </Change>
            <Change id="425">
               <Axiom>Bromocriptine Mesylate SubClassOf Neuroprotective Agent</Axiom>
               <New_Terms>Bromocriptine Mesylate</New_Terms>
            </Change>
            <Change id="426">
               <Axiom>Pathname SubClassOf Document</Axiom>
               <New_Terms>Pathname</New_Terms>
            </Change>
            <Change id="427">
               <Axiom>Clindamycin Hydrochloride SubClassOf Protein Synthesis Inhibitor</Axiom>
               <New_Terms>Clindamycin Hydrochloride</New_Terms>
            </Change>
            <Change id="428">
               <Axiom>Left Breast SubClassOf Breast</Axiom>
               <New_Terms>Left Breast</New_Terms>
            </Change>
            <Change id="429">
               <Axiom>Chlorpromazine Hydrochloride SubClassOf Phenothiazine</Axiom>
               <New_Terms>Chlorpromazine Hydrochloride</New_Terms>
            </Change>
            <Change id="430">
               <Axiom>Pseudocode SubClassOf Document</Axiom>
               <New_Terms>Pseudocode</New_Terms>
            </Change>
            <Change id="431">
               <Axiom>Protein Helix SubClassOf Secondary Protein Structure</Axiom>
               <New_Terms>Protein Helix</New_Terms>
            </Change>
            <Change id="432">
               <Axiom>Indinavir Sulfate SubClassOf Anti-HIV Agent</Axiom>
               <New_Terms>Indinavir Sulfate</New_Terms>
            </Change>
            <Change id="433">
               <Axiom>Tamoxifen Citrate SubClassOf Endothelial Cell Inhibitor</Axiom>
               <New_Terms>Tamoxifen Citrate</New_Terms>
            </Change>
            <Change id="434">
               <Axiom>Phenytoin Sodium SubClassOf Anticonvulsant Agent</Axiom>
               <New_Terms>Phenytoin Sodium</New_Terms>
            </Change>
            <Change id="435">
               <Axiom>Extensive SubClassOf General Qualifier</Axiom>
               <New_Terms>Extensive</New_Terms>
            </Change>
            <Change id="436">
               <Axiom>Cephalothin Sodium SubClassOf Cephalosporin Antibiotic</Axiom>
               <New_Terms>Cephalothin Sodium</New_Terms>
            </Change>
            <Change id="437">
               <Axiom>Neoplastic Thyroid Gland Follicular Signet Ring Cell SubClassOf Signet Ring Cell</Axiom>
               <New_Terms>Neoplastic Thyroid Gland Follicular Signet Ring Cell</New_Terms>
            </Change>
            <Change id="438">
               <Axiom>Albuterol Sulfate SubClassOf Bronchodilator</Axiom>
               <New_Terms>Albuterol Sulfate</New_Terms>
            </Change>
            <Change id="439">
               <Axiom>Hoarseness SubClassOf Symptom</Axiom>
               <New_Terms>Hoarseness</New_Terms>
            </Change>
            <Change id="440">
               <Axiom>Nuclear Pseudoinclusion SubClassOf Nuclear Inclusion</Axiom>
               <New_Terms>Nuclear Pseudoinclusion</New_Terms>
            </Change>
            <Change id="441">
               <Axiom>Fluphenazine Decanoate SubClassOf Antipsychotic Agent</Axiom>
               <New_Terms>Fluphenazine Decanoate</New_Terms>
            </Change>
            <Change id="442">
               <Axiom>Phenoxybenzamine Hydrochloride SubClassOf Carcinogenic Aromatic Amine</Axiom>
               <New_Terms>Phenoxybenzamine Hydrochloride</New_Terms>
            </Change>
            <Change id="443">
               <Axiom>Levobunolol Hydrochloride SubClassOf Anti-glaucoma Agent</Axiom>
               <New_Terms>Levobunolol Hydrochloride</New_Terms>
            </Change>
            <Change id="444">
               <Axiom>Naltrexone Hydrochloride SubClassOf Opiate Antagonist</Axiom>
               <New_Terms>Naltrexone Hydrochloride</New_Terms>
            </Change>
            <Change id="445">
               <Axiom>Clindamycin Phosphate SubClassOf Protein Synthesis Inhibitor</Axiom>
               <New_Terms>Clindamycin Phosphate</New_Terms>
            </Change>
            <Change id="446">
               <Axiom>Active Site SubClassOf Protein Structure</Axiom>
               <New_Terms>Active Site</New_Terms>
            </Change>
            <Change id="447">
               <Axiom>Microliter SubClassOf Unit of Mass</Axiom>
               <New_Terms>Microliter</New_Terms>
            </Change>
            <Change id="448">
               <Axiom>Rabeprazole Sodium SubClassOf Proton Pump Inhibitor</Axiom>
               <New_Terms>Rabeprazole Sodium</New_Terms>
            </Change>
            <Change id="449">
               <Axiom>Null SubClassOf Data Type</Axiom>
               <New_Terms>Null</New_Terms>
            </Change>
            <Change id="450">
               <Axiom>Scanning Procedure or Technique SubClassOf Procedure</Axiom>
               <New_Terms>Scanning Procedure or Technique</New_Terms>
            </Change>
            <Change id="451">
               <Axiom>Diaphragm Dosage Form SubClassOf Solid Dosage Form</Axiom>
               <New_Terms>Diaphragm Dosage Form</New_Terms>
            </Change>
            <Change id="452">
               <Axiom>Trimethoprim Sulfate SubClassOf Urinary Anti-Infective Agent</Axiom>
               <New_Terms>Trimethoprim Sulfate</New_Terms>
            </Change>
            <Change id="453">
               <Axiom>Disposal SubClassOf Techniques</Axiom>
               <New_Terms>Disposal</New_Terms>
            </Change>
            <Change id="454">
               <Axiom>Forced Expiratory Volume in 6 Seconds SubClassOf Pulmonary Function Test</Axiom>
               <New_Terms>Forced Expiratory Volume in 6 Seconds</New_Terms>
            </Change>
            <Change id="455">
               <Axiom>Energy SubClassOf Physical Phenomenon or Property</Axiom>
               <New_Terms>Energy</New_Terms>
            </Change>
            <Change id="456">
               <Axiom>XML Path Language SubClassOf Language</Axiom>
               <New_Terms>XML Path Language</New_Terms>
            </Change>
            <Change id="457">
               <Axiom>Routine Contract SubClassOf Logical Condition</Axiom>
               <New_Terms>Routine Contract, Logical Condition</New_Terms>
            </Change>
            <Change id="458">
               <Axiom>Acyclovir Sodium SubClassOf Nucleic Acid Synthesis Inhibitor</Axiom>
               <New_Terms>Acyclovir Sodium</New_Terms>
            </Change>
            <Change id="459">
               <Axiom>Neoplastic Osteoclast-Like Giant Cell SubClassOf Osteoclast-Like Giant Cell</Axiom>
               <New_Terms>Neoplastic Osteoclast-Like Giant Cell</New_Terms>
            </Change>
            <Change id="460">
               <Axiom>Thyroglobulin Positive Neoplastic Cells Present SubClassOf Positive Immunophenotypic Test Result</Axiom>
               <New_Terms>Thyroglobulin Positive Neoplastic Cells Present</New_Terms>
            </Change>
            <Change id="461">
               <Axiom>Helix SubClassOf Macromolecular Structure</Axiom>
               <New_Terms>Helix</New_Terms>
            </Change>
            <Change id="462">
               <Axiom>Isoproterenol Hydrochloride SubClassOf Bronchodilator</Axiom>
               <New_Terms>Isoproterenol Hydrochloride</New_Terms>
            </Change>
            <Change id="463">
               <Axiom>Integration SubClassOf Data Processing</Axiom>
               <New_Terms>Integration, Data Processing</New_Terms>
            </Change>
            <Change id="464">
               <Axiom>Ethacrynate Sodium SubClassOf Glutathione Transferase Inhibitor</Axiom>
               <New_Terms>Ethacrynate Sodium</New_Terms>
            </Change>
            <Change id="465">
               <Axiom>Bupropion Hydrochloride SubClassOf Antidepressant Agent</Axiom>
               <New_Terms>Bupropion Hydrochloride</New_Terms>
            </Change>
         </NewDescription>
         <PureAddition id="padd" size="300">
            <Change id="466">
               <Axiom>Collecting Cell SubClassOf Cuboidal Cell</Axiom>
            </Change>
            <Change id="467">
               <Axiom>CYP3A7 Gene SubClassOf Gene_Plays_Role_in_Process some Oxidation</Axiom>
            </Change>
            <Change id="468">
               <Axiom>CYP2D6*2 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Cytosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="469">
               <Axiom>Percutaneous Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="470">
               <Axiom>Cubic Meter SubClassOf Unit of Volume</Axiom>
            </Change>
            <Change id="471">
               <Axiom>Supersack SubClassOf Bag</Axiom>
            </Change>
            <Change id="472">
               <Axiom>CYP2C19*12 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
            </Change>
            <Change id="473">
               <Axiom>CYP2D6*6 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Cytosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="474">
               <Axiom>CYP2C9*18 Allele SubClassOf Allele_Has_Abnormality some Adenosine to Cytosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="475">
               <Axiom>CYP3A5*10 Allele SubClassOf Allele_In_Chromosomal_Location some 7q22.1</Axiom>
            </Change>
            <Change id="476">
               <Axiom>CYP2D6*41 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="477">
               <Axiom>CYP3A5 Gene SubClassOf Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway</Axiom>
            </Change>
            <Change id="478">
               <Axiom>CYP2D6*6 Allele SubClassOf Allele_Has_Abnormality some Multiple Transition Abnormalities</Axiom>
            </Change>
            <Change id="479">
               <Axiom>CYP2C8*3 Allele SubClassOf Allele_Has_Abnormality some Adenosine to Guanosine Transition Abnormality</Axiom>
            </Change>
            <Change id="480">
               <Axiom>Interstitial Cell of the Pineal Gland SubClassOf Interstitial Cell</Axiom>
            </Change>
            <Change id="481">
               <Axiom>Type I Epithelial Receptor Cell SubClassOf Taste Bud Cell</Axiom>
            </Change>
            <Change id="482">
               <Axiom>Pyrithione Zinc SubClassOf Anti-psoriatic Agent</Axiom>
            </Change>
            <Change id="483">
               <Axiom>CYP2D6*36 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="484">
               <Axiom>CYP2C19*9 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
            </Change>
            <Change id="485">
               <Axiom>Irrigation-Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="486">
               <Axiom>CYP2C19*2 Allele SubClassOf Allele_Has_Abnormality some Protein Truncation Abnormality</Axiom>
            </Change>
            <Change id="487">
               <Axiom>CYP2C19*12 Allele SubClassOf Allele_Has_Abnormality some Adenosine to Cytosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="488">
               <Axiom>Pulmonary Function Test SubClassOf Lab Test</Axiom>
            </Change>
            <Change id="489">
               <Axiom>CYP3A7 Gene SubClassOf Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway</Axiom>
            </Change>
            <Change id="490">
               <Axiom>CYP2C19*1 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
            </Change>
            <Change id="491">
               <Axiom>Adrenal Gland Neoplasm SubClassOf Retroperitoneal Neoplasm</Axiom>
            </Change>
            <Change id="492">
               <Axiom>CYP2C9*3 Allele SubClassOf Allele_Has_Abnormality some Adenosine to Cytosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="493">
               <Axiom>Endosinusial Route of Administration SubClassOf Intrasinal Route of Administration</Axiom>
            </Change>
            <Change id="494">
               <Axiom>CYP2D6*13 Allele SubClassOf Allele_Has_Abnormality some Deletion Abnormality</Axiom>
            </Change>
            <Change id="495">
               <Axiom>CYP2C19*5 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="496">
               <Axiom>Applicator Tube SubClassOf Applicator</Axiom>
            </Change>
            <Change id="497">
               <Axiom>CYP2C19*2 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="498">
               <Axiom>Dosage Form By Phase of Matter SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="499">
               <Axiom>Speed SubClassOf Characteristic</Axiom>
            </Change>
            <Change id="500">
               <Axiom>Malignant Adrenal Gland Neoplasm SubClassOf Malignant Retroperitoneal Neoplasm</Axiom>
            </Change>
            <Change id="501">
               <Axiom>CYP2C8*8 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="502">
               <Axiom>Tetrahydrozoline Hydrochloride SubClassOf Alpha-adrenergic Agonist</Axiom>
            </Change>
            <Change id="503">
               <Axiom>CYP3A7 Gene SubClassOf Gene_Plays_Role_in_Process some Xenobiotic Metabolism</Axiom>
            </Change>
            <Change id="504">
               <Axiom>CYP2D6*41 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="505">
               <Axiom>Angiosarcoma SubClassOf Disease_Has_Normal_Cell_Origin only Endothelial Cell</Axiom>
            </Change>
            <Change id="506">
               <Axiom>Intrabiliary Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="507">
               <Axiom>Placental Choriocarcinoma SubClassOf Malignant Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="508">
               <Axiom>CYP2D6*42 Allele SubClassOf Allele_Has_Abnormality some Multiple Transversion Abnormalities</Axiom>
            </Change>
            <Change id="509">
               <Axiom>CYP2D6*16 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="510">
               <Axiom>CYP2C19*4 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
            </Change>
            <Change id="511">
               <Axiom>CYP2D6*10 Allele SubClassOf Allele_Has_Abnormality some Multiple Transversion Abnormalities</Axiom>
            </Change>
            <Change id="512">
               <Axiom>Applicator Bottle SubClassOf Applicator</Axiom>
            </Change>
            <Change id="513">
               <Axiom>CYP3A5*8 Allele SubClassOf Allele_In_Chromosomal_Location some 7q22.1</Axiom>
            </Change>
            <Change id="514">
               <Axiom>CYP2D6*3 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="515">
               <Axiom>CYP2D6*15 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="516">
               <Axiom>Scale SubClassOf Conceptual Entity</Axiom>
            </Change>
            <Change id="517">
               <Axiom>Cloning Site SubClassOf DNA Sequence</Axiom>
            </Change>
            <Change id="518">
               <Axiom>Douche Dosage Form SubClassOf Solution Dosage Form</Axiom>
            </Change>
            <Change id="519">
               <Axiom>CYP2D6*19 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
            </Change>
            <Change id="520">
               <Axiom>CYP2D6*12 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="521">
               <Axiom>CYP2D6*35X2 Allele SubClassOf Allele_Has_Abnormality some Multiple Transition Abnormalities</Axiom>
            </Change>
            <Change id="522">
               <Axiom>CYP3A5*6 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="523">
               <Axiom>CYP2D6*40 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="524">
               <Axiom>CYP2D6*35X2 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="525">
               <Axiom>Thyrotroph Cell SubClassOf Acidophilic Cell</Axiom>
            </Change>
            <Change id="526">
               <Axiom>CYP2C9*5 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="527">
               <Axiom>CYP2C8*3 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="528">
               <Axiom>CYP2C8*3 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="529">
               <Axiom>Syrup Dosage Form SubClassOf Solution Dosage Form</Axiom>
            </Change>
            <Change id="530">
               <Axiom>CYP2C19*3 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
            </Change>
            <Change id="531">
               <Axiom>Non-Neoplastic Adrenal Gland Disorder SubClassOf Non-Neoplastic Retroperitoneal Disorder</Axiom>
            </Change>
            <Change id="532">
               <Axiom>CYP2C19*4 Allele SubClassOf Allele_Has_Abnormality some Adenosine to Guanosine Transition Abnormality</Axiom>
            </Change>
            <Change id="533">
               <Axiom>TSH Producing Pituitary Gland Neoplasm EquivalentTo Anterior Pituitary Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Thyrotroph Cell) and (Disease_Has_Normal_Cell_Origin only Thyrotroph Cell)</Axiom>
            </Change>
            <Change id="534">
               <Axiom>CYP3A4*18 Allele SubClassOf Allele_In_Chromosomal_Location some 7q22.1</Axiom>
            </Change>
            <Change id="535">
               <Axiom>CYP2C19*1 Allele SubClassOf Allele_Has_Abnormality some Adenosine to Guanosine Transition Abnormality</Axiom>
            </Change>
            <Change id="536">
               <Axiom>RASVAC-V SubClassOf Antineoplastic Vaccine</Axiom>
            </Change>
            <Change id="537">
               <Axiom>CYP2D6*42 Allele SubClassOf Allele_Has_Abnormality some Deletion Abnormality</Axiom>
            </Change>
            <Change id="538">
               <Axiom>Low Grade Adenosquamous Breast Carcinoma SubClassOf Adenosquamous Breast Carcinoma</Axiom>
            </Change>
            <Change id="539">
               <Axiom>Concentration SubClassOf Characteristic</Axiom>
            </Change>
            <Change id="540">
               <Axiom>CYP2D6*21 Allele SubClassOf Allele_Has_Abnormality some Multiple Transversion Abnormalities</Axiom>
            </Change>
            <Change id="541">
               <Axiom>CYP2D6*9 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="542">
               <Axiom>CYP2D6*10 Allele SubClassOf Allele_Has_Abnormality some Deletion Abnormality</Axiom>
            </Change>
            <Change id="543">
               <Axiom>CYP2D6*11 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
            </Change>
            <Change id="544">
               <Axiom>CYP2C19*7 Allele SubClassOf Allele_Has_Abnormality some Thymidine to Adenosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="545">
               <Axiom>Intrabronchial Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="546">
               <Axiom>M A TAC Conjugated Pseudomonas EXO SubClassOf Radioimmunoconjugate</Axiom>
            </Change>
            <Change id="547">
               <Axiom>CYP2D6*42 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="548">
               <Axiom>CYP2D6*20 Allele SubClassOf Allele_Has_Abnormality some Multiple Transition Abnormalities</Axiom>
            </Change>
            <Change id="549">
               <Axiom>CYP2C9*6 Allele SubClassOf Allele_Has_Abnormality some Deletion Abnormality</Axiom>
            </Change>
            <Change id="550">
               <Axiom>CYP3A5 Gene SubClassOf Gene_Plays_Role_in_Process some Steroid Metabolism</Axiom>
            </Change>
            <Change id="551">
               <Axiom>CYP1A2*1 Allele SubClassOf Allele_In_Chromosomal_Location some 15q22-qter</Axiom>
            </Change>
            <Change id="552">
               <Axiom>Intraepidermal Route of Administration SubClassOf Intraepithelial Route of Administration</Axiom>
            </Change>
            <Change id="553">
               <Axiom>Thyroid Gland Undifferentiated Small Cell Carcinoma SubClassOf Neoplasm by Obsolete Classification</Axiom>
            </Change>
            <Change id="554">
               <Axiom>CYP11A1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_In_Chromosomal_Location some 15q23-q24) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism)</Axiom>
            </Change>
            <Change id="555">
               <Axiom>CYP2D6*11 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Cytosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="556">
               <Axiom>CYP2C9*11 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="557">
               <Axiom>Irrigant Dosage Form SubClassOf Solution Dosage Form</Axiom>
            </Change>
            <Change id="558">
               <Axiom>CYP3A7*2 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Guanosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="559">
               <Axiom>CYP2D6*11 Allele SubClassOf Allele_Has_Abnormality some Multiple Transversion Abnormalities</Axiom>
            </Change>
            <Change id="560">
               <Axiom>CYP1A2*1 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="561">
               <Axiom>Somatotroph Cell SubClassOf Acidophilic Cell</Axiom>
            </Change>
            <Change id="562">
               <Axiom>Oropharyngeal Route of Administration SubClassOf Oral Route of Administration</Axiom>
            </Change>
            <Change id="563">
               <Axiom>M A Radiolabeled T101 Human T-LYMP SubClassOf Radioimmunoconjugate</Axiom>
            </Change>
            <Change id="564">
               <Axiom>CYP2D6*44 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Cytosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="565">
               <Axiom>CYP2C19*3 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
            </Change>
            <Change id="566">
               <Axiom>Peak Expiratory Flow SubClassOf Pulmonary Function Test</Axiom>
            </Change>
            <Change id="567">
               <Axiom>Abbreviation SubClassOf Terminology Entity</Axiom>
            </Change>
            <Change id="568">
               <Axiom>Gamma Particle SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="569">
               <Axiom>M A Radiolabeled Anti-BRST Cancer SubClassOf Radioimmunoconjugate</Axiom>
            </Change>
            <Change id="570">
               <Axiom>Intratumoral Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="571">
               <Axiom>RASVAC-C SubClassOf Antineoplastic Vaccine</Axiom>
            </Change>
            <Change id="572">
               <Axiom>M A Radiolabeled Anti-Carcinoma SubClassOf Radioimmunoconjugate</Axiom>
            </Change>
            <Change id="573">
               <Axiom>MoAb Bombesin (DTPA) SubClassOf Radioimmunoconjugate</Axiom>
            </Change>
            <Change id="574">
               <Axiom>CYP2C8*5 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="575">
               <Axiom>CYP2C19*7 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
            </Change>
            <Change id="576">
               <Axiom>Scan SubClassOf Medical Image</Axiom>
            </Change>
            <Change id="577">
               <Axiom>Boolean SubClassOf Data Type</Axiom>
            </Change>
            <Change id="578">
               <Axiom>CYP2C9*8 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="579">
               <Axiom>CYP2C19*8 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
            </Change>
            <Change id="580">
               <Axiom>Inhaler Refill SubClassOf Inhaler</Axiom>
            </Change>
            <Change id="581">
               <Axiom>Sodium Acetate SubClassOf Electrolyte Replacement Agent</Axiom>
            </Change>
            <Change id="582">
               <Axiom>CYP2D6*16 Allele SubClassOf Allele_Has_Abnormality some Gene Fusion Abnormality</Axiom>
            </Change>
            <Change id="583">
               <Axiom>CYP3A5*10 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="584">
               <Axiom>CYP2D6*42 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
            </Change>
            <Change id="585">
               <Axiom>CYP2E1*2 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="586">
               <Axiom>String SubClassOf Data Type</Axiom>
            </Change>
            <Change id="587">
               <Axiom>CYP2C9*16 Allele SubClassOf Allele_Has_Abnormality some Adenosine to Guanosine Transition Abnormality</Axiom>
            </Change>
            <Change id="588">
               <Axiom>CYP3A5 Gene SubClassOf Gene_Plays_Role_in_Process some Xenobiotic Metabolism</Axiom>
            </Change>
            <Change id="589">
               <Axiom>Sodium Gluconate SubClassOf Chelating Agent</Axiom>
            </Change>
            <Change id="590">
               <Axiom>CYP2D6*44 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="591">
               <Axiom>CYP3A7 Gene SubClassOf Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway</Axiom>
            </Change>
            <Change id="592">
               <Axiom>CYP3A5 Gene SubClassOf Gene_Plays_Role_in_Process some Oxidation</Axiom>
            </Change>
            <Change id="593">
               <Axiom>CYP1A2*1 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Adenosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="594">
               <Axiom>Intraepithelial Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="595">
               <Axiom>CYP3A5*8 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="596">
               <Axiom>CYP2D6*12 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="597">
               <Axiom>Pharmaceutical Product-related Substance SubClassOf Pharmacologic Substance</Axiom>
            </Change>
            <Change id="598">
               <Axiom>Reproductive Endocrine Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Reproductive System</Axiom>
            </Change>
            <Change id="599">
               <Axiom>CYP2C9*18 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="600">
               <Axiom>CYP2D6*36 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="601">
               <Axiom>CYP2C8*4 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Guanosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="602">
               <Axiom>Endocrine Disorder SubClassOf Disease_Has_Primary_Anatomic_Site only Endocrine System</Axiom>
            </Change>
            <Change id="603">
               <Axiom>CYP2C19*6 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="604">
               <Axiom>CYP2C9*3 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="605">
               <Axiom>CYP2C9*2 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
            </Change>
            <Change id="606">
               <Axiom>Uranium Ore Dust SubClassOf Inorganic Carcinogen</Axiom>
            </Change>
            <Change id="607">
               <Axiom>CYP3A5 Gene SubClassOf Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway</Axiom>
            </Change>
            <Change id="608">
               <Axiom>CYP2D6*5 Allele SubClassOf Allele_Absent_From_Wild-type_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="609">
               <Axiom>CYP2C9*2 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="610">
               <Axiom>Growth Hormone Producing Pituitary Gland Neoplasm EquivalentTo Anterior Pituitary Gland Neoplasm and (Disease_Has_Normal_Cell_Origin some Somatotroph Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Somatotroph Cell)</Axiom>
            </Change>
            <Change id="611">
               <Axiom>CYP2D6*38 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="612">
               <Axiom>Thimerosal SubClassOf Topical Anti-Infective Agent</Axiom>
            </Change>
            <Change id="613">
               <Axiom>CYP2C19*1 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
            </Change>
            <Change id="614">
               <Axiom>CYP2C8 Gene SubClassOf Gene_Plays_Role_in_Process some Oxidation</Axiom>
            </Change>
            <Change id="615">
               <Axiom>Diabetes Insipidus SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
            </Change>
            <Change id="616">
               <Axiom>Benign Adrenal Gland Neoplasm SubClassOf Benign Retroperitoneal Neoplasm</Axiom>
            </Change>
            <Change id="617">
               <Axiom>Endocervical Route of Administration SubClassOf Intracavitary Route of Administration</Axiom>
            </Change>
            <Change id="618">
               <Axiom>Adrenal Gland Insufficiency SubClassOf Disease_Has_Primary_Anatomic_Site only Adrenal Gland</Axiom>
            </Change>
            <Change id="619">
               <Axiom>CYP3A7 Gene SubClassOf Gene_Plays_Role_in_Process some Drug Metabolism</Axiom>
            </Change>
            <Change id="620">
               <Axiom>CYP2C19*7 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transversion Abnormality</Axiom>
            </Change>
            <Change id="621">
               <Axiom>CYP2D6*19 Allele SubClassOf Allele_Has_Abnormality some Multiple Transversion Abnormalities</Axiom>
            </Change>
            <Change id="622">
               <Axiom>Lactotroph Cell SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="623">
               <Axiom>Individual SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="624">
               <Axiom>Lactotroph Cell SubClassOf Acidophilic Cell</Axiom>
            </Change>
            <Change id="625">
               <Axiom>Enema Dosage Form SubClassOf Solution Dosage Form</Axiom>
            </Change>
            <Change id="626">
               <Axiom>CYP2C9*3 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transversion Abnormality</Axiom>
            </Change>
            <Change id="627">
               <Axiom>CYP3A7 Gene SubClassOf Gene_Plays_Role_in_Process some Fatty Acid Metabolism</Axiom>
            </Change>
            <Change id="628">
               <Axiom>CYP2D6*4 Allele SubClassOf Allele_Has_Abnormality some Protein Truncation Abnormality</Axiom>
            </Change>
            <Change id="629">
               <Axiom>CYP2C19*5 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
            </Change>
            <Change id="630">
               <Axiom>CYP2D6*3 Allele SubClassOf Allele_Has_Abnormality some Adenosine to Guanosine Transition Abnormality</Axiom>
            </Change>
            <Change id="631">
               <Axiom>Projected SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="632">
               <Axiom>CYP3A4*17 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="633">
               <Axiom>CYP2D6*41 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Cytosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="634">
               <Axiom>CYP2D6*21 Allele SubClassOf Allele_Has_Abnormality some Multiple Transition Abnormalities</Axiom>
            </Change>
            <Change id="635">
               <Axiom>Blood Cell Count SubClassOf Lab Test</Axiom>
            </Change>
            <Change id="636">
               <Axiom>Intrauterine Route of Administration SubClassOf Intracavitary Route of Administration</Axiom>
            </Change>
            <Change id="637">
               <Axiom>CYP2D6*7 Allele SubClassOf Allele_Has_Abnormality some Adenosine to Cytosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="638">
               <Axiom>Liniment Dosage Form SubClassOf Solution Dosage Form</Axiom>
            </Change>
            <Change id="639">
               <Axiom>Injectable Extended Release Suspension Dosage Form SubClassOf Extended Release Suspension Dosage Form</Axiom>
            </Change>
            <Change id="640">
               <Axiom>CYP2C9*12 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="641">
               <Axiom>CYP2D6*19 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="642">
               <Axiom>Milliliter SubClassOf Unit of Volume</Axiom>
            </Change>
            <Change id="643">
               <Axiom>Injectable Solution Dosage Form SubClassOf Solution Dosage Form</Axiom>
            </Change>
            <Change id="644">
               <Axiom>Strategic Code SubClassOf Code</Axiom>
            </Change>
            <Change id="645">
               <Axiom>Rinse Dosage Form SubClassOf Solution Dosage Form</Axiom>
            </Change>
            <Change id="646">
               <Axiom>CYP2D6*14 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="647">
               <Axiom>CYP2D6*21 Allele SubClassOf Allele_Has_Abnormality some Deletion Abnormality</Axiom>
            </Change>
            <Change id="648">
               <Axiom>CYP2C8 Gene SubClassOf Gene_Plays_Role_in_Process some Xenobiotic Metabolism</Axiom>
            </Change>
            <Change id="649">
               <Axiom>CYP1A2 Gene SubClassOf Gene_Plays_Role_in_Process some Xenobiotic Metabolism</Axiom>
            </Change>
            <Change id="650">
               <Axiom>CYP3A4 Gene SubClassOf Gene_In_Chromosomal_Location some 7q22.1</Axiom>
            </Change>
            <Change id="651">
               <Axiom>Mucoepidermoid Carcinoma SubClassOf Disease_May_Have_Finding some Globular Hyaline Body</Axiom>
            </Change>
            <Change id="652">
               <Axiom>CYP2C8*8 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Guanosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="653">
               <Axiom>Adrenal Gland Disorder SubClassOf Retroperitoneal Disorder</Axiom>
            </Change>
            <Change id="654">
               <Axiom>CYP3A5*9 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="655">
               <Axiom>Mouthwash Dosage Form SubClassOf Solution Dosage Form</Axiom>
            </Change>
            <Change id="656">
               <Axiom>Barcode SubClassOf Code</Axiom>
            </Change>
            <Change id="657">
               <Axiom>CYP2C19*3 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="658">
               <Axiom>CYP2C8*2 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="659">
               <Axiom>CYP2C19*10 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="660">
               <Axiom>CYP3A4*17 Allele SubClassOf Allele_In_Chromosomal_Location some 7q22.1</Axiom>
            </Change>
            <Change id="661">
               <Axiom>CYP2C9*11 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="662">
               <Axiom>Type III Epithelial Receptor Cell SubClassOf Taste Bud Cell</Axiom>
            </Change>
            <Change id="663">
               <Axiom>Sequence Object SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="664">
               <Axiom>CYP1A2*11 Allele SubClassOf Allele_In_Chromosomal_Location some 15q22-qter</Axiom>
            </Change>
            <Change id="665">
               <Axiom>Binary SubClassOf Data Type</Axiom>
            </Change>
            <Change id="666">
               <Axiom>CYP2D6*14 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="667">
               <Axiom>CYP3A5*9 Allele SubClassOf Allele_In_Chromosomal_Location some 7q22.1</Axiom>
            </Change>
            <Change id="668">
               <Axiom>Potassium Perchlorate SubClassOf Antithyroid Agent</Axiom>
            </Change>
            <Change id="669">
               <Axiom>Sulfinpyrazone SubClassOf Uricosuric Agent</Axiom>
            </Change>
            <Change id="670">
               <Axiom>M A Idiotypic Determinants SubClassOf Radioimmunoconjugate</Axiom>
            </Change>
            <Change id="671">
               <Axiom>MoAb Bombesin (ITC-D) SubClassOf Radioimmunoconjugate</Axiom>
            </Change>
            <Change id="672">
               <Axiom>CYP2D6*17 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="673">
               <Axiom>CYP2C19*4 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
            </Change>
            <Change id="674">
               <Axiom>CYP3A5 Gene SubClassOf Gene_In_Chromosomal_Location some 7q22.1</Axiom>
            </Change>
            <Change id="675">
               <Axiom>Reference Document SubClassOf Document</Axiom>
            </Change>
            <Change id="676">
               <Axiom>CYP2E1 Gene SubClassOf Gene_Plays_Role_in_Process some Xenobiotic Metabolism</Axiom>
            </Change>
            <Change id="677">
               <Axiom>Intralesional Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="678">
               <Axiom>CYP2C9*12 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="679">
               <Axiom>CYP2C8 Gene SubClassOf Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway</Axiom>
            </Change>
            <Change id="680">
               <Axiom>Pyrazole SubClassOf Pyrazole</Axiom>
            </Change>
            <Change id="681">
               <Axiom>CYP3A5*10 Allele SubClassOf Allele_Has_Abnormality some Splice-Site Mutation Abnormality</Axiom>
            </Change>
            <Change id="682">
               <Axiom>CYP2D6*35X2 Allele SubClassOf Allele_Has_Abnormality some Multiple Transversion Abnormalities</Axiom>
            </Change>
            <Change id="683">
               <Axiom>CYP2D6*20 Allele SubClassOf Allele_Has_Abnormality some Multiple Transversion Abnormalities</Axiom>
            </Change>
            <Change id="684">
               <Axiom>CYP2C8*7 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="685">
               <Axiom>Finished Pharmaceutical Product SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
            </Change>
            <Change id="686">
               <Axiom>Pyrazole SubClassOf Heterocyclic Compound</Axiom>
            </Change>
            <Change id="687">
               <Axiom>CYP2C19 Gene SubClassOf Gene_Plays_Role_in_Process some Drug Metabolism</Axiom>
            </Change>
            <Change id="688">
               <Axiom>CYP2D6*7 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="689">
               <Axiom>Thyrotroph Cell SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="690">
               <Axiom>Drug Kit SubClassOf Kit</Axiom>
            </Change>
            <Change id="691">
               <Axiom>CYP2D6*3 Allele SubClassOf Allele_Has_Abnormality some Deletion Abnormality</Axiom>
            </Change>
            <Change id="692">
               <Axiom>Selenium Sulfide SubClassOf Topical Anti-Infective Agent</Axiom>
            </Change>
            <Change id="693">
               <Axiom>CYP2C19*10 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
            </Change>
            <Change id="694">
               <Axiom>CYP2D6*13 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="695">
               <Axiom>Intraluminal Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="696">
               <Axiom>CYP3A7 Gene SubClassOf Gene_Plays_Role_in_Process some Steroid Metabolism</Axiom>
            </Change>
            <Change id="697">
               <Axiom>CYP2C8 Gene SubClassOf Gene_Plays_Role_in_Process some Fatty Acid Metabolism</Axiom>
            </Change>
            <Change id="698">
               <Axiom>Retrobulbar Route of Administration SubClassOf Ophthalmic Route of Administration</Axiom>
            </Change>
            <Change id="699">
               <Axiom>Phosphorous SubClassOf General Qualifier</Axiom>
            </Change>
            <Change id="700">
               <Axiom>CYP2E1 Gene SubClassOf Gene_Plays_Role_in_Process some Drug Metabolism</Axiom>
            </Change>
            <Change id="701">
               <Axiom>Renal Interstitial Tissue SubClassOf Connective and Soft Tissue</Axiom>
            </Change>
            <Change id="702">
               <Axiom>CYP2C19*8 Allele SubClassOf Allele_Has_Abnormality some Thymidine to Cytosine Transition Abnormality</Axiom>
            </Change>
            <Change id="703">
               <Axiom>CYP2C9*5 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Guanosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="704">
               <Axiom>CYP2C8 Gene SubClassOf Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway</Axiom>
            </Change>
            <Change id="705">
               <Axiom>Phendimetrazine Tartrate SubClassOf CNS Stimulant</Axiom>
            </Change>
            <Change id="706">
               <Axiom>CYP2C9*1 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="707">
               <Axiom>Links List SubClassOf List</Axiom>
            </Change>
            <Change id="708">
               <Axiom>CYP2D6*10 Allele SubClassOf Allele_Has_Abnormality some Multiple Transition Abnormalities</Axiom>
            </Change>
            <Change id="709">
               <Axiom>CYP2D6*11 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="710">
               <Axiom>Parathyroid Gland Carcinoma SubClassOf Malignant Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="711">
               <Axiom>CYP1A2*7 Allele SubClassOf Allele_In_Chromosomal_Location some 15q22-qter</Axiom>
            </Change>
            <Change id="712">
               <Axiom>Enteric-Coated Tablet Dosage Form SubClassOf Coated Tablet Dosage Form</Axiom>
            </Change>
            <Change id="713">
               <Axiom>CYP2C19*6 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
            </Change>
            <Change id="714">
               <Axiom>Dentifrice Paste Dosage Form SubClassOf Paste Dosage Form</Axiom>
            </Change>
            <Change id="715">
               <Axiom>CYP2C19*12 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
            </Change>
            <Change id="716">
               <Axiom>Neuroendocrine Carcinoma SubClassOf Malignant Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="717">
               <Axiom>CYP2D6*18 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="718">
               <Axiom>CYP1A2*11 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Adenosine Transversion Abnormality</Axiom>
            </Change>
            <Change id="719">
               <Axiom>Intrasinal Route of Administration SubClassOf Nasal Route of Administration</Axiom>
            </Change>
            <Change id="720">
               <Axiom>CYP2C8*6 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="721">
               <Axiom>CYP2C9*6 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="722">
               <Axiom>Intradermal Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="723">
               <Axiom>Stilbene Aldehyde SubClassOf Industrial Aid</Axiom>
            </Change>
            <Change id="724">
               <Axiom>Intracoronal Dental Route of Administration SubClassOf Dental Route of Administration</Axiom>
            </Change>
            <Change id="725">
               <Axiom>CYP2D6*20 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="726">
               <Axiom>CYP3A5*3 Allele SubClassOf Allele_Has_Abnormality some Adenosine to Guanosine Transition Abnormality</Axiom>
            </Change>
            <Change id="727">
               <Axiom>Intraductal Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="728">
               <Axiom>Congenital Adrenal Gland Disorder SubClassOf Disease_Has_Primary_Anatomic_Site only Adrenal Gland</Axiom>
            </Change>
            <Change id="729">
               <Axiom>CYP2C8*6 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="730">
               <Axiom>CYP2C8 Gene SubClassOf Gene_Plays_Role_in_Process some Drug Metabolism</Axiom>
            </Change>
            <Change id="731">
               <Axiom>Gonadal Disorder SubClassOf Reproductive System Disorder</Axiom>
            </Change>
            <Change id="732">
               <Axiom>CYP2C9*2 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="733">
               <Axiom>Type II Epithelial Receptor Cell SubClassOf Taste Bud Cell</Axiom>
            </Change>
            <Change id="734">
               <Axiom>Somatotroph Cell SubClassOf Retired Concept</Axiom>
            </Change>
            <Change id="735">
               <Axiom>CYP2C8*2 Allele SubClassOf Allele_Has_Abnormality some Adenosine to Thymidine Transversion Abnormality</Axiom>
            </Change>
            <Change id="736">
               <Axiom>CYP3A5 Gene SubClassOf Gene_Plays_Role_in_Process some Drug Metabolism</Axiom>
            </Change>
            <Change id="737">
               <Axiom>Intracorneal Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="738">
               <Axiom>Sites of Care Delivery SubClassOf Geographic Area</Axiom>
            </Change>
            <Change id="739">
               <Axiom>CYP2D6*2 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="740">
               <Axiom>Collecting Cell SubClassOf Anatomic_Structure_is_Physical_Part_of some Collecting Tube</Axiom>
            </Change>
            <Change id="741">
               <Axiom>Prolactin Producing Pituitary Gland Neoplasm EquivalentTo Anterior Pituitary Gland Neoplasm and (Disease_Has_Normal_Cell_Origin some Lactotroph Cell) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Lactotroph Cell)</Axiom>
            </Change>
            <Change id="742">
               <Axiom>CYP2C8*4 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="743">
               <Axiom>Intraocular Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="744">
               <Axiom>CYP2C19*2 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
            </Change>
            <Change id="745">
               <Axiom>Parameter SubClassOf Conceptual Entity</Axiom>
            </Change>
            <Change id="746">
               <Axiom>CYP2C9*16 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="747">
               <Axiom>CYP3A5*3 Allele SubClassOf Allele_In_Chromosomal_Location some 7q22.1</Axiom>
            </Change>
            <Change id="748">
               <Axiom>CYP2C8*7 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="749">
               <Axiom>CYP2D6*21 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="750">
               <Axiom>27-35(27L):MART-1 SubClassOf Vaccine Antigen</Axiom>
            </Change>
            <Change id="751">
               <Axiom>CYP1A2*7 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="752">
               <Axiom>Elixir Dosage Form SubClassOf Solution Dosage Form</Axiom>
            </Change>
            <Change id="753">
               <Axiom>CYP2C8*2 Allele SubClassOf Allele_Has_Activity some Decreased Activity</Axiom>
            </Change>
            <Change id="754">
               <Axiom>CYP1A2 Gene SubClassOf Gene_Plays_Role_in_Process some Drug Metabolism</Axiom>
            </Change>
            <Change id="755">
               <Axiom>CYP2C8*8 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transversion Abnormality</Axiom>
            </Change>
            <Change id="756">
               <Axiom>CYP3A5*6 Allele SubClassOf Allele_In_Chromosomal_Location some 7q22.1</Axiom>
            </Change>
            <Change id="757">
               <Axiom>CYP3A5 Gene SubClassOf Gene_Plays_Role_in_Process some Fatty Acid Metabolism</Axiom>
            </Change>
            <Change id="758">
               <Axiom>Periodontal Route of Administration SubClassOf Dental Route of Administration</Axiom>
            </Change>
            <Change id="759">
               <Axiom>Internal Elastic Membrane SubClassOf Anatomic_Structure_is_Physical_Part_of some Tunica Intima</Axiom>
            </Change>
            <Change id="760">
               <Axiom>CYP2D6*2 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
            </Change>
            <Change id="761">
               <Axiom>Intratubular Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="762">
               <Axiom>CYP3A4*18 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
            </Change>
            <Change id="763">
               <Axiom>Mucoepidermoid Carcinoma SubClassOf Disease_Has_Finding only Cystic Changes</Axiom>
            </Change>
            <Change id="764">
               <Axiom>M A 131I Osteogenic Sarcoma SubClassOf Radioimmunoconjugate</Axiom>
            </Change>
            <Change id="765">
               <Axiom>Mucoepidermoid Carcinoma SubClassOf Disease_Has_Finding only Fibrotic Stroma Formation</Axiom>
            </Change>
         </PureAddition>
         <PureAdditionWithNewTerms id="paddnt" size="46">
            <Change id="766">
               <Axiom>Thyroid Gland Follicle SubClassOf Thyroid Gland Epithelial Tissue</Axiom>
               <New_Terms>Thyroid Gland Epithelial Tissue</New_Terms>
            </Change>
            <Change id="767">
               <Axiom>Pulmonary Function Test SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="768">
               <Axiom>Blood Cell Count SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="769">
               <Axiom>PSA Assay SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="770">
               <Axiom>Paget's Disease of the Nipple SubClassOf Paget's Disease of the Breast</Axiom>
               <New_Terms>Paget's Disease of the Breast</New_Terms>
            </Change>
            <Change id="771">
               <Axiom>Mucoepidermoid Carcinoma SubClassOf Disease_Has_Abnormal_Cell only Malignant Cuboidal Mucous Cell</Axiom>
               <New_Terms>Malignant Cuboidal Mucous Cell</New_Terms>
            </Change>
            <Change id="772">
               <Axiom>Paget's Disease and Intraductal Carcinoma of the Breast SubClassOf Paget's Disease of the Breast without Invasive Carcinoma</Axiom>
               <New_Terms>Paget's Disease of the Breast without Invasive Carcinoma</New_Terms>
            </Change>
            <Change id="773">
               <Axiom>Deidentification SubClassOf Data Processing</Axiom>
               <New_Terms>Data Processing</New_Terms>
            </Change>
            <Change id="774">
               <Axiom>Radionuclide Ventriculogram Scan SubClassOf Scanning Procedure or Technique</Axiom>
               <New_Terms>Scanning Procedure or Technique</New_Terms>
            </Change>
            <Change id="775">
               <Axiom>Lymph Node Mapping SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="776">
               <Axiom>Extra-Adrenal Paraganglioma SubClassOf Disease_Has_Finding only Nesting (Zellballen) Growth Pattern</Axiom>
               <New_Terms>Nesting (Zellballen) Growth Pattern</New_Terms>
            </Change>
            <Change id="777">
               <Axiom>Mucoepidermoid Carcinoma SubClassOf Disease_Has_Abnormal_Cell only Malignant Goblet-Like Mucous Cell</Axiom>
               <New_Terms>Malignant Goblet-Like Mucous Cell</New_Terms>
            </Change>
            <Change id="778">
               <Axiom>Square Meter SubClassOf Unit of Area</Axiom>
               <New_Terms>Unit of Area</New_Terms>
            </Change>
            <Change id="779">
               <Axiom>Cutaneous Oximetry SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="780">
               <Axiom>Schiller Test SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="781">
               <Axiom>I-131 Uptake Test SubClassOf Scanning Procedure or Technique</Axiom>
               <New_Terms>Scanning Procedure or Technique</New_Terms>
            </Change>
            <Change id="782">
               <Axiom>Mucoepidermoid Carcinoma SubClassOf Disease_Has_Abnormal_Cell only Malignant Squamoid Cell</Axiom>
               <New_Terms>Malignant Squamoid Cell</New_Terms>
            </Change>
            <Change id="783">
               <Axiom>Purdue Pegboard Test SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="784">
               <Axiom>Hormone Receptor Test SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="785">
               <Axiom>Urinalysis SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="786">
               <Axiom>Ritodrine Hydrochloride SubClassOf Beta-adrenergic Agonist</Axiom>
               <New_Terms>Beta-adrenergic Agonist</New_Terms>
            </Change>
            <Change id="787">
               <Axiom>Lung Perfusion Scan SubClassOf Scanning Procedure or Technique</Axiom>
               <New_Terms>Scanning Procedure or Technique</New_Terms>
            </Change>
            <Change id="788">
               <Axiom>Gallium Scan SubClassOf Scanning Procedure or Technique</Axiom>
               <New_Terms>Scanning Procedure or Technique</New_Terms>
            </Change>
            <Change id="789">
               <Axiom>Whole-Body Scintigraphy SubClassOf Scanning Procedure or Technique</Axiom>
               <New_Terms>Scanning Procedure or Technique</New_Terms>
            </Change>
            <Change id="790">
               <Axiom>Diagnostic Test SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="791">
               <Axiom>HercepTest SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="792">
               <Axiom>Radioisotope SubClassOf Isotope</Axiom>
               <New_Terms>Isotope</New_Terms>
            </Change>
            <Change id="793">
               <Axiom>Creatinine Clearance SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="794">
               <Axiom>Diagnostic or Prognostic Tests SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="795">
               <Axiom>Skin Patch SubClassOf Patch</Axiom>
               <New_Terms>Patch</New_Terms>
            </Change>
            <Change id="796">
               <Axiom>Angiosarcoma SubClassOf Disease_Has_Abnormal_Cell only Malignant Endothelial Cell</Axiom>
               <New_Terms>Malignant Endothelial Cell</New_Terms>
            </Change>
            <Change id="797">
               <Axiom>Iron Binding Capacity SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="798">
               <Axiom>Fluorophotometry SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="799">
               <Axiom>Chemosensitivity Assay SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="800">
               <Axiom>Fecal Occult Blood Test SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="801">
               <Axiom>CYP2C8 Gene SubClassOf Gene_In_Chromosomal_Location some 10q23.33</Axiom>
               <New_Terms>10q23.33</New_Terms>
            </Change>
            <Change id="802">
               <Axiom>Partial Thromboplastin Time SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="803">
               <Axiom>Gal SubClassOf Unit of Linear Acceleration</Axiom>
               <New_Terms>Unit of Linear Acceleration</New_Terms>
            </Change>
            <Change id="804">
               <Axiom>Indium Scan SubClassOf Scanning Procedure or Technique</Axiom>
               <New_Terms>Scanning Procedure or Technique</New_Terms>
            </Change>
            <Change id="805">
               <Axiom>Bone Scan SubClassOf Scanning Procedure or Technique</Axiom>
               <New_Terms>Scanning Procedure or Technique</New_Terms>
            </Change>
            <Change id="806">
               <Axiom>CYP3A7 Gene SubClassOf Gene_In_Chromosomal_Location some 7q21-q22.1</Axiom>
               <New_Terms>7q21-q22.1</New_Terms>
            </Change>
            <Change id="807">
               <Axiom>CEA Assay SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="808">
               <Axiom>Assessment of Gonadal Function SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="809">
               <Axiom>Sestamibi Scan SubClassOf Scanning Procedure or Technique</Axiom>
               <New_Terms>Scanning Procedure or Technique</New_Terms>
            </Change>
            <Change id="810">
               <Axiom>Shortening Fraction SubClassOf Test</Axiom>
               <New_Terms>Test</New_Terms>
            </Change>
            <Change id="811">
               <Axiom>Paget's Disease of the Breast with Invasive Ductal Carcinoma SubClassOf Paget's Disease of the Breast</Axiom>
               <New_Terms>Paget's Disease of the Breast</New_Terms>
            </Change>
         </PureAdditionWithNewTerms>
         <NewModifiedDefinition id="stequiv" size="4">
            <Change id="812">
               <Axiom>CYP17A1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Adrenal Cortical Hyperplasia) and (Gene_In_Chromosomal_Location some 10q24.3) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Sexual Maturation)</Axiom>
               <Source>
                  <Axiom>CYP17A1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Adrenal Cortical Hyperplasia) and (Gene_Has_Physical_Location some 10: 104587168-104580284) and (Gene_In_Chromosomal_Location some 10q24.3) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Sexual Maturation)</Axiom>
               </Source>
            </Change>
            <Change id="813">
               <Axiom>CYP11B2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Hypertension) and (Gene_In_Chromosomal_Location some 8q21-q22) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP11B2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Hypertension) and (Gene_Has_Physical_Location some 8: 143996261-143988977) and (Gene_In_Chromosomal_Location some 8q21-q22) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism)</Axiom>
               </Source>
            </Change>
            <Change id="814">
               <Axiom>Thyroid Gland Oncocytic Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and Thyroid Gland Oncocytic Neoplasm and (Disease_May_Have_Molecular_Abnormality some PPAR-gamma Rearrangement)</Axiom>
               <Source>
                  <Axiom>Thyroid Gland Oncocytic Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and Thyroid Gland Oncocytic Neoplasm and (Disease_May_Have_Molecular_Abnormality some PPAR-gamma Rearrangement) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion)</Axiom>
               </Source>
            </Change>
            <Change id="815">
               <Axiom>CYP11B1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Adrenal Cortical Hyperplasia) and (Gene_In_Chromosomal_Location some 8q21) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP11B1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Adrenal Cortical Hyperplasia) and (Gene_Has_Physical_Location some 8: 143958238-143952218) and (Gene_In_Chromosomal_Location some 8q21) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism)</Axiom>
               </Source>
            </Change>
         </NewModifiedDefinition>
         <NewModifiedDefinitionWithNewTerms id="stequivnt" size="0"/>
      </Effectual>
      <Ineffectual id="ineffadds" size="202">
         <AddedRedundancy id="ared" size="0"/>
         <AddedRewrite id="arws" size="0">
            <AddedCompleteRewrite id="arw" size="0"/>
            <AddedPartialRewrite id="aprw" size="0"/>
         </AddedRewrite>
         <AddedProspectiveRedundancy id="apred" size="202">
            <AddedReshuffleProspectiveRedundancy id="aavred" size="0"/>
            <AddedNewProspectiveRedundancy id="anpred" size="202">
               <AddedNovelProspectiveRedundancy id="weak" size="84">
                  <Change id="816">
                     <Axiom>Intraventricular Route of Drug Administration SubClassOf Parenteral Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Intracranial Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                        <Axiom>Intracerebral Route of Administration SubClassOf Intracranial Route of Administration</Axiom>
                        <Axiom>Intraventricular Route of Drug Administration SubClassOf Intracerebral Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="817">
                     <Axiom>Intratympanic Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Intracranial Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                        <Axiom>Intratympanic Route of Administration SubClassOf Intracranial Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="818">
                     <Axiom>Aerosol Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Aerosol Dosage Form SubClassOf Gas Dosage Form</Axiom>
                        <Axiom>Gas Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Topical Dosage Form SubClassOf Dosage Form By Route Of Administration</Axiom>
                        <Axiom shared="true">Dosage Form By Route Of Administration SubClassOf Pharmaceutical Dosage Form</Axiom>
                        <Axiom>Aerosol Dosage Form SubClassOf Topical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="819">
                     <Axiom>Gamma Radiation SubClassOf Ionizing Radiation</Axiom>
                     <Source>
                        <Axiom>Gamma Radiation SubClassOf Radiation, Charged Particles</Axiom>
                        <Axiom shared="true">Radiation, Charged Particles SubClassOf Ionizing Radiation</Axiom>
                     </Source>
                  </Change>
                  <Change id="820">
                     <Axiom>Adrenal Gland Insufficiency SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom>Non-Neoplastic Adrenal Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                        <Axiom shared="true">Adrenal Gland Insufficiency SubClassOf Non-Neoplastic Adrenal Gland Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="821">
                     <Axiom>Auricular Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Topical Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Auricular Route of Administration SubClassOf Topical Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="822">
                     <Axiom>Thyroid Gland Malformation SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom>Non-Neoplastic Thyroid Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                        <Axiom shared="true">Thyroid Gland Malformation SubClassOf Non-Neoplastic Thyroid Gland Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="823">
                     <Axiom>Adrenal Cortex Adenocarcinoma SubClassOf Malignant Endocrine Neoplasm</Axiom>
                     <Source>
                        <Axiom shared="true">Adrenal Cortex Carcinoma SubClassOf Adrenal Gland Carcinoma</Axiom>
                        <Axiom>Malignant Adrenal Gland Neoplasm SubClassOf Malignant Endocrine Neoplasm</Axiom>
                        <Axiom shared="true">Adrenal Gland Carcinoma SubClassOf Malignant Adrenal Gland Neoplasm</Axiom>
                        <Axiom shared="true">Adrenal Cortex Adenocarcinoma SubClassOf Adrenal Cortex Carcinoma</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Adrenal Cortex Carcinoma SubClassOf Malignant Adrenal Cortex Neoplasm</Axiom>
                        <Axiom shared="true">Malignant Adrenal Cortex Neoplasm SubClassOf Malignant Adrenal Gland Neoplasm</Axiom>
                        <Axiom>Malignant Adrenal Gland Neoplasm SubClassOf Malignant Endocrine Neoplasm</Axiom>
                        <Axiom shared="true">Adrenal Cortex Adenocarcinoma SubClassOf Adrenal Cortex Carcinoma</Axiom>
                     </Source>
                  </Change>
                  <Change id="824">
                     <Axiom>Liquid Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Liquid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="825">
                     <Axiom>Packaging Tube SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Packaging Tube SubClassOf Container</Axiom>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="826">
                     <Axiom>Retrobulbar Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Intracranial Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                        <Axiom>Retrobulbar Route of Administration SubClassOf Intracranial Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="827">
                     <Axiom>Oil Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Liquid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Oil Dosage Form SubClassOf Liquid Dosage Form</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="828">
                     <Axiom>Lotion Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom shared="true">Topical Dosage Form SubClassOf Dosage Form By Route Of Administration</Axiom>
                        <Axiom shared="true">Dosage Form By Route Of Administration SubClassOf Pharmaceutical Dosage Form</Axiom>
                        <Axiom>Lotion Dosage Form SubClassOf Topical Dosage Form</Axiom>
                     </Source>
                     <Source>
                        <Axiom>Liquid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Lotion Dosage Form SubClassOf Liquid Dosage Form</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="829">
                     <Axiom>Alpha Particle Emitter SubClassOf Physical Phenomenon or Property</Axiom>
                     <Source>
                        <Axiom shared="true">Electromagnetic Radiation SubClassOf Physical Phenomenon or Property</Axiom>
                        <Axiom shared="true">Radiation, Charged Particles SubClassOf Ionizing Radiation</Axiom>
                        <Axiom shared="true">Ionizing Radiation SubClassOf Electromagnetic Radiation</Axiom>
                        <Axiom>Alpha Particle Emitter SubClassOf Radiation, Charged Particles</Axiom>
                     </Source>
                  </Change>
                  <Change id="830">
                     <Axiom>Carton SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom shared="true">Box SubClassOf Drug Packaging Device</Axiom>
                        <Axiom>Carton SubClassOf Box</Axiom>
                     </Source>
                  </Change>
                  <Change id="831">
                     <Axiom>Thyroiditis SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom>Non-Neoplastic Thyroid Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                        <Axiom shared="true">Thyroiditis SubClassOf Non-Neoplastic Thyroid Gland Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="832">
                     <Axiom>Gas Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Gas Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="833">
                     <Axiom>Suspension Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Liquid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Suspension Dosage Form SubClassOf Liquid Dosage Form</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="834">
                     <Axiom>Jar SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Jar SubClassOf Container</Axiom>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="835">
                     <Axiom>Benign Testicular Sertoli Cell Tumor SubClassOf Benign Endocrine Neoplasm</Axiom>
                     <Source>
                        <Axiom shared="true">Benign Testicular Sertoli Cell Tumor SubClassOf Benign Testicular Neoplasm</Axiom>
                        <Axiom>Benign Testicular Neoplasm SubClassOf Benign Endocrine Neoplasm</Axiom>
                     </Source>
                  </Change>
                  <Change id="836">
                     <Axiom>Periarticular Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Soft Tissue Route Of Administration SubClassOf Parenteral Route of Administration</Axiom>
                        <Axiom>Periarticular Route of Administration SubClassOf Soft Tissue Route Of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="837">
                     <Axiom>Detector SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
                     <Source>
                        <Axiom shared="true">Medical Device SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
                        <Axiom>Detector SubClassOf Medical Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="838">
                     <Axiom>Piggyback Vial SubClassOf Vial</Axiom>
                     <Source>
                        <Axiom shared="true">Parenteral Vial SubClassOf Vial</Axiom>
                        <Axiom>Piggyback Vial SubClassOf Parenteral Vial</Axiom>
                     </Source>
                  </Change>
                  <Change id="839">
                     <Axiom>Congenital Thyroid Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom>Non-Neoplastic Thyroid Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                        <Axiom shared="true">Congenital Thyroid Gland Disorder SubClassOf Non-Neoplastic Thyroid Gland Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="840">
                     <Axiom>Dental Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Topical Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Dental Route of Administration SubClassOf Topical Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="841">
                     <Axiom>Pituitary Gland Hypoplasia SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom>Non-Neoplastic Pituitary Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                        <Axiom shared="true">Pituitary Gland Hypoplasia SubClassOf Non-Neoplastic Pituitary Gland Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="842">
                     <Axiom>Loss of Chromosome 5q SubClassOf Chromosomal Loss</Axiom>
                     <Source>
                        <Axiom shared="true">Loss of Chromosome 5 SubClassOf Chromosomal Loss</Axiom>
                        <Axiom>Loss of Chromosome 5q SubClassOf Loss of Chromosome 5</Axiom>
                     </Source>
                  </Change>
                  <Change id="843">
                     <Axiom>Single Use Vial SubClassOf Vial</Axiom>
                     <Source>
                        <Axiom>Single Use Vial SubClassOf Parenteral Vial</Axiom>
                        <Axiom shared="true">Parenteral Vial SubClassOf Vial</Axiom>
                     </Source>
                  </Change>
                  <Change id="844">
                     <Axiom>Benign Adrenal Medulla Neoplasm SubClassOf Benign Endocrine Neoplasm</Axiom>
                     <Source>
                        <Axiom>Benign Adrenal Gland Neoplasm SubClassOf Benign Endocrine Neoplasm</Axiom>
                        <Axiom shared="true">Benign Adrenal Medulla Neoplasm SubClassOf Benign Adrenal Gland Neoplasm</Axiom>
                     </Source>
                  </Change>
                  <Change id="845">
                     <Axiom>Ampule SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Ampule SubClassOf Container</Axiom>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="846">
                     <Axiom>Malignant Adrenal Gland Pheochromocytoma SubClassOf Malignant Endocrine Neoplasm</Axiom>
                     <Source>
                        <Axiom>Malignant Adrenal Gland Neoplasm SubClassOf Malignant Endocrine Neoplasm</Axiom>
                        <Axiom shared="true">Malignant Adrenal Medulla Neoplasm SubClassOf Malignant Adrenal Gland Neoplasm</Axiom>
                        <Axiom shared="true">Malignant Adrenal Gland Pheochromocytoma SubClassOf Malignant Adrenal Medulla Neoplasm</Axiom>
                     </Source>
                  </Change>
                  <Change id="847">
                     <Axiom>Plastic Vial SubClassOf Vial</Axiom>
                     <Source>
                        <Axiom>Plastic Vial SubClassOf Parenteral Vial</Axiom>
                        <Axiom shared="true">Parenteral Vial SubClassOf Vial</Axiom>
                     </Source>
                  </Change>
                  <Change id="848">
                     <Axiom>Injectable Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom shared="true">Dosage Form By Route Of Administration SubClassOf Pharmaceutical Dosage Form</Axiom>
                        <Axiom>Injectable Dosage Form SubClassOf Parenteral Dosage Form</Axiom>
                        <Axiom shared="true">Parenteral Dosage Form SubClassOf Dosage Form By Route Of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="849">
                     <Axiom>Kit SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
                     <Source>
                        <Axiom>Kit SubClassOf Medical Device</Axiom>
                        <Axiom shared="true">Medical Device SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
                     </Source>
                  </Change>
                  <Change id="850">
                     <Axiom>Bag SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Bag SubClassOf Container</Axiom>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="851">
                     <Axiom>Packet SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                        <Axiom>Packet SubClassOf Container</Axiom>
                     </Source>
                  </Change>
                  <Change id="852">
                     <Axiom>Tabminder SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Tabminder SubClassOf Container</Axiom>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="853">
                     <Axiom>Solution Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Liquid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Solution Dosage Form SubClassOf Liquid Dosage Form</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="854">
                     <Axiom>Hyperthyroidism SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom>Non-Neoplastic Thyroid Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                        <Axiom shared="true">Hyperthyroidism SubClassOf Non-Neoplastic Thyroid Gland Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="855">
                     <Axiom>Emulsion Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Liquid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                        <Axiom>Emulsion Dosage Form SubClassOf Liquid Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="856">
                     <Axiom>Vaginal Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Topical Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Vaginal Route of Administration SubClassOf Topical Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="857">
                     <Axiom>TPMT*3A Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
                     <Source>
                        <Axiom shared="true">Guanosine to Adenosine Transition Abnormality SubClassOf Nucleotide Transition Abnormality</Axiom>
                        <Axiom>TPMT*3A Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
                     </Source>
                  </Change>
                  <Change id="858">
                     <Axiom>Blister Pack SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Blister Pack SubClassOf Container</Axiom>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="859">
                     <Axiom>Perineural Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     <Source>
                        <Axiom>Perineural Route of Administration SubClassOf Soft Tissue Route Of Administration</Axiom>
                        <Axiom shared="true">Soft Tissue Route Of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="860">
                     <Axiom>Extended Release Film Coated Capsule Dosage Form SubClassOf Coated Capsule Dosage Form</Axiom>
                     <Source>
                        <Axiom>Extended Release Film Coated Capsule Dosage Form SubClassOf Extended Release Coated Capsule Dosage Form</Axiom>
                        <Axiom shared="true">Extended Release Coated Capsule Dosage Form SubClassOf Coated Capsule Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="861">
                     <Axiom>Combination Package SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Combination Package SubClassOf Package</Axiom>
                        <Axiom shared="true">Package SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="862">
                     <Axiom>Fluoride SubClassOf Inorganic Chemical</Axiom>
                     <Source>
                        <Axiom>Fluoride SubClassOf Element</Axiom>
                        <Axiom shared="true">Element SubClassOf Inorganic Chemical</Axiom>
                     </Source>
                  </Change>
                  <Change id="863">
                     <Axiom>Hypogonadotropism SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom shared="true">Hypogonadotropism SubClassOf Non-Neoplastic Gonadal Disorder</Axiom>
                        <Axiom>Non-Neoplastic Gonadal Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="864">
                     <Axiom>Intratendinous Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     <Source>
                        <Axiom>Intratendinous Route of Administration SubClassOf Soft Tissue Route Of Administration</Axiom>
                        <Axiom shared="true">Soft Tissue Route Of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="865">
                     <Axiom>Nasal Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Mucosal Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Nasal Route of Administration SubClassOf Mucosal Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="866">
                     <Axiom>Multi Dose Vial SubClassOf Vial</Axiom>
                     <Source>
                        <Axiom>Multi Dose Vial SubClassOf Parenteral Vial</Axiom>
                        <Axiom shared="true">Parenteral Vial SubClassOf Vial</Axiom>
                     </Source>
                  </Change>
                  <Change id="867">
                     <Axiom>Pharmacy Bulk Vial SubClassOf Vial</Axiom>
                     <Source>
                        <Axiom shared="true">Parenteral Vial SubClassOf Vial</Axiom>
                        <Axiom>Pharmacy Bulk Vial SubClassOf Parenteral Vial</Axiom>
                     </Source>
                  </Change>
                  <Change id="868">
                     <Axiom>Transplacental Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Parenteral Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Transplacental Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="869">
                     <Axiom>Semisolid Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                        <Axiom>Semisolid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                     </Source>
                  </Change>
                  <Change id="870">
                     <Axiom>Single Dose Vial SubClassOf Vial</Axiom>
                     <Source>
                        <Axiom shared="true">Parenteral Vial SubClassOf Vial</Axiom>
                        <Axiom>Single Dose Vial SubClassOf Parenteral Vial</Axiom>
                     </Source>
                  </Change>
                  <Change id="871">
                     <Axiom>Parathyroid Gland Adenoma SubClassOf Benign Endocrine Neoplasm</Axiom>
                     <Source>
                        <Axiom>Benign Parathyroid Gland Neoplasm SubClassOf Benign Endocrine Neoplasm</Axiom>
                        <Axiom shared="true">Parathyroid Gland Adenoma SubClassOf Benign Parathyroid Gland Neoplasm</Axiom>
                     </Source>
                  </Change>
                  <Change id="872">
                     <Axiom>Osteoclast-Like Giant Cell SubClassOf Giant Cell</Axiom>
                     <Source>
                        <Axiom shared="true">Neoplastic Multinucleated Giant Cell SubClassOf Giant Cell</Axiom>
                        <Axiom>Osteoclast-Like Giant Cell SubClassOf Neoplastic Multinucleated Giant Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="873">
                     <Axiom>Cartridge SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Cartridge SubClassOf Container</Axiom>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="874">
                     <Axiom>Spray Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Liquid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                        <Axiom>Spray Dosage Form SubClassOf Liquid Dosage Form</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Topical Dosage Form SubClassOf Dosage Form By Route Of Administration</Axiom>
                        <Axiom shared="true">Dosage Form By Route Of Administration SubClassOf Pharmaceutical Dosage Form</Axiom>
                        <Axiom>Spray Dosage Form SubClassOf Topical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="875">
                     <Axiom>Gonadal Agenesis SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom shared="true">Gonadal Agenesis SubClassOf Non-Neoplastic Gonadal Disorder</Axiom>
                        <Axiom>Non-Neoplastic Gonadal Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="876">
                     <Axiom>Shampoo Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Shampoo Dosage Form SubClassOf Liquid Dosage Form</Axiom>
                        <Axiom>Liquid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                     </Source>
                     <Source>
                        <Axiom shared="true">Topical Dosage Form SubClassOf Dosage Form By Route Of Administration</Axiom>
                        <Axiom shared="true">Dosage Form By Route Of Administration SubClassOf Pharmaceutical Dosage Form</Axiom>
                        <Axiom>Shampoo Dosage Form SubClassOf Topical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="877">
                     <Axiom>Adrenal Gland Adenoma SubClassOf Benign Endocrine Neoplasm</Axiom>
                     <Source>
                        <Axiom>Benign Adrenal Gland Neoplasm SubClassOf Benign Endocrine Neoplasm</Axiom>
                        <Axiom shared="true">Adrenal Gland Adenoma SubClassOf Benign Adrenal Gland Neoplasm</Axiom>
                     </Source>
                  </Change>
                  <Change id="878">
                     <Axiom>Solid Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Solid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="879">
                     <Axiom>Tincture Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Liquid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Tincture Dosage Form SubClassOf Liquid Dosage Form</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="880">
                     <Axiom>Intracerebral Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Intracranial Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                        <Axiom>Intracerebral Route of Administration SubClassOf Intracranial Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="881">
                     <Axiom>Dose Pack SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Dose Pack SubClassOf Container</Axiom>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="882">
                     <Axiom>Oral Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Enteral Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Oral Route of Administration SubClassOf Enteral Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="883">
                     <Axiom>Rectal Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Enteral Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Rectal Route of Administration SubClassOf Enteral Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="884">
                     <Axiom>Genitourinary Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Topical Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Genitourinary Route of Administration SubClassOf Topical Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="885">
                     <Axiom>Bottle SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Bottle SubClassOf Container</Axiom>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="886">
                     <Axiom>Soap Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom shared="true">Topical Dosage Form SubClassOf Dosage Form By Route Of Administration</Axiom>
                        <Axiom shared="true">Dosage Form By Route Of Administration SubClassOf Pharmaceutical Dosage Form</Axiom>
                        <Axiom>Soap Dosage Form SubClassOf Topical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="887">
                     <Axiom>Thyroid Gland Atrophy SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom>Non-Neoplastic Thyroid Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                        <Axiom shared="true">Thyroid Gland Atrophy SubClassOf Non-Neoplastic Thyroid Gland Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="888">
                     <Axiom>Hypothyroidism SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom>Non-Neoplastic Thyroid Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                        <Axiom shared="true">Hypothyroidism SubClassOf Non-Neoplastic Thyroid Gland Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="889">
                     <Axiom>Intragingival Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Soft Tissue Route Of Administration SubClassOf Parenteral Route of Administration</Axiom>
                        <Axiom>Intragingival Route of Administration SubClassOf Soft Tissue Route Of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="890">
                     <Axiom>Intracavernous Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Topical Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Intracavernous Route of Administration SubClassOf Topical Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="891">
                     <Axiom>Mucoepidermoid Carcinoma SubClassOf Disease_Has_Finding only Mucoid Stroma Formation</Axiom>
                     <Source>
                        <Axiom shared="true">Mucinous Neoplasm SubClassOf Disease_Has_Finding only Mucoid Stroma Formation</Axiom>
                        <Axiom>Mucoepidermoid Carcinoma SubClassOf Mucinous Neoplasm</Axiom>
                     </Source>
                  </Change>
                  <Change id="892">
                     <Axiom>Transtympanic Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Intracranial Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                        <Axiom shared="true">Parenteral Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Transtympanic Route of Administration SubClassOf Intracranial Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="893">
                     <Axiom>Glass Vial SubClassOf Vial</Axiom>
                     <Source>
                        <Axiom shared="true">Parenteral Vial SubClassOf Vial</Axiom>
                        <Axiom>Glass Vial SubClassOf Parenteral Vial</Axiom>
                     </Source>
                  </Change>
                  <Change id="894">
                     <Axiom>Inhalant Dosage Form SubClassOf Pharmaceutical Dosage Form</Axiom>
                     <Source>
                        <Axiom>Gas Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
                        <Axiom>Inhalant Dosage Form SubClassOf Gas Dosage Form</Axiom>
                        <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="895">
                     <Axiom>Dewar SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Dewar SubClassOf Container</Axiom>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="896">
                     <Axiom>Intradiscal Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     <Source>
                        <Axiom>Intradiscal Route of Administration SubClassOf Intracartilaginous Route of Administration</Axiom>
                        <Axiom shared="true">Intracartilaginous Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="897">
                     <Axiom>Gas Cylinder SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Gas Cylinder SubClassOf Container</Axiom>
                        <Axiom shared="true">Container SubClassOf Drug Packaging Device</Axiom>
                     </Source>
                  </Change>
                  <Change id="898">
                     <Axiom>Goiter SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom>Non-Neoplastic Thyroid Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                        <Axiom shared="true">Goiter SubClassOf Non-Neoplastic Thyroid Gland Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="899">
                     <Axiom>Congenital Adrenal Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom>Non-Neoplastic Adrenal Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                        <Axiom shared="true">Congenital Adrenal Gland Disorder SubClassOf Non-Neoplastic Adrenal Gland Disorder</Axiom>
                     </Source>
                  </Change>
               </AddedNovelProspectiveRedundancy>
               <AddedPseudoNovelProspectiveRedundancy id="apseudopred" size="118">
                  <Change id="900">
                     <Axiom>CYP2D6*2N Allele SubClassOf Allele_Has_Abnormality some Gene Amplification Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*2N Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Amplification Abnormality) and (Allele_Has_Activity some Enhanced Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="901">
                     <Axiom>CYP2C9*2 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C9*2 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Mixed Nucleotide Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="902">
                     <Axiom>CYP2C19*2 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
                     <Source>
                        <Axiom>CYP2C19*2 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 10q24.1-q24.3) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="903">
                     <Axiom>CYP2C19*4 Allele SubClassOf CYP2C19 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2C19*4 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Abnormality some Translation Initiation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="904">
                     <Axiom>CYP2E1 Gene SubClassOf Gene_Is_Element_in_Pathway some Acetaminophen Pathway</Axiom>
                     <Source>
                        <Axiom>CYP2E1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Lung Carcinoma) and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 10: 135229746-135241501) and (Gene_In_Chromosomal_Location some 10q24.3-10qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Ethanol Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="905">
                     <Axiom>CYP2D6*6 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*6 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="906">
                     <Axiom>CYP2C19*2 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
                     <Source>
                        <Axiom>CYP2C19*2 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 10q24.1-q24.3) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="907">
                     <Axiom>CYP2C9*5 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C9*5 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="908">
                     <Axiom>CYP2C19*3 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C19*3 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Premature Termination Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="909">
                     <Axiom>CYP2C19*3 Allele SubClassOf CYP2C19 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2C19*3 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Premature Termination Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="910">
                     <Axiom>CYP2D6*6 Allele SubClassOf CYP2D6 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2D6*6 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="911">
                     <Axiom>CYP2D6*2N Allele SubClassOf CYP2D6 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2D6*2N Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Amplification Abnormality) and (Allele_Has_Activity some Enhanced Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="912">
                     <Axiom>CYP2D6*10 Allele SubClassOf Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*10 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="913">
                     <Axiom>CYP2D6*8 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
                     <Source>
                        <Axiom>CYP2D6*8 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Thymidine Transversion Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="914">
                     <Axiom>CYP2C19*5 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C19*5 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="915">
                     <Axiom>CYP2D6*4 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*4 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="916">
                     <Axiom>CYP2D6*6 Allele SubClassOf Allele_Has_Abnormality some Frameshift Mutation Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*6 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="917">
                     <Axiom>CYP2D6*6 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
                     <Source>
                        <Axiom>CYP2D6*6 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="918">
                     <Axiom>CYP2D6*5 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*5 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Deletion Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="919">
                     <Axiom>CYP2D6*10 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*10 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="920">
                     <Axiom>CYP2C19*2 Allele SubClassOf CYP2C19 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2C19*2 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 10q24.1-q24.3) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="921">
                     <Axiom>CYP2D6*4 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
                     <Source>
                        <Axiom>CYP2D6*4 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="922">
                     <Axiom>CYP2C9*2 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C9*2 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Mixed Nucleotide Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="923">
                     <Axiom>CYP2D6*4 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
                     <Source>
                        <Axiom>CYP2D6*4 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="924">
                     <Axiom>CYP2C19*4 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C19*4 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Abnormality some Translation Initiation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="925">
                     <Axiom>CYP2C19*3 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C19*3 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Premature Termination Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="926">
                     <Axiom>CYP2D6*8 Allele SubClassOf CYP2D6 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2D6*8 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Thymidine Transversion Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="927">
                     <Axiom>CYP3A4 Gene SubClassOf Gene_Plays_Role_in_Process some Carcinogen Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP3A4 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 7: 99026459-98999255) and (Gene_In_Chromosomal_Location some 7q21-q22) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Fatty Acid Metabolism) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism) and (Gene_Plays_Role_in_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="928">
                     <Axiom>CYP1A2 Gene SubClassOf Gene_Plays_Role_in_Process some Carcinogen Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP1A2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 15: 72828237-72835994) and (Gene_In_Chromosomal_Location some 15q22-qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Drug Efflux)</Axiom>
                     </Source>
                  </Change>
                  <Change id="929">
                     <Axiom>CYP2E1 Gene SubClassOf Gene_In_Chromosomal_Location some 10q24.3-10qter</Axiom>
                     <Source>
                        <Axiom>CYP2E1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Lung Carcinoma) and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 10: 135229746-135241501) and (Gene_In_Chromosomal_Location some 10q24.3-10qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Ethanol Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="930">
                     <Axiom>CYP2D6*6 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
                     <Source>
                        <Axiom>CYP2D6*6 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="931">
                     <Axiom>CYP2C9*5 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C9*5 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="932">
                     <Axiom>CYP1A2 Gene SubClassOf Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway</Axiom>
                     <Source>
                        <Axiom>CYP1A2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 15: 72828237-72835994) and (Gene_In_Chromosomal_Location some 15q22-qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Drug Efflux)</Axiom>
                     </Source>
                  </Change>
                  <Change id="933">
                     <Axiom>CYP2D6*8 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*8 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Thymidine Transversion Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="934">
                     <Axiom>CYP2C19*5 Allele SubClassOf CYP2C19 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2C19*5 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="935">
                     <Axiom>CYP2D6*1 Allele SubClassOf Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antipsychotic Agent</Axiom>
                     <Source>
                        <Axiom>CYP2D6*1 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antidepressant Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antipsychotic Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Lidocaine)</Axiom>
                     </Source>
                  </Change>
                  <Change id="936">
                     <Axiom>CYP2D6*5 Allele SubClassOf CYP2D6 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2D6*5 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Deletion Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="937">
                     <Axiom>CYP2D6*5 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*5 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Deletion Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="938">
                     <Axiom>CYP1A2 Gene SubClassOf Gene_Is_Element_in_Pathway some Acetaminophen Pathway</Axiom>
                     <Source>
                        <Axiom>CYP1A2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 15: 72828237-72835994) and (Gene_In_Chromosomal_Location some 15q22-qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Drug Efflux)</Axiom>
                     </Source>
                  </Change>
                  <Change id="939">
                     <Axiom>CYP2D6*10 Allele SubClassOf Allele_Has_Activity some Decreased Activity</Axiom>
                     <Source>
                        <Axiom>CYP2D6*10 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="940">
                     <Axiom>CYP2D6*17 Allele SubClassOf CYP2D6 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2D6*17 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="941">
                     <Axiom>CYP2D6*4 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*4 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="942">
                     <Axiom>CYP2D6*1 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*1 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antidepressant Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antipsychotic Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Lidocaine)</Axiom>
                     </Source>
                  </Change>
                  <Change id="943">
                     <Axiom>CYP2C19*4 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C19*4 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Abnormality some Translation Initiation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="944">
                     <Axiom>CYP2C9*1 Allele SubClassOf Allele_Has_Abnormality some Deletion Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2C9*1 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Thymidine to Cytosine Transition Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Ibuprofen) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Phenytoin) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Warfarin)</Axiom>
                     </Source>
                  </Change>
                  <Change id="945">
                     <Axiom>CYP2D6*10 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
                     <Source>
                        <Axiom>CYP2D6*10 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="946">
                     <Axiom>CYP2D6*2N Allele SubClassOf Allele_Has_Activity some Enhanced Activity</Axiom>
                     <Source>
                        <Axiom>CYP2D6*2N Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Amplification Abnormality) and (Allele_Has_Activity some Enhanced Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="947">
                     <Axiom>CYP2D6*4 Allele SubClassOf CYP2D6 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2D6*4 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="948">
                     <Axiom>CYP2E1 Gene SubClassOf Gene_Plays_Role_in_Process some Carcinogen Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2E1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Lung Carcinoma) and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 10: 135229746-135241501) and (Gene_In_Chromosomal_Location some 10q24.3-10qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Ethanol Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="949">
                     <Axiom>CYP1A2 Gene SubClassOf Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway</Axiom>
                     <Source>
                        <Axiom>CYP1A2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 15: 72828237-72835994) and (Gene_In_Chromosomal_Location some 15q22-qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Drug Efflux)</Axiom>
                     </Source>
                  </Change>
                  <Change id="950">
                     <Axiom>CYP3A4 Gene SubClassOf Gene_Plays_Role_in_Process some Steroid Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP3A4 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 7: 99026459-98999255) and (Gene_In_Chromosomal_Location some 7q21-q22) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Fatty Acid Metabolism) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism) and (Gene_Plays_Role_in_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="951">
                     <Axiom>CYP2D6*17 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*17 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="952">
                     <Axiom>CYP2C9*5 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transversion Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2C9*5 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="953">
                     <Axiom>CYP2C19*3 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
                     <Source>
                        <Axiom>CYP2C19*3 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Premature Termination Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="954">
                     <Axiom>CYP2D6*1 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transversion Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*1 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antidepressant Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antipsychotic Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Lidocaine)</Axiom>
                     </Source>
                  </Change>
                  <Change id="955">
                     <Axiom>CYP2E1 Gene SubClassOf Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway</Axiom>
                     <Source>
                        <Axiom>CYP2E1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Lung Carcinoma) and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 10: 135229746-135241501) and (Gene_In_Chromosomal_Location some 10q24.3-10qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Ethanol Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="956">
                     <Axiom>CYP2C19*4 Allele SubClassOf Allele_Has_Abnormality some Translation Initiation Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2C19*4 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Abnormality some Translation Initiation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="957">
                     <Axiom>CYP2E1 Gene SubClassOf Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway</Axiom>
                     <Source>
                        <Axiom>CYP2E1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Lung Carcinoma) and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 10: 135229746-135241501) and (Gene_In_Chromosomal_Location some 10q24.3-10qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Ethanol Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="958">
                     <Axiom>CYP2E1 Gene SubClassOf Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway</Axiom>
                     <Source>
                        <Axiom>CYP2E1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Lung Carcinoma) and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 10: 135229746-135241501) and (Gene_In_Chromosomal_Location some 10q24.3-10qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Ethanol Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="959">
                     <Axiom>CYP1A2 Gene SubClassOf Gene_In_Chromosomal_Location some 15q22-qter</Axiom>
                     <Source>
                        <Axiom>CYP1A2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 15: 72828237-72835994) and (Gene_In_Chromosomal_Location some 15q22-qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Drug Efflux)</Axiom>
                     </Source>
                  </Change>
                  <Change id="960">
                     <Axiom>CYP2D6*1 Allele SubClassOf Allele_Has_Activity some Standard Activity</Axiom>
                     <Source>
                        <Axiom>CYP2D6*1 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antidepressant Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antipsychotic Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Lidocaine)</Axiom>
                     </Source>
                  </Change>
                  <Change id="961">
                     <Axiom>CYP2D6*4 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*4 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                        <Axiom shared="true">Guanosine to Adenosine Transition Abnormality SubClassOf Nucleotide Transition Abnormality</Axiom>
                     </Source>
                  </Change>
                  <Change id="962">
                     <Axiom>CYP2D6*2N Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*2N Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Amplification Abnormality) and (Allele_Has_Activity some Enhanced Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="963">
                     <Axiom>CYP2D6*17 Allele SubClassOf Allele_Has_Activity some Decreased Activity</Axiom>
                     <Source>
                        <Axiom>CYP2D6*17 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="964">
                     <Axiom>CYP2D6*8 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*8 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Thymidine Transversion Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="965">
                     <Axiom>CYP3A4 Gene SubClassOf Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway</Axiom>
                     <Source>
                        <Axiom>CYP3A4 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 7: 99026459-98999255) and (Gene_In_Chromosomal_Location some 7q21-q22) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Fatty Acid Metabolism) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism) and (Gene_Plays_Role_in_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="966">
                     <Axiom>CYP2D6*1 Allele SubClassOf CYP2D6 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2D6*1 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antidepressant Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antipsychotic Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Lidocaine)</Axiom>
                     </Source>
                  </Change>
                  <Change id="967">
                     <Axiom>CYP2D6*5 Allele SubClassOf Allele_Has_Abnormality some Gene Deletion Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*5 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Deletion Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="968">
                     <Axiom>CYP2E1 Gene SubClassOf Gene_Plays_Role_in_Process some Ethanol Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2E1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Lung Carcinoma) and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 10: 135229746-135241501) and (Gene_In_Chromosomal_Location some 10q24.3-10qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Ethanol Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="969">
                     <Axiom>CYP2C9*1 Allele SubClassOf Allele_Has_Activity some Standard Activity</Axiom>
                     <Source>
                        <Axiom>CYP2C9*1 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Thymidine to Cytosine Transition Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Ibuprofen) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Phenytoin) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Warfarin)</Axiom>
                     </Source>
                  </Change>
                  <Change id="970">
                     <Axiom>CYP2C19*3 Allele SubClassOf Allele_Has_Abnormality some Frameshift Mutation Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2C19*3 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Premature Termination Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="971">
                     <Axiom>CYP3A4 Gene SubClassOf Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway</Axiom>
                     <Source>
                        <Axiom>CYP3A4 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 7: 99026459-98999255) and (Gene_In_Chromosomal_Location some 7q21-q22) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Fatty Acid Metabolism) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism) and (Gene_Plays_Role_in_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="972">
                     <Axiom>CYP3A4 Gene SubClassOf Gene_Plays_Role_in_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP3A4 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 7: 99026459-98999255) and (Gene_In_Chromosomal_Location some 7q21-q22) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Fatty Acid Metabolism) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism) and (Gene_Plays_Role_in_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="973">
                     <Axiom>CYP3A4 Gene SubClassOf Gene_Found_In_Organism some Human</Axiom>
                     <Source>
                        <Axiom>CYP3A4 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 7: 99026459-98999255) and (Gene_In_Chromosomal_Location some 7q21-q22) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Fatty Acid Metabolism) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism) and (Gene_Plays_Role_in_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="974">
                     <Axiom>CYP2C19*2 Allele SubClassOf Allele_Has_Abnormality some Frameshift Mutation Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2C19*2 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 10q24.1-q24.3) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="975">
                     <Axiom>CYP1A2 Gene SubClassOf Cytochrome P450 Family Gene</Axiom>
                     <Source>
                        <Axiom>CYP1A2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 15: 72828237-72835994) and (Gene_In_Chromosomal_Location some 15q22-qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Drug Efflux)</Axiom>
                     </Source>
                  </Change>
                  <Change id="976">
                     <Axiom>CYP2D6*4 Allele SubClassOf Allele_Has_Abnormality some Splice-Site Mutation Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*4 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="977">
                     <Axiom>CYP2D6*10 Allele SubClassOf CYP2D6 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2D6*10 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="978">
                     <Axiom>CYP2E1 Gene SubClassOf Gene_Associated_With_Disease some Lung Carcinoma</Axiom>
                     <Source>
                        <Axiom>CYP2E1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Lung Carcinoma) and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 10: 135229746-135241501) and (Gene_In_Chromosomal_Location some 10q24.3-10qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Ethanol Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="979">
                     <Axiom>CYP2C19*4 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
                     <Source>
                        <Axiom>CYP2C19*4 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Abnormality some Translation Initiation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="980">
                     <Axiom>CYP2C19*5 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2C19*5 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="981">
                     <Axiom>CYP2D6*8 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Thymidine Transversion Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*8 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Thymidine Transversion Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="982">
                     <Axiom>CYP2C19*5 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
                     <Source>
                        <Axiom>CYP2C19*5 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="983">
                     <Axiom>CYP2D6*1 Allele SubClassOf Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antidepressant Agent</Axiom>
                     <Source>
                        <Axiom>CYP2D6*1 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antidepressant Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antipsychotic Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Lidocaine)</Axiom>
                     </Source>
                  </Change>
                  <Change id="984">
                     <Axiom>CYP2C9*2 Allele SubClassOf Allele_Has_Activity some Decreased Activity</Axiom>
                     <Source>
                        <Axiom>CYP2C9*2 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Mixed Nucleotide Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="985">
                     <Axiom>CYP2D6*8 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
                     <Source>
                        <Axiom>CYP2D6*8 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Thymidine Transversion Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="986">
                     <Axiom>CYP2C9*5 Allele SubClassOf CYP2C9 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2C9*5 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="987">
                     <Axiom>CYP2C19*2 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C19*2 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 10q24.1-q24.3) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="988">
                     <Axiom>CYP2C9*5 Allele SubClassOf Allele_Has_Activity some Decreased Activity</Axiom>
                     <Source>
                        <Axiom>CYP2C9*5 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="989">
                     <Axiom>CYP2D6*17 Allele SubClassOf Allele_In_Chromosomal_Location some 22q13.1</Axiom>
                     <Source>
                        <Axiom>CYP2D6*17 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="990">
                     <Axiom>CYP2D6*6 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*6 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="991">
                     <Axiom>CYP2E1 Gene SubClassOf Gene_Found_In_Organism some Human</Axiom>
                     <Source>
                        <Axiom>CYP2E1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Lung Carcinoma) and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 10: 135229746-135241501) and (Gene_In_Chromosomal_Location some 10q24.3-10qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Ethanol Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="992">
                     <Axiom>CYP3A4 Gene SubClassOf Gene_Plays_Role_in_Process some Fatty Acid Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP3A4 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 7: 99026459-98999255) and (Gene_In_Chromosomal_Location some 7q21-q22) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Fatty Acid Metabolism) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism) and (Gene_Plays_Role_in_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="993">
                     <Axiom>CYP2D6*1 Allele SubClassOf Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Lidocaine</Axiom>
                     <Source>
                        <Axiom>CYP2D6*1 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antidepressant Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antipsychotic Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Lidocaine)</Axiom>
                     </Source>
                  </Change>
                  <Change id="994">
                     <Axiom>CYP2C9*1 Allele SubClassOf CYP2C9 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2C9*1 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Thymidine to Cytosine Transition Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Ibuprofen) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Phenytoin) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Warfarin)</Axiom>
                     </Source>
                  </Change>
                  <Change id="995">
                     <Axiom>CYP2D6*2N Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*2N Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Amplification Abnormality) and (Allele_Has_Activity some Enhanced Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="996">
                     <Axiom>CYP2C19*2 Allele SubClassOf Allele_Has_Abnormality some Splice-Site Mutation Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2C19*2 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 10q24.1-q24.3) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="997">
                     <Axiom>CYP2C9*2 Allele SubClassOf CYP2C9 Gene</Axiom>
                     <Source>
                        <Axiom>CYP2C9*2 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Mixed Nucleotide Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="998">
                     <Axiom>CYP2D6*6 Allele SubClassOf Allele_Has_Abnormality some Protein Truncation Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*6 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="999">
                     <Axiom>CYP1A2 Gene SubClassOf Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway</Axiom>
                     <Source>
                        <Axiom>CYP1A2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 15: 72828237-72835994) and (Gene_In_Chromosomal_Location some 15q22-qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Drug Efflux)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1000">
                     <Axiom>CYP2C19*2 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C19*2 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 10q24.1-q24.3) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1001">
                     <Axiom>CYP2E1 Gene SubClassOf Cytochrome P450 Family Gene</Axiom>
                     <Source>
                        <Axiom>CYP2E1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Lung Carcinoma) and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 10: 135229746-135241501) and (Gene_In_Chromosomal_Location some 10q24.3-10qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Ethanol Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1002">
                     <Axiom>CYP2D6*8 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transversion Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*8 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Thymidine Transversion Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                        <Axiom shared="true">Guanosine to Thymidine Transversion Abnormality SubClassOf Nucleotide Transversion Abnormality</Axiom>
                     </Source>
                  </Change>
                  <Change id="1003">
                     <Axiom>CYP2D6*5 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
                     <Source>
                        <Axiom>CYP2D6*5 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Deletion Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1004">
                     <Axiom>CYP3A4 Gene SubClassOf Gene_Plays_Role_in_Process some Oxidation</Axiom>
                     <Source>
                        <Axiom>CYP3A4 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 7: 99026459-98999255) and (Gene_In_Chromosomal_Location some 7q21-q22) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Fatty Acid Metabolism) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism) and (Gene_Plays_Role_in_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1005">
                     <Axiom>CYP2D6*17 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*17 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1006">
                     <Axiom>CYP3A4 Gene SubClassOf Cytochrome P450 Family Gene</Axiom>
                     <Source>
                        <Axiom>CYP3A4 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 7: 99026459-98999255) and (Gene_In_Chromosomal_Location some 7q21-q22) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Fatty Acid Metabolism) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism) and (Gene_Plays_Role_in_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1007">
                     <Axiom>CYP3A4 Gene SubClassOf Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway</Axiom>
                     <Source>
                        <Axiom>CYP3A4 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 7: 99026459-98999255) and (Gene_In_Chromosomal_Location some 7q21-q22) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Fatty Acid Metabolism) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism) and (Gene_Plays_Role_in_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1008">
                     <Axiom>CYP2D6*10 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*10 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1009">
                     <Axiom>CYP2C9*1 Allele SubClassOf Allele_Has_Abnormality some Thymidine to Cytosine Transition Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2C9*1 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Thymidine to Cytosine Transition Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Ibuprofen) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Phenytoin) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Warfarin)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1010">
                     <Axiom>CYP2D6*4 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2D6*4 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1011">
                     <Axiom>CYP2D6*17 Allele SubClassOf Allele_Has_Abnormality some Multiple Transition Abnormalities</Axiom>
                     <Source>
                        <Axiom>CYP2D6*17 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1012">
                     <Axiom>CYP2D6*6 Allele SubClassOf Allele_Has_Abnormality some Deletion Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*6 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1013">
                     <Axiom>CYP2C19*3 Allele SubClassOf Allele_Has_Abnormality some Premature Termination Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2C19*3 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Premature Termination Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1014">
                     <Axiom>CYP1A2 Gene SubClassOf Gene_Found_In_Organism some Human</Axiom>
                     <Source>
                        <Axiom>CYP1A2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 15: 72828237-72835994) and (Gene_In_Chromosomal_Location some 15q22-qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Drug Efflux)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1015">
                     <Axiom>CYP2C9*1 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
                     <Source>
                        <Axiom shared="true">Thymidine to Cytosine Transition Abnormality SubClassOf Nucleotide Transition Abnormality</Axiom>
                        <Axiom>CYP2C9*1 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Thymidine to Cytosine Transition Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Ibuprofen) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Phenytoin) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Warfarin)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1016">
                     <Axiom>CYP2C19*5 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
                     <Source>
                        <Axiom>CYP2C19*5 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1017">
                     <Axiom>CYP2D6*8 Allele SubClassOf Allele_Has_Abnormality some Protein Truncation Abnormality</Axiom>
                     <Source>
                        <Axiom>CYP2D6*8 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Thymidine Transversion Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
                     </Source>
                  </Change>
               </AddedPseudoNovelProspectiveRedundancy>
            </AddedNewProspectiveRedundancy>
         </AddedProspectiveRedundancy>
      </Ineffectual>
   </Additions>
   <Removals id="rems" size="487">
      <Effectual id="effrems" size="287">
         <Weakening id="wk" size="18">
            <Change id="1018">
               <Axiom>CYP2C9*2 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Mixed Nucleotide Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2C9*2 Allele SubClassOf Allele_Has_Activity some Decreased Activity</Axiom>
               </Source>
            </Change>
            <Change id="1019">
               <Axiom>CYP2E1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Lung Carcinoma) and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 10: 135229746-135241501) and (Gene_In_Chromosomal_Location some 10q24.3-10qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Ethanol Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2E1 Gene SubClassOf Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway</Axiom>
               </Source>
            </Change>
            <Change id="1020">
               <Axiom>CYP2D6*17 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2D6*17 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
               </Source>
            </Change>
            <Change id="1021">
               <Axiom>CYP2D6*2N Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Amplification Abnormality) and (Allele_Has_Activity some Enhanced Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2D6*2N Allele SubClassOf CYP2D6 Gene</Axiom>
               </Source>
            </Change>
            <Change id="1022">
               <Axiom>CYP2D6*5 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Gene Deletion Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2D6*5 Allele SubClassOf Allele_Has_Abnormality some Gene Deletion Abnormality</Axiom>
               </Source>
            </Change>
            <Change id="1023">
               <Axiom>CYP2C9*5 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2C9*5 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
               </Source>
            </Change>
            <Change id="1024">
               <Axiom>CYP3A4 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 7: 99026459-98999255) and (Gene_In_Chromosomal_Location some 7q21-q22) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Fatty Acid Metabolism) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism) and (Gene_Plays_Role_in_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP3A4 Gene SubClassOf Gene_Plays_Role_in_Process some Xenobiotic Metabolism</Axiom>
               </Source>
            </Change>
            <Change id="1025">
               <Axiom>CYP2D6*8 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Thymidine Transversion Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2D6*8 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism</Axiom>
               </Source>
            </Change>
            <Change id="1026">
               <Axiom>CYP2C19*5 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Missense Mutation Abnormality) and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2C19*5 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
               </Source>
            </Change>
            <Change id="1027">
               <Axiom>CYP2C19*4 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Multiple Transition Abnormalities) and (Allele_Has_Abnormality some Translation Initiation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2C19*4 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
               </Source>
            </Change>
            <Change id="1028">
               <Axiom>CYP2C19*3 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Premature Termination Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2C19*3 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
               </Source>
            </Change>
            <Change id="1029">
               <Axiom>CYP2D6*4 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2D6*4 Allele SubClassOf Allele_Has_Activity some Inactive</Axiom>
               </Source>
            </Change>
            <Change id="1030">
               <Axiom>CYP1A2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Found_In_Organism some Human) and (Gene_Has_Physical_Location some 15: 72828237-72835994) and (Gene_In_Chromosomal_Location some 15q22-qter) and (Gene_Is_Element_in_Pathway some Acetaminophen Pathway) and (Gene_Is_Element_in_Pathway some Fatty Acid Metabolism Pathway) and (Gene_Is_Element_in_Pathway some Lipid Metabolism and Toxicity Pathway) and (Gene_Is_Element_in_Pathway some Tryptophan Metabolism Pathway) and (Gene_Plays_Role_in_Process some Carcinogen Metabolism) and (Gene_Plays_Role_in_Process some Drug Efflux)</Axiom>
               <Source>
                  <Axiom>CYP1A2 Gene SubClassOf Gene_In_Chromosomal_Location some 15q22-qter</Axiom>
               </Source>
            </Change>
            <Change id="1031">
               <Axiom>CYP2C9*1 Allele EquivalentTo CYP2C9 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Thymidine to Cytosine Transition Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Ibuprofen) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Phenytoin) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Warfarin)</Axiom>
               <Source>
                  <Axiom>CYP2C9*1 Allele SubClassOf Allele_Has_Activity some Standard Activity</Axiom>
               </Source>
            </Change>
            <Change id="1032">
               <Axiom>CYP2D6*6 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Deletion Abnormality) and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Protein Truncation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2D6*6 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
               </Source>
            </Change>
            <Change id="1033">
               <Axiom>CYP2D6*10 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Cytosine to Thymidine Transition Abnormality) and (Allele_Has_Activity some Decreased Activity) and (Allele_In_Chromosomal_Location some 22q13.1) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2D6*10 Allele SubClassOf Allele_Plays_Altered_Role_In_Process some Drug Metabolism</Axiom>
               </Source>
            </Change>
            <Change id="1034">
               <Axiom>CYP2C19*2 Allele EquivalentTo CYP2C19 Gene and (Allele_Has_Abnormality some Frameshift Mutation Abnormality) and (Allele_Has_Abnormality some Splice-Site Mutation Abnormality) and (Allele_Has_Activity some Inactive) and (Allele_In_Chromosomal_Location some 10q24.1-q24.3) and (Allele_Plays_Altered_Role_In_Process some Drug Metabolism) and (Allele_Plays_Altered_Role_In_Process some Xenobiotic Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP2C19*2 Allele SubClassOf Allele_In_Chromosomal_Location some 10q24.1-q24.3</Axiom>
               </Source>
            </Change>
            <Change id="1035">
               <Axiom>CYP2D6*1 Allele EquivalentTo CYP2D6 Gene and (Allele_Has_Abnormality some Nucleotide Transition Abnormality) and (Allele_Has_Abnormality some Nucleotide Transversion Abnormality) and (Allele_Has_Activity some Standard Activity) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antidepressant Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antipsychotic Agent) and (Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Lidocaine)</Axiom>
               <Source>
                  <Axiom>CYP2D6*1 Allele SubClassOf Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Antidepressant Agent</Axiom>
               </Source>
            </Change>
         </Weakening>
         <WeakeningWithRetiredTerms id="wkrt" size="0"/>
         <RetiredDescription id="retdesc" size="0"/>
         <PureRemoval id="prem" size="266">
            <Change id="1036">
               <Axiom>Parameter SubClassOf UML Entity</Axiom>
            </Change>
            <Change id="1037">
               <Axiom>Non-Neoplastic Adrenal Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
            </Change>
            <Change id="1038">
               <Axiom>Bag SubClassOf Container</Axiom>
            </Change>
            <Change id="1039">
               <Axiom>Auricular Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1040">
               <Axiom>Retrobulbar Route of Administration SubClassOf Intracranial Route of Administration</Axiom>
            </Change>
            <Change id="1041">
               <Axiom>Alpha Particle Emitter SubClassOf Radiation, Charged Particles</Axiom>
            </Change>
            <Change id="1042">
               <Axiom>Endocrine Disorder SubClassOf Disease_Has_Associated_Anatomic_Site only Endocrine System</Axiom>
            </Change>
            <Change id="1043">
               <Axiom>Somatotroph Cell SubClassOf Acidophilic Cell</Axiom>
            </Change>
            <Change id="1044">
               <Axiom>Patch Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1045">
               <Axiom>Douche Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1046">
               <Axiom>Plaster Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1047">
               <Axiom>Injectable Solution Dosage Form SubClassOf Injectable Dosage Form</Axiom>
            </Change>
            <Change id="1048">
               <Axiom>RASVAC-V SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1049">
               <Axiom>Intraepidermal Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1050">
               <Axiom>Lotion Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1051">
               <Axiom>Stick Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1052">
               <Axiom>Powder For Injectable Extended Release Suspension Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1053">
               <Axiom>Detector SubClassOf Medical Device</Axiom>
            </Change>
            <Change id="1054">
               <Axiom>Extended Release Granule For Suspension Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1055">
               <Axiom>Emulsion For Injection Dosage Form SubClassOf Injectable Dosage Form</Axiom>
            </Change>
            <Change id="1056">
               <Axiom>Extended Release Coated Pellets Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1057">
               <Axiom>M A Radiolabeled Anti-BRST Cancer SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1058">
               <Axiom>Internal Elastic Membrane SubClassOf Anatomic_Structure_is_Physical_Part_of some Tunica Media</Axiom>
            </Change>
            <Change id="1059">
               <Axiom>Packaging Tube SubClassOf Container</Axiom>
            </Change>
            <Change id="1060">
               <Axiom>Thyroid Gland Carcinoma SubClassOf Malignant Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="1061">
               <Axiom>CYP2C9*3 Allele SubClassOf Allele_Has_Abnormality some Missense Mutation Abnormality</Axiom>
            </Change>
            <Change id="1062">
               <Axiom>Globule Dosage Form SubClassOf Oral Dosage Form</Axiom>
            </Change>
            <Change id="1063">
               <Axiom>Delayed Release Granule Dosage Form SubClassOf Delayed-Release Dosage Form</Axiom>
            </Change>
            <Change id="1064">
               <Axiom>Intradermal Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1065">
               <Axiom>Malignant Placental Neoplasm SubClassOf Malignant Female Reproductive System Neoplasm</Axiom>
            </Change>
            <Change id="1066">
               <Axiom>CYP2C19 Gene SubClassOf Gene_Has_Physical_Location some 10: 96512453-96602661</Axiom>
            </Change>
            <Change id="1067">
               <Axiom>27-35(27L):MART-1 SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1068">
               <Axiom>Intraepithelial Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1069">
               <Axiom>Pyrazole SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1070">
               <Axiom>Suppository Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1071">
               <Axiom>Delayed Release Pellets in Capsule Dosage Form SubClassOf Delayed-Release Dosage Form</Axiom>
            </Change>
            <Change id="1072">
               <Axiom>Injectable Suspension Dosage Form SubClassOf Injectable Dosage Form</Axiom>
            </Change>
            <Change id="1073">
               <Axiom>Oil Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1074">
               <Axiom>Jar SubClassOf Container</Axiom>
            </Change>
            <Change id="1075">
               <Axiom>Prolactin Producing Pituitary Gland Neoplasm EquivalentTo Anterior Pituitary Gland Neoplasm and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Lactotroph Cell) and (Disease_Has_Normal_Cell_Origin only Lactotroph Cell)</Axiom>
            </Change>
            <Change id="1076">
               <Axiom>Abbreviation SubClassOf Conceptual Entity</Axiom>
            </Change>
            <Change id="1077">
               <Axiom>Dewar SubClassOf Container</Axiom>
            </Change>
            <Change id="1078">
               <Axiom>Single Use Vial SubClassOf Parenteral Vial</Axiom>
            </Change>
            <Change id="1079">
               <Axiom>Peak Expiratory Flow SubClassOf Diagnostic or Prognostic Tests</Axiom>
            </Change>
            <Change id="1080">
               <Axiom>Thyroid Gland Nodule SubClassOf Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue</Axiom>
            </Change>
            <Change id="1081">
               <Axiom>Liquid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
            </Change>
            <Change id="1082">
               <Axiom>Enteric-Coated Tablet Dosage Form SubClassOf Oral Dosage Form</Axiom>
            </Change>
            <Change id="1083">
               <Axiom>Benign Parathyroid Gland Neoplasm SubClassOf Benign Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="1084">
               <Axiom>Extended Release Film Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1085">
               <Axiom>Mucoepidermoid Carcinoma SubClassOf Disease_Has_Finding only Mucinous Differentiation</Axiom>
            </Change>
            <Change id="1086">
               <Axiom>Mucoepidermoid Carcinoma SubClassOf Disease_Has_Finding only Squamoid Differentiation</Axiom>
            </Change>
            <Change id="1087">
               <Axiom>Glass Vial SubClassOf Parenteral Vial</Axiom>
            </Change>
            <Change id="1088">
               <Axiom>Lotion Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1089">
               <Axiom>Intragingival Route of Administration SubClassOf Soft Tissue Route Of Administration</Axiom>
            </Change>
            <Change id="1090">
               <Axiom>Strategic Code SubClassOf Business Rules</Axiom>
            </Change>
            <Change id="1091">
               <Axiom>Aerosol Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1092">
               <Axiom>Non-Neoplastic Pituitary Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
            </Change>
            <Change id="1093">
               <Axiom>Lozenge Dosage Form SubClassOf Oral Dosage Form</Axiom>
            </Change>
            <Change id="1094">
               <Axiom>Carton SubClassOf Box</Axiom>
            </Change>
            <Change id="1095">
               <Axiom>Cone Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1096">
               <Axiom>Irrigant Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1097">
               <Axiom>Rinse Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1098">
               <Axiom>Troche Dosage Form SubClassOf Oral Dosage Form</Axiom>
            </Change>
            <Change id="1099">
               <Axiom>M A Idiotypic Determinants SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1100">
               <Axiom>Indium Scan SubClassOf Scan</Axiom>
            </Change>
            <Change id="1101">
               <Axiom>Extended Release Suppository Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1102">
               <Axiom>CYP2D6*35X2 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transversion Abnormality</Axiom>
            </Change>
            <Change id="1103">
               <Axiom>Transtympanic Route of Administration SubClassOf Intracranial Route of Administration</Axiom>
            </Change>
            <Change id="1104">
               <Axiom>Spray Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1105">
               <Axiom>Mouthwash Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1106">
               <Axiom>Loss of Chromosome 5q SubClassOf Loss of Chromosome 5</Axiom>
            </Change>
            <Change id="1107">
               <Axiom>Extended Release Film Coated Capsule Dosage Form SubClassOf Extended Release Coated Capsule Dosage Form</Axiom>
            </Change>
            <Change id="1108">
               <Axiom>Aerosol Dosage Form SubClassOf Gas Dosage Form</Axiom>
            </Change>
            <Change id="1109">
               <Axiom>Kit SubClassOf Medical Device</Axiom>
            </Change>
            <Change id="1110">
               <Axiom>Intratendinous Route of Administration SubClassOf Soft Tissue Route Of Administration</Axiom>
            </Change>
            <Change id="1111">
               <Axiom>Soap Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1112">
               <Axiom>Deidentification SubClassOf Clinical or Research Activity</Axiom>
            </Change>
            <Change id="1113">
               <Axiom>Lactotroph Cell SubClassOf Acidophilic Cell</Axiom>
            </Change>
            <Change id="1114">
               <Axiom>Injectable Lipid Complex Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1115">
               <Axiom>Spray Suspension Dosage Form SubClassOf Spray Dosage Form</Axiom>
            </Change>
            <Change id="1116">
               <Axiom>RASVAC-C SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1117">
               <Axiom>Intradiscal Route of Administration SubClassOf Intracartilaginous Route of Administration</Axiom>
            </Change>
            <Change id="1118">
               <Axiom>Syrup Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1119">
               <Axiom>Non-Neoplastic Gonadal Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
            </Change>
            <Change id="1120">
               <Axiom>Paste Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1121">
               <Axiom>Cream Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1122">
               <Axiom>Intracavernous Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1123">
               <Axiom>Paget's Disease of the Breast with Invasive Ductal Carcinoma SubClassOf Complex Epithelial Neoplasm</Axiom>
            </Change>
            <Change id="1124">
               <Axiom>Dental Liner Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1125">
               <Axiom>Irrigant Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1126">
               <Axiom>Multilayered Extended Release Tablet Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1127">
               <Axiom>Individual SubClassOf Person</Axiom>
            </Change>
            <Change id="1128">
               <Axiom>Swish and Swallow Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1129">
               <Axiom>Radionuclide Ventriculogram Scan SubClassOf Scan</Axiom>
            </Change>
            <Change id="1130">
               <Axiom>Film Coated Extended Release Tablet Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1131">
               <Axiom>CYP3A5 Gene SubClassOf Gene_In_Chromosomal_Location some 7q22</Axiom>
            </Change>
            <Change id="1132">
               <Axiom>Sulfinpyrazone SubClassOf Miscellaneous Adjuvant</Axiom>
            </Change>
            <Change id="1133">
               <Axiom>Benign Placental Neoplasm SubClassOf Benign Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="1134">
               <Axiom>Hypodermic Tablet Dosage Form SubClassOf Injectable Dosage Form</Axiom>
            </Change>
            <Change id="1135">
               <Axiom>Gamma Particle SubClassOf Ionizing Radiation</Axiom>
            </Change>
            <Change id="1136">
               <Axiom>Applicator Tube SubClassOf Packaging Tube</Axiom>
            </Change>
            <Change id="1137">
               <Axiom>Vaginal Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1138">
               <Axiom>Piggyback Vial SubClassOf Parenteral Vial</Axiom>
            </Change>
            <Change id="1139">
               <Axiom>Dosage Form By Phase of Matter SubClassOf Pharmaceutical Dosage Form</Axiom>
            </Change>
            <Change id="1140">
               <Axiom>ISIS 3521 SubClassOf Protein Kinase C Inhibitor</Axiom>
            </Change>
            <Change id="1141">
               <Axiom>Lymphokine-Activated Natural Killer Cell SubClassOf Activated Lymphocyte</Axiom>
            </Change>
            <Change id="1142">
               <Axiom>CYP2C9 Gene SubClassOf Gene_Has_Physical_Location some 10: 96688430-96739137</Axiom>
            </Change>
            <Change id="1143">
               <Axiom>Extended Release Core Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1144">
               <Axiom>Oral Route of Administration SubClassOf Enteral Route of Administration</Axiom>
            </Change>
            <Change id="1145">
               <Axiom>Rectal Route of Administration SubClassOf Enteral Route of Administration</Axiom>
            </Change>
            <Change id="1146">
               <Axiom>Concentration SubClassOf Measurement</Axiom>
            </Change>
            <Change id="1147">
               <Axiom>Pulmonary Function Test SubClassOf Procedure</Axiom>
            </Change>
            <Change id="1148">
               <Axiom>Scan SubClassOf Procedure</Axiom>
            </Change>
            <Change id="1149">
               <Axiom>Delayed Release Capsule Dosage Form SubClassOf Delayed-Release Dosage Form</Axiom>
            </Change>
            <Change id="1150">
               <Axiom>Delayed Release Particles Tablet Dosage Form SubClassOf Delayed-Release Dosage Form</Axiom>
            </Change>
            <Change id="1151">
               <Axiom>Fluoride SubClassOf Element</Axiom>
            </Change>
            <Change id="1152">
               <Axiom>Nasal Route of Administration SubClassOf Mucosal Route of Administration</Axiom>
            </Change>
            <Change id="1153">
               <Axiom>Powder For Injectable Solution Dosage Form SubClassOf Injectable Dosage Form</Axiom>
            </Change>
            <Change id="1154">
               <Axiom>Enema Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1155">
               <Axiom>Douche Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1156">
               <Axiom>Malignant Adrenal Gland Neoplasm SubClassOf Malignant Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="1157">
               <Axiom>M A Radiolabeled T101 Human T-LYMP SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1158">
               <Axiom>Paget's Disease and Intraductal Carcinoma of the Breast SubClassOf Complex Epithelial Neoplasm</Axiom>
            </Change>
            <Change id="1159">
               <Axiom>Pharmaceutical Product-related Substance SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1160">
               <Axiom>Mucoepidermoid Carcinoma SubClassOf Mucinous Neoplasm</Axiom>
            </Change>
            <Change id="1161">
               <Axiom>Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia SubClassOf Disease_Has_Finding only Squamoid Differentiation</Axiom>
            </Change>
            <Change id="1162">
               <Axiom>Blister Pack SubClassOf Container</Axiom>
            </Change>
            <Change id="1163">
               <Axiom>Packet SubClassOf Container</Axiom>
            </Change>
            <Change id="1164">
               <Axiom>Intracoronal Dental Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1165">
               <Axiom>MoAb Bombesin (ITC-D) SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1166">
               <Axiom>Barcode SubClassOf Business Rules</Axiom>
            </Change>
            <Change id="1167">
               <Axiom>Injectable Dosage Form SubClassOf Parenteral Dosage Form</Axiom>
            </Change>
            <Change id="1168">
               <Axiom>Benign Testicular Neoplasm SubClassOf Benign Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="1169">
               <Axiom>M A Radiolabeled Anti-Carcinoma SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1170">
               <Axiom>Benign Placental Neoplasm SubClassOf Benign Female Reproductive System Neoplasm</Axiom>
            </Change>
            <Change id="1171">
               <Axiom>Sodium Acetate SubClassOf Drug Vehicle</Axiom>
            </Change>
            <Change id="1172">
               <Axiom>Tablet Triturate Dosage Form SubClassOf Oral Dosage Form</Axiom>
            </Change>
            <Change id="1173">
               <Axiom>Delayed Release Tablet Dosage Form SubClassOf Delayed-Release Dosage Form</Axiom>
            </Change>
            <Change id="1174">
               <Axiom>Transplacental Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
            </Change>
            <Change id="1175">
               <Axiom>Shampoo Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1176">
               <Axiom>Binary SubClassOf Value</Axiom>
            </Change>
            <Change id="1177">
               <Axiom>Reference Document SubClassOf UML Entity</Axiom>
            </Change>
            <Change id="1178">
               <Axiom>Periodontal Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1179">
               <Axiom>Inhalant Dosage Form SubClassOf Gas Dosage Form</Axiom>
            </Change>
            <Change id="1180">
               <Axiom>Skin Patch SubClassOf Patch Dosage Form</Axiom>
            </Change>
            <Change id="1181">
               <Axiom>Gallium Scan SubClassOf Scan</Axiom>
            </Change>
            <Change id="1182">
               <Axiom>Sites of Care Delivery SubClassOf NCI Administrative Concept</Axiom>
            </Change>
            <Change id="1183">
               <Axiom>Multi Dose Vial SubClassOf Parenteral Vial</Axiom>
            </Change>
            <Change id="1184">
               <Axiom>Stilbene Aldehyde SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1185">
               <Axiom>Combination Package SubClassOf Package</Axiom>
            </Change>
            <Change id="1186">
               <Axiom>Dental Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1187">
               <Axiom>TSH Producing Pituitary Gland Neoplasm EquivalentTo Anterior Pituitary Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Thyrotroph Cell) and (Disease_Has_Normal_Cell_Origin only Thyrotroph Cell)</Axiom>
            </Change>
            <Change id="1188">
               <Axiom>Lipstick Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1189">
               <Axiom>Sequence Object SubClassOf UML Entity</Axiom>
            </Change>
            <Change id="1190">
               <Axiom>Lyophilized Powder For Extended Release Injectable Suspension Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1191">
               <Axiom>Tabminder SubClassOf Container</Axiom>
            </Change>
            <Change id="1192">
               <Axiom>Single Dose Vial SubClassOf Parenteral Vial</Axiom>
            </Change>
            <Change id="1193">
               <Axiom>Gonadal Disorder SubClassOf Endocrine Disorder</Axiom>
            </Change>
            <Change id="1194">
               <Axiom>Cartridge SubClassOf Container</Axiom>
            </Change>
            <Change id="1195">
               <Axiom>Pill Dosage Form SubClassOf Oral Dosage Form</Axiom>
            </Change>
            <Change id="1196">
               <Axiom>Extended Release Patch Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1197">
               <Axiom>Liniment Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1198">
               <Axiom>Lung Perfusion Scan SubClassOf Scan</Axiom>
            </Change>
            <Change id="1199">
               <Axiom>Powder Aerosol Dosage Form SubClassOf Powder Dosage Form</Axiom>
            </Change>
            <Change id="1200">
               <Axiom>Thyroid Gland Undifferentiated Small Cell Carcinoma SubClassOf Thyroid Gland Undifferentiated (Anaplastic) Carcinoma</Axiom>
            </Change>
            <Change id="1201">
               <Axiom>CYP11A1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Has_Physical_Location some 15: 72447020-72417157) and (Gene_In_Chromosomal_Location some 15q23-q24) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism)</Axiom>
            </Change>
            <Change id="1202">
               <Axiom>Injectable Extended Release Suspension Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1203">
               <Axiom>Gas Cylinder SubClassOf Container</Axiom>
            </Change>
            <Change id="1204">
               <Axiom>Non-Neoplastic Parathyroid Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
            </Change>
            <Change id="1205">
               <Axiom>CYP2C8 Gene SubClassOf Gene_In_Chromosomal_Location some 10q24</Axiom>
            </Change>
            <Change id="1206">
               <Axiom>Extended Release Coated Capsule Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1207">
               <Axiom>M A 131I Osteogenic Sarcoma SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1208">
               <Axiom>Mouthwash Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1209">
               <Axiom>Wafer Dosage Form SubClassOf Parenteral Dosage Form</Axiom>
            </Change>
            <Change id="1210">
               <Axiom>Extended Release Core Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1211">
               <Axiom>Intratumoral Route of Administration SubClassOf Intralesional Route of Administration</Axiom>
            </Change>
            <Change id="1212">
               <Axiom>CYP2D6*35X2 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
            </Change>
            <Change id="1213">
               <Axiom>Phosphorous SubClassOf Element</Axiom>
            </Change>
            <Change id="1214">
               <Axiom>Extended Release Gel Forming Solution Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1215">
               <Axiom>Bone Scan SubClassOf Scan</Axiom>
            </Change>
            <Change id="1216">
               <Axiom>Spray Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1217">
               <Axiom>CYP2C8*2 Allele SubClassOf Allele_Has_Activity some Standard Activity</Axiom>
            </Change>
            <Change id="1218">
               <Axiom>Parathyroid Gland Disorder SubClassOf Endocrine Disorder</Axiom>
            </Change>
            <Change id="1219">
               <Axiom>CYP3A7 Gene SubClassOf Gene_In_Chromosomal_Location some 7q22</Axiom>
            </Change>
            <Change id="1220">
               <Axiom>Elixir Dosage Form SubClassOf Oral Dosage Form</Axiom>
            </Change>
            <Change id="1221">
               <Axiom>MoAb Bombesin (DTPA) SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1222">
               <Axiom>Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia SubClassOf Disease_Has_Finding only Eosinophilia</Axiom>
            </Change>
            <Change id="1223">
               <Axiom>Genitourinary Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1224">
               <Axiom>Intrabiliary Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1225">
               <Axiom>Bottle SubClassOf Container</Axiom>
            </Change>
            <Change id="1226">
               <Axiom>Powder For Injectable Suspension Dosage Form SubClassOf Injectable Dosage Form</Axiom>
            </Change>
            <Change id="1227">
               <Axiom>Placental Neoplasm SubClassOf Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="1228">
               <Axiom>Plastic Vial SubClassOf Parenteral Vial</Axiom>
            </Change>
            <Change id="1229">
               <Axiom>Dose Pack SubClassOf Container</Axiom>
            </Change>
            <Change id="1230">
               <Axiom>CYP2D6 Gene SubClassOf Gene_Has_Physical_Location some 22: 40851379-40847001</Axiom>
            </Change>
            <Change id="1231">
               <Axiom>CYP2C8*8 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transition Abnormality</Axiom>
            </Change>
            <Change id="1232">
               <Axiom>Endosinusial Route of Administration SubClassOf Intracranial Route of Administration</Axiom>
            </Change>
            <Change id="1233">
               <Axiom>Finished Pharmaceutical Product SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1234">
               <Axiom>Chewable Bar Dosage Form SubClassOf Oral Dosage Form</Axiom>
            </Change>
            <Change id="1235">
               <Axiom>Dentifrice Paste Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1236">
               <Axiom>Speed SubClassOf Measurement</Axiom>
            </Change>
            <Change id="1237">
               <Axiom>Injectable Extended Release Suspension Dosage Form SubClassOf Injectable Suspension Dosage Form</Axiom>
            </Change>
            <Change id="1238">
               <Axiom>Adrenal Gland Neoplasm SubClassOf Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="1239">
               <Axiom>I-131 Uptake Test SubClassOf Scan</Axiom>
            </Change>
            <Change id="1240">
               <Axiom>Pharmacy Bulk Vial SubClassOf Parenteral Vial</Axiom>
            </Change>
            <Change id="1241">
               <Axiom>Thyroid Gland Carcinoma SubClassOf Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle</Axiom>
            </Change>
            <Change id="1242">
               <Axiom>TPMT*3A Allele SubClassOf Allele_Has_Abnormality some Guanosine to Adenosine Transition Abnormality</Axiom>
            </Change>
            <Change id="1243">
               <Axiom>Thyrotroph Cell SubClassOf Acidophilic Cell</Axiom>
            </Change>
            <Change id="1244">
               <Axiom>Benign Adrenal Gland Neoplasm SubClassOf Benign Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="1245">
               <Axiom>Syrup Dosage Form SubClassOf Oral Dosage Form</Axiom>
            </Change>
            <Change id="1246">
               <Axiom>Oral Tablet Dosage Form SubClassOf Oral Dosage Form</Axiom>
            </Change>
            <Change id="1247">
               <Axiom>Gamma Radiation SubClassOf Radiation, Charged Particles</Axiom>
            </Change>
            <Change id="1248">
               <Axiom>Solid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
            </Change>
            <Change id="1249">
               <Axiom>Intratympanic Route of Administration SubClassOf Intracranial Route of Administration</Axiom>
            </Change>
            <Change id="1250">
               <Axiom>Intrasinal Route of Administration SubClassOf Intracranial Route of Administration</Axiom>
            </Change>
            <Change id="1251">
               <Axiom>Suspension Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1252">
               <Axiom>Salve Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1253">
               <Axiom>Shampoo Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1254">
               <Axiom>Sodium Gluconate SubClassOf Nutritional Supplement</Axiom>
            </Change>
            <Change id="1255">
               <Axiom>Gas Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
            </Change>
            <Change id="1256">
               <Axiom>Elixir Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1257">
               <Axiom>Selenium Sulfide SubClassOf Inorganic Carcinogen</Axiom>
            </Change>
            <Change id="1258">
               <Axiom>Boolean SubClassOf Value</Axiom>
            </Change>
            <Change id="1259">
               <Axiom>Parathyroid Gland Neoplasm SubClassOf Endocrine Neoplasm</Axiom>
            </Change>
            <Change id="1260">
               <Axiom>Liniment Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1261">
               <Axiom>Placental Non-Neoplastic Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
            </Change>
            <Change id="1262">
               <Axiom>Perineural Route of Administration SubClassOf Soft Tissue Route Of Administration</Axiom>
            </Change>
            <Change id="1263">
               <Axiom>Rinse Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1264">
               <Axiom>Potassium Perchlorate SubClassOf Diagnostic Reagent</Axiom>
            </Change>
            <Change id="1265">
               <Axiom>M A TAC Conjugated Pseudomonas EXO SubClassOf Unclassified Drugs and Chemicals</Axiom>
            </Change>
            <Change id="1266">
               <Axiom>Intracerebral Route of Administration SubClassOf Intracranial Route of Administration</Axiom>
            </Change>
            <Change id="1267">
               <Axiom>Intralesional Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1268">
               <Axiom>CYP2C19*1 Allele SubClassOf Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug some Proton Pump Inhibitor</Axiom>
            </Change>
            <Change id="1269">
               <Axiom>Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia SubClassOf Disease_Has_Finding only Fibrosis</Axiom>
            </Change>
            <Change id="1270">
               <Axiom>Whole-Body Scintigraphy SubClassOf Scan</Axiom>
            </Change>
            <Change id="1271">
               <Axiom>Semisolid Dosage Form SubClassOf Dosage Form By Phase of Matter</Axiom>
            </Change>
            <Change id="1272">
               <Axiom>Intraventricular Route of Drug Administration SubClassOf Intracerebral Route of Administration</Axiom>
            </Change>
            <Change id="1273">
               <Axiom>Adrenal Gland Disorder SubClassOf Endocrine Disorder</Axiom>
            </Change>
            <Change id="1274">
               <Axiom>Extended Release Insert Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1275">
               <Axiom>Gum Dosage Form SubClassOf Oral Dosage Form</Axiom>
            </Change>
            <Change id="1276">
               <Axiom>Sestamibi Scan SubClassOf Scan</Axiom>
            </Change>
            <Change id="1277">
               <Axiom>CYP2C9*3 Allele SubClassOf Allele_Has_Abnormality some Mixed Nucleotide Abnormalities</Axiom>
            </Change>
            <Change id="1278">
               <Axiom>Projected SubClassOf General Qualifier</Axiom>
            </Change>
            <Change id="1279">
               <Axiom>Enema Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1280">
               <Axiom>Thyroid Gland Nodule SubClassOf Disease_Has_Primary_Anatomic_Site only Thyroid Gland</Axiom>
            </Change>
            <Change id="1281">
               <Axiom>Radioisotope SubClassOf Element</Axiom>
            </Change>
            <Change id="1282">
               <Axiom>Emulsion Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1283">
               <Axiom>Solution Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1284">
               <Axiom>Uranium Ore Dust SubClassOf Radioactive Element</Axiom>
            </Change>
            <Change id="1285">
               <Axiom>Dressing Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1286">
               <Axiom>Osteoclast-Like Giant Cell SubClassOf Neoplastic Multinucleated Giant Cell</Axiom>
            </Change>
            <Change id="1287">
               <Axiom>Blood Cell Count SubClassOf Laboratory Study</Axiom>
            </Change>
            <Change id="1288">
               <Axiom>Endocervical Route of Administration SubClassOf Topical Route of Administration</Axiom>
            </Change>
            <Change id="1289">
               <Axiom>Placenta Disorder SubClassOf Endocrine Disorder</Axiom>
            </Change>
            <Change id="1290">
               <Axiom>Non-Neoplastic Thyroid Gland Disorder SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
            </Change>
            <Change id="1291">
               <Axiom>Extended Release Tablet Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1292">
               <Axiom>Periarticular Route of Administration SubClassOf Soft Tissue Route Of Administration</Axiom>
            </Change>
            <Change id="1293">
               <Axiom>Extended Release Suspension Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1294">
               <Axiom>Tincture Dosage Form SubClassOf Liquid Dosage Form</Axiom>
            </Change>
            <Change id="1295">
               <Axiom>Ointment Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1296">
               <Axiom>Growth Hormone Producing Pituitary Gland Neoplasm EquivalentTo Anterior Pituitary Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Somatotroph Cell) and (Disease_Has_Normal_Cell_Origin only Somatotroph Cell)</Axiom>
            </Change>
            <Change id="1297">
               <Axiom>Cloning Site SubClassOf Miscellaneous Molecular Biology Terms</Axiom>
            </Change>
            <Change id="1298">
               <Axiom>Ampule SubClassOf Container</Axiom>
            </Change>
            <Change id="1299">
               <Axiom>Extended Release Insert Dosage Form SubClassOf Topical Dosage Form</Axiom>
            </Change>
            <Change id="1300">
               <Axiom>Extended Release Capsule Dosage Form SubClassOf Extended-Release Dosage Form</Axiom>
            </Change>
            <Change id="1301">
               <Axiom>Scale SubClassOf General Qualifier</Axiom>
            </Change>
         </PureRemoval>
         <PureRemovalWithRetiredTerms id="premrt" size="0"/>
         <RetiredModifiedDefinition id="wkequiv" size="3">
            <Change id="1302">
               <Axiom>CYP11B2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Hypertension) and (Gene_Has_Physical_Location some 8: 143996261-143988977) and (Gene_In_Chromosomal_Location some 8q21-q22) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP11B2 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Hypertension) and (Gene_In_Chromosomal_Location some 8q21-q22) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism)</Axiom>
               </Source>
            </Change>
            <Change id="1303">
               <Axiom>CYP17A1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Adrenal Cortical Hyperplasia) and (Gene_Has_Physical_Location some 10: 104587168-104580284) and (Gene_In_Chromosomal_Location some 10q24.3) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Sexual Maturation)</Axiom>
               <Source>
                  <Axiom>CYP17A1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Adrenal Cortical Hyperplasia) and (Gene_In_Chromosomal_Location some 10q24.3) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Sexual Maturation)</Axiom>
               </Source>
            </Change>
            <Change id="1304">
               <Axiom>CYP11B1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Adrenal Cortical Hyperplasia) and (Gene_Has_Physical_Location some 8: 143958238-143952218) and (Gene_In_Chromosomal_Location some 8q21) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism)</Axiom>
               <Source>
                  <Axiom>CYP11B1 Gene EquivalentTo Cytochrome P450 Family Gene and (Gene_Associated_With_Disease some Adrenal Cortical Hyperplasia) and (Gene_In_Chromosomal_Location some 8q21) and (Gene_Plays_Role_in_Process some Oxidation) and (Gene_Plays_Role_in_Process some Steroid Metabolism)</Axiom>
               </Source>
            </Change>
         </RetiredModifiedDefinition>
         <RetiredModifiedDefinitionWithRetiredTerms id="wkequivrt" size="0"/>
      </Effectual>
      <Ineffectual id="ineffrems" size="200">
         <RemovedRedundancy id="rred" size="1">
            <Change id="1305">
               <Axiom>Sex Cord-Stromal Tumor SubClassOf Neoplasm by Morphology</Axiom>
               <Source>
                  <Axiom shared="true">Epithelial Neoplasm SubClassOf Neoplasm by Morphology</Axiom>
                  <Axiom shared="true">Reproductive Endocrine Neoplasm SubClassOf Endocrine Neoplasm</Axiom>
                  <Axiom shared="true">Endocrine Neoplasm SubClassOf Epithelial Neoplasm</Axiom>
                  <Axiom shared="true">Sex Cord-Stromal Tumor SubClassOf Reproductive Endocrine Neoplasm</Axiom>
               </Source>
            </Change>
         </RemovedRedundancy>
         <RemovedRewrite id="rrws" size="0">
            <RemovedCompleteRewrite id="rrw" size="0"/>
            <RemovedPartialRewrite id="rprw" size="0"/>
         </RemovedRewrite>
         <RemovedProspectiveRedundancy id="rpred" size="199">
            <RemovedReshuffleProspectiveRedundancy id="ravred" size="0"/>
            <RemovedNewProspectiveRedundancy id="rnpred" size="199">
               <RemovedNovelProspectiveRedundancy id="strength" size="37">
                  <Change id="1306">
                     <Axiom>Intrauterine Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Intracavitary Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Intrauterine Route of Administration SubClassOf Intracavitary Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="1307">
                     <Axiom>Paget's Disease and Intraductal Carcinoma of the Breast SubClassOf Breast Adenocarcinoma</Axiom>
                     <Source>
                        <Axiom>Paget's Disease and Intraductal Carcinoma of the Breast SubClassOf Paget's Disease of the Breast without Invasive Carcinoma</Axiom>
                        <Axiom>Paget's Disease of the Breast SubClassOf Breast Adenocarcinoma</Axiom>
                        <Axiom>Paget's Disease of the Breast without Invasive Carcinoma SubClassOf Paget's Disease of the Breast</Axiom>
                     </Source>
                  </Change>
                  <Change id="1308">
                     <Axiom>Somatotroph Cell SubClassOf Glandular Cell</Axiom>
                     <Source>
                        <Axiom>Somatotroph Cell SubClassOf Acidophilic Cell</Axiom>
                        <Axiom shared="true">Acidophilic Cell SubClassOf Adenohypophysial Cell</Axiom>
                        <Axiom shared="true">Adenohypophysial Cell SubClassOf Glandular Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="1309">
                     <Axiom>Thyroid Gland Papillary Carcinoma SubClassOf Disease_May_Have_Finding some Radiation Toxicity</Axiom>
                     <Source>
                        <Axiom>Differentiated Thyroid Gland Carcinoma EquivalentTo Thyroid Gland Adenocarcinoma and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Has_Finding only Follicular Cell Differentiation)</Axiom>
                        <Axiom>Thyroid Gland Papillary Carcinoma EquivalentTo Papillary Adenocarcinoma and Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_May_Have_Molecular_Abnormality some TRK Rearrangement) and (Disease_Has_Finding only Ground Glass Nuclear Inclusion) and (Disease_Has_Finding only Nuclear Grooves) and (Disease_Has_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1310">
                     <Axiom>Percutaneous Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Topical Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Percutaneous Route of Administration SubClassOf Topical Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="1311">
                     <Axiom>Enteric-Coated Tablet Dosage Form SubClassOf Tablet Dosage Form</Axiom>
                     <Source>
                        <Axiom shared="true">Coated Tablet Dosage Form SubClassOf Tablet Dosage Form</Axiom>
                        <Axiom>Enteric-Coated Tablet Dosage Form SubClassOf Coated Tablet Dosage Form</Axiom>
                     </Source>
                  </Change>
                  <Change id="1312">
                     <Axiom>Thyroid Gland Follicle SubClassOf Thyroid Gland Tissue</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicle SubClassOf Thyroid Gland Epithelial Tissue</Axiom>
                        <Axiom>Thyroid Gland Epithelial Tissue SubClassOf Thyroid Gland Tissue</Axiom>
                     </Source>
                  </Change>
                  <Change id="1313">
                     <Axiom>Lactotroph Cell SubClassOf Anatomic_Structure_is_Physical_Part_of some Anterior Lobe of the Pituitary Gland</Axiom>
                     <Source>
                        <Axiom shared="true">Acidophilic Cell SubClassOf Adenohypophysial Cell</Axiom>
                        <Axiom shared="true">Adenohypophysial Cell SubClassOf Anatomic_Structure_is_Physical_Part_of some Anterior Lobe of the Pituitary Gland</Axiom>
                        <Axiom>Lactotroph Cell SubClassOf Acidophilic Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="1314">
                     <Axiom>Thyrotroph Cell SubClassOf Anatomic_Structure_is_Physical_Part_of some Anterior Lobe of the Pituitary Gland</Axiom>
                     <Source>
                        <Axiom>Thyrotroph Cell SubClassOf Acidophilic Cell</Axiom>
                        <Axiom shared="true">Acidophilic Cell SubClassOf Adenohypophysial Cell</Axiom>
                        <Axiom shared="true">Adenohypophysial Cell SubClassOf Anatomic_Structure_is_Physical_Part_of some Anterior Lobe of the Pituitary Gland</Axiom>
                     </Source>
                  </Change>
                  <Change id="1315">
                     <Axiom>Diabetes Insipidus SubClassOf Endocrine Disorder</Axiom>
                     <Source>
                        <Axiom shared="true">Non-Neoplastic Endocrine Disorder SubClassOf Endocrine Disorder</Axiom>
                        <Axiom>Diabetes Insipidus SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="1316">
                     <Axiom>Type II Epithelial Receptor Cell SubClassOf Epithelial Receptor Cell</Axiom>
                     <Source>
                        <Axiom>Type II Epithelial Receptor Cell SubClassOf Taste Bud Cell</Axiom>
                        <Axiom shared="true">Taste Bud Cell SubClassOf Epithelial Receptor Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="1317">
                     <Axiom>Paget's Disease of the Nipple SubClassOf Breast Adenocarcinoma</Axiom>
                     <Source>
                        <Axiom>Paget's Disease of the Breast SubClassOf Breast Adenocarcinoma</Axiom>
                        <Axiom>Paget's Disease of the Nipple SubClassOf Paget's Disease of the Breast</Axiom>
                     </Source>
                  </Change>
                  <Change id="1318">
                     <Axiom>Links List SubClassOf Document</Axiom>
                     <Source>
                        <Axiom shared="true">List SubClassOf Document</Axiom>
                        <Axiom>Links List SubClassOf List</Axiom>
                     </Source>
                  </Change>
                  <Change id="1319">
                     <Axiom>Lactotroph Cell SubClassOf Glandular Cell</Axiom>
                     <Source>
                        <Axiom shared="true">Acidophilic Cell SubClassOf Adenohypophysial Cell</Axiom>
                        <Axiom shared="true">Adenohypophysial Cell SubClassOf Glandular Cell</Axiom>
                        <Axiom>Lactotroph Cell SubClassOf Acidophilic Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="1320">
                     <Axiom>Intrabronchial Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom>Intrabronchial Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                        <Axiom shared="true">Parenteral Route of Administration SubClassOf Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="1321">
                     <Axiom>Intratubular Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Parenteral Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Intratubular Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="1322">
                     <Axiom>Paget's Disease of the Nipple SubClassOf Paget's Disease</Axiom>
                     <Source>
                        <Axiom>Paget's Disease of the Breast SubClassOf Paget's Disease</Axiom>
                        <Axiom>Paget's Disease of the Nipple SubClassOf Paget's Disease of the Breast</Axiom>
                     </Source>
                  </Change>
                  <Change id="1323">
                     <Axiom>Cubic Meter SubClassOf Unit by Category</Axiom>
                     <Source>
                        <Axiom shared="true">Unit of Volume SubClassOf Unit by Category</Axiom>
                        <Axiom>Cubic Meter SubClassOf Unit of Volume</Axiom>
                     </Source>
                  </Change>
                  <Change id="1324">
                     <Axiom>Paget's Disease of the Breast with Invasive Ductal Carcinoma SubClassOf Breast Adenocarcinoma</Axiom>
                     <Source>
                        <Axiom>Paget's Disease of the Breast with Invasive Ductal Carcinoma SubClassOf Paget's Disease of the Breast</Axiom>
                        <Axiom>Paget's Disease of the Breast SubClassOf Breast Adenocarcinoma</Axiom>
                     </Source>
                  </Change>
                  <Change id="1325">
                     <Axiom>Collecting Cell SubClassOf Epithelial Cell</Axiom>
                     <Source>
                        <Axiom shared="true">Cuboidal Cell SubClassOf Glandular Cell</Axiom>
                        <Axiom>Collecting Cell SubClassOf Cuboidal Cell</Axiom>
                        <Axiom shared="true">Glandular Cell SubClassOf Epithelial Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="1326">
                     <Axiom>Oropharyngeal Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom>Oropharyngeal Route of Administration SubClassOf Oral Route of Administration</Axiom>
                        <Axiom>Oral Route of Administration SubClassOf Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="1327">
                     <Axiom>Square Meter SubClassOf Unit by Category</Axiom>
                     <Source>
                        <Axiom>Square Meter SubClassOf Unit of Area</Axiom>
                        <Axiom>Unit of Area SubClassOf Unit by Category</Axiom>
                     </Source>
                  </Change>
                  <Change id="1328">
                     <Axiom>Tetrahydrozoline Hydrochloride SubClassOf Adrenergic Agent</Axiom>
                     <Source>
                        <Axiom shared="true">Alpha-adrenergic Agonist SubClassOf Adrenergic Agent</Axiom>
                        <Axiom>Tetrahydrozoline Hydrochloride SubClassOf Alpha-adrenergic Agonist</Axiom>
                     </Source>
                  </Change>
                  <Change id="1329">
                     <Axiom>Type I Epithelial Receptor Cell SubClassOf Epithelial Receptor Cell</Axiom>
                     <Source>
                        <Axiom>Type I Epithelial Receptor Cell SubClassOf Taste Bud Cell</Axiom>
                        <Axiom shared="true">Taste Bud Cell SubClassOf Epithelial Receptor Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="1330">
                     <Axiom>Somatotroph Cell SubClassOf Anatomic_Structure_is_Physical_Part_of some Anterior Lobe of the Pituitary Gland</Axiom>
                     <Source>
                        <Axiom>Somatotroph Cell SubClassOf Acidophilic Cell</Axiom>
                        <Axiom shared="true">Acidophilic Cell SubClassOf Adenohypophysial Cell</Axiom>
                        <Axiom shared="true">Adenohypophysial Cell SubClassOf Anatomic_Structure_is_Physical_Part_of some Anterior Lobe of the Pituitary Gland</Axiom>
                     </Source>
                  </Change>
                  <Change id="1331">
                     <Axiom>Low Grade Adenosquamous Breast Carcinoma SubClassOf Metaplastic Breast Carcinoma</Axiom>
                     <Source>
                        <Axiom shared="true">Adenosquamous Breast Carcinoma SubClassOf Metaplastic Breast Carcinoma</Axiom>
                        <Axiom>Low Grade Adenosquamous Breast Carcinoma SubClassOf Adenosquamous Breast Carcinoma</Axiom>
                     </Source>
                  </Change>
                  <Change id="1332">
                     <Axiom>Gal SubClassOf Unit of Measure</Axiom>
                     <Source>
                        <Axiom>Unit of Linear Acceleration SubClassOf Unit by Category</Axiom>
                        <Axiom shared="true">Unit by Category SubClassOf Unit of Measure</Axiom>
                        <Axiom>Gal SubClassOf Unit of Linear Acceleration</Axiom>
                     </Source>
                  </Change>
                  <Change id="1333">
                     <Axiom>Inhaler Refill SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom shared="true">Inhaler SubClassOf Drug Packaging Device</Axiom>
                        <Axiom>Inhaler Refill SubClassOf Inhaler</Axiom>
                     </Source>
                  </Change>
                  <Change id="1334">
                     <Axiom>Type III Epithelial Receptor Cell SubClassOf Epithelial Receptor Cell</Axiom>
                     <Source>
                        <Axiom>Type III Epithelial Receptor Cell SubClassOf Taste Bud Cell</Axiom>
                        <Axiom shared="true">Taste Bud Cell SubClassOf Epithelial Receptor Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="1335">
                     <Axiom>Pyrazole SubClassOf Heterocyclic Compound</Axiom>
                     <Source>
                        <Axiom>Pyrazole SubClassOf Heterocyclic Compound</Axiom>
                        <Axiom>Pyrazole SubClassOf Pyrazole</Axiom>
                     </Source>
                  </Change>
                  <Change id="1336">
                     <Axiom>Intraluminal Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom>Intraluminal Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                        <Axiom shared="true">Parenteral Route of Administration SubClassOf Route of Administration</Axiom>
                     </Source>
                  </Change>
                  <Change id="1337">
                     <Axiom>CYP2D6*11 Allele SubClassOf Allele_Has_Abnormality some Nucleotide Transversion Abnormality</Axiom>
                     <Source>
                        <Axiom shared="true">Guanosine to Cytosine Transversion Abnormality SubClassOf Nucleotide Transversion Abnormality</Axiom>
                        <Axiom>CYP2D6*11 Allele SubClassOf Allele_Has_Abnormality some Guanosine to Cytosine Transversion Abnormality</Axiom>
                     </Source>
                  </Change>
                  <Change id="1338">
                     <Axiom>Thyrotroph Cell SubClassOf Glandular Cell</Axiom>
                     <Source>
                        <Axiom>Thyrotroph Cell SubClassOf Acidophilic Cell</Axiom>
                        <Axiom shared="true">Acidophilic Cell SubClassOf Adenohypophysial Cell</Axiom>
                        <Axiom shared="true">Adenohypophysial Cell SubClassOf Glandular Cell</Axiom>
                     </Source>
                  </Change>
                  <Change id="1339">
                     <Axiom>Milliliter SubClassOf Unit of Measure</Axiom>
                     <Source>
                        <Axiom>Milliliter SubClassOf Unit of Volume</Axiom>
                        <Axiom shared="true">Unit of Volume SubClassOf Unit by Category</Axiom>
                        <Axiom shared="true">Unit by Category SubClassOf Unit of Measure</Axiom>
                     </Source>
                  </Change>
                  <Change id="1340">
                     <Axiom>Ritodrine Hydrochloride SubClassOf Adrenergic Agent</Axiom>
                     <Source>
                        <Axiom>Ritodrine Hydrochloride SubClassOf Beta-adrenergic Agonist</Axiom>
                        <Axiom>Beta-adrenergic Agonist SubClassOf Adrenergic Agent</Axiom>
                     </Source>
                  </Change>
                  <Change id="1341">
                     <Axiom>Supersack SubClassOf Drug Packaging Device</Axiom>
                     <Source>
                        <Axiom>Bag SubClassOf Drug Packaging Device</Axiom>
                        <Axiom>Supersack SubClassOf Bag</Axiom>
                     </Source>
                  </Change>
                  <Change id="1342">
                     <Axiom>Intraductal Route of Administration SubClassOf Route of Administration</Axiom>
                     <Source>
                        <Axiom shared="true">Parenteral Route of Administration SubClassOf Route of Administration</Axiom>
                        <Axiom>Intraductal Route of Administration SubClassOf Parenteral Route of Administration</Axiom>
                     </Source>
                  </Change>
               </RemovedNovelProspectiveRedundancy>
               <RemovedPseudoNovelProspectiveRedundancy id="rpseudopred" size="162">
                  <Change id="1343">
                     <Axiom>Thyroid Gland Diffuse Sclerosing Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Diffuse Sclerosing Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_Has_Finding only Diffuse Lesion) and (Disease_Has_Finding only Fibrotic Stroma Formation) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Finding only Squamous Metaplasia)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1344">
                     <Axiom>Thyroid Gland Lipoadenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Lipoadenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Normal_Cell_Origin only Adipocyte)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1345">
                     <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation SubClassOf Thyroid Gland Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Epithelial Spindle Cell) and (Disease_May_Have_Finding some Biphasic Pattern) and (Disease_May_Have_Finding some Monophasic Pattern) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell) and (Disease_Has_Finding only Slow Growing Mass)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1346">
                     <Axiom>Follicular Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Follicular Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Papillary Pattern) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Nuclear Clearing)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1347">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1348">
                     <Axiom>Neoplastic C-Cell Hyperplasia SubClassOf Atypical Hyperplasia</Axiom>
                     <Source>
                        <Axiom>Neoplastic C-Cell Hyperplasia EquivalentTo Atypical Hyperplasia and C-Cell Hyperplasia and Thyroid Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic C-Cell) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1349">
                     <Axiom>Thyroid Gland Mucoepidermoid Carcinoma SubClassOf Mucoepidermoid Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Mucoepidermoid Carcinoma EquivalentTo Mucoepidermoid Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Circumscribed Lesion) and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Indolent Clinical Course)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1350">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1351">
                     <Axiom>Thyroid Gland Teratoma SubClassOf Teratoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Teratoma EquivalentTo Teratoma and Thyroid Gland Neoplasm and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Hoarseness) and (Disease_Has_Finding only Multicystic Lesion) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1352">
                     <Axiom>Thyroid Gland Angiosarcoma SubClassOf Disease_Has_Finding only Cold Nodule</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Angiosarcoma EquivalentTo Angiosarcoma and Thyroid Gland Sarcoma and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1353">
                     <Axiom>Neoplastic C-Cell Hyperplasia SubClassOf C-Cell Hyperplasia</Axiom>
                     <Source>
                        <Axiom>Neoplastic C-Cell Hyperplasia EquivalentTo Atypical Hyperplasia and C-Cell Hyperplasia and Thyroid Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic C-Cell) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1354">
                     <Axiom>Stage III Thyroid Gland Medullary Carcinoma SubClassOf Thyroid Gland Medullary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage III Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage III)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1355">
                     <Axiom>Neoplastic C-Cell Hyperplasia SubClassOf Disease_Has_Molecular_Abnormality only RET Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Neoplastic C-Cell Hyperplasia EquivalentTo Atypical Hyperplasia and C-Cell Hyperplasia and Thyroid Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic C-Cell) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1356">
                     <Axiom>Thyroid Gland Atypical Follicular Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Atypical Follicular Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Excludes_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell with Large and Hyperchromatic Nucleus) and (Disease_Has_Finding only Nuclear Atypia)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1357">
                     <Axiom>Thyroid Gland Paraganglioma SubClassOf Disease_Has_Primary_Anatomic_Site only Thyroid Gland</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Paraganglioma EquivalentTo Head and Neck Paraganglioma and Thyroid Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1358">
                     <Axiom>Thyroid Gland Follicular Carcinoma SubClassOf Differentiated Thyroid Gland Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Carcinoma EquivalentTo Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PPAR-gamma Rearrangement) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1359">
                     <Axiom>Thyroid Gland Adenocarcinoma SubClassOf Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Adenocarcinoma EquivalentTo Adenocarcinoma and Common Carcinoma and Malignant Endocrine Neoplasm and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cold Nodule) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1360">
                     <Axiom>Thyroid Gland Squamous Cell Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Squamous Cell Carcinoma EquivalentTo Squamous Cell Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1361">
                     <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor SubClassOf Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor EquivalentTo Thyroid Gland Neoplasm and (Disease_May_Have_Associated_Disease some Thyroid Gland Papillary Carcinoma) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Finding only Hyalinized Stroma Formation) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Trabecular Pattern) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1362">
                     <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor SubClassOf Disease_Has_Finding only Cold Nodule</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor EquivalentTo Thyroid Gland Neoplasm and (Disease_May_Have_Associated_Disease some Thyroid Gland Papillary Carcinoma) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Finding only Hyalinized Stroma Formation) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Trabecular Pattern) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1363">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Disease_Has_Finding only Encapsulated Mass</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1364">
                     <Axiom>Thyroid Gland Follicular Adenoma with Papillary Hyperplasia SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma with Papillary Hyperplasia EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_May_Have_Finding some Multifocal Lesion) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1365">
                     <Axiom>Thyroid Gland Undifferentiated Carcinoma, Osteoclastic Variant SubClassOf Thyroid Gland Undifferentiated (Anaplastic) Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Undifferentiated Carcinoma, Osteoclastic Variant EquivalentTo Thyroid Gland Undifferentiated (Anaplastic) Carcinoma and (Disease_Has_Abnormal_Cell only Non-Neoplastic Osteoclast-Like Giant Cell)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1366">
                     <Axiom>Thyroid Gland Teratoma SubClassOf Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Teratoma EquivalentTo Teratoma and Thyroid Gland Neoplasm and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Hoarseness) and (Disease_Has_Finding only Multicystic Lesion) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1367">
                     <Axiom>Stage IV Thyroid Gland Medullary Carcinoma SubClassOf Disease_is_Stage only Stage IV</Axiom>
                     <Source>
                        <Axiom>Stage IV Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage IV)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1368">
                     <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor SubClassOf Thyroid Gland Neoplasm</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor EquivalentTo Thyroid Gland Neoplasm and (Disease_May_Have_Associated_Disease some Thyroid Gland Papillary Carcinoma) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Finding only Hyalinized Stroma Formation) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Trabecular Pattern) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1369">
                     <Axiom>Thyroid Gland Adenocarcinoma SubClassOf Common Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Adenocarcinoma EquivalentTo Adenocarcinoma and Common Carcinoma and Malignant Endocrine Neoplasm and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cold Nodule) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1370">
                     <Axiom>Thyroid Gland Angiosarcoma SubClassOf Thyroid Gland Sarcoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Angiosarcoma EquivalentTo Angiosarcoma and Thyroid Gland Sarcoma and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1371">
                     <Axiom>Thyroid Gland Undifferentiated (Anaplastic) Carcinoma SubClassOf Thyroid Gland Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Undifferentiated (Anaplastic) Carcinoma EquivalentTo Thyroid Gland Carcinoma and Undifferentiated Carcinoma and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_May_Have_Finding some Coagulative Necrosis) and (Disease_May_Have_Finding some Dysphagia) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Hoarseness) and (Disease_May_Have_Finding some Vocal Cord Paralysis) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Abnormal_Cell only Anaplastic Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Giant Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelioid Cell) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Rapidly Enlarging Mass)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1372">
                     <Axiom>Stage I Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage I Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage I)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1373">
                     <Axiom>Thyroid Gland Papillary Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Papillary Carcinoma EquivalentTo Papillary Adenocarcinoma and Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_May_Have_Molecular_Abnormality some TRK Rearrangement) and (Disease_Has_Finding only Ground Glass Nuclear Inclusion) and (Disease_Has_Finding only Nuclear Grooves) and (Disease_Has_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1374">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Thyroid Gland Nodule</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1375">
                     <Axiom>Hereditary Thyroid Gland Medullary Carcinoma SubClassOf Hereditary Malignant Neoplasm</Axiom>
                     <Source>
                        <Axiom>Hereditary Thyroid Gland Medullary Carcinoma EquivalentTo Hereditary Malignant Neoplasm and Thyroid Gland Medullary Carcinoma and (Disease_Has_Associated_Disease only Neoplastic C-Cell Hyperplasia) and (Disease_Has_Finding only Bilateral Mass) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1376">
                     <Axiom>Thyroid Gland Medullary Carcinoma SubClassOf Neuroendocrine Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Medullary Carcinoma EquivalentTo Medullary Carcinoma and Neuroendocrine Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Polygonal Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Round Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Spindle Cell) and (Disease_May_Have_Associated_Disease some Paraneoplastic Syndrome) and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Metastatic Neoplasm to the Lymph Node) and (Disease_May_Have_Finding some Organoid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Serum Calcitonin Level Increased) and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1377">
                     <Axiom>Benign Thyroid Gland Neoplasm SubClassOf Thyroid Gland Neoplasm</Axiom>
                     <Source>
                        <Axiom>Benign Thyroid Gland Neoplasm EquivalentTo Benign Neck Neoplasm and Thyroid Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1378">
                     <Axiom>Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia SubClassOf Disease_May_Have_Associated_Disease some Chronic Lymphocytic Thyroiditis</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia EquivalentTo Thyroid Gland Mucoepidermoid Carcinoma and (Disease_May_Have_Associated_Disease some Chronic Lymphocytic Thyroiditis) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1379">
                     <Axiom>Thyroid Gland Medullary Carcinoma with Amyloid Stroma SubClassOf Disease_Has_Finding only Amyloid Deposition</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Medullary Carcinoma with Amyloid Stroma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_Has_Finding only Amyloid Deposition)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1380">
                     <Axiom>Reactive C-Cell Hyperplasia SubClassOf C-Cell Hyperplasia</Axiom>
                     <Source>
                        <Axiom>Reactive C-Cell Hyperplasia EquivalentTo C-Cell Hyperplasia and Non-Neoplastic Endocrine Disorder and Non-Neoplastic Thyroid Gland Disorder and (Disease_Excludes_Abnormal_Cell only Neoplastic C-Cell)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1381">
                     <Axiom>Sporadic Thyroid Gland Micromedullary Carcinoma SubClassOf Disease_Has_Finding only Lesion with Diameter of 10mm or Less</Axiom>
                     <Source>
                        <Axiom>Sporadic Thyroid Gland Micromedullary Carcinoma EquivalentTo Sporadic Thyroid Gland Medullary Carcinoma and (Disease_Has_Finding only Lesion with Diameter of 10mm or Less)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1382">
                     <Axiom>Thyroid Gland Toxic (Hyperfunctioning) Adenoma SubClassOf Disease_Has_Finding only Hot Nodule</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Toxic (Hyperfunctioning) Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Associated_Disease only Hyperthyroidism) and (Disease_Has_Finding only Hot Nodule)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1383">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Adenoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1384">
                     <Axiom>Thyroid Gland Signet Ring Cell Follicular Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Signet Ring Cell Follicular Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Signet Ring Cell)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1385">
                     <Axiom>Thyroid Gland Oncocytic Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and Thyroid Gland Oncocytic Neoplasm and (Disease_May_Have_Molecular_Abnormality some PPAR-gamma Rearrangement) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion)</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Oncocytic Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and Thyroid Gland Oncocytic Neoplasm and (Disease_May_Have_Molecular_Abnormality some PPAR-gamma Rearrangement)</Axiom>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1386">
                     <Axiom>Columnar Cell Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Columnar Cell Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Papillary Pattern) and (Disease_Has_Finding only Pseudostratified Columnar Tumor Cells Present)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1387">
                     <Axiom>Stage I Thyroid Gland Follicular Carcinoma SubClassOf Thyroid Gland Follicular Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage I Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage I)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1388">
                     <Axiom>Clear Cell Variant Thyroid Gland Follicular Carcinoma SubClassOf Thyroid Gland Follicular Carcinoma</Axiom>
                     <Source>
                        <Axiom>Clear Cell Variant Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Clear Cell)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1389">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1390">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Benign Endocrine Neoplasm</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1391">
                     <Axiom>Sporadic Thyroid Gland Medullary Carcinoma SubClassOf Thyroid Gland Medullary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Sporadic Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_May_Have_Molecular_Abnormality some RET Gene Mutation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1392">
                     <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor SubClassOf Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor EquivalentTo Thyroid Gland Neoplasm and (Disease_May_Have_Associated_Disease some Thyroid Gland Papillary Carcinoma) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Finding only Hyalinized Stroma Formation) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Trabecular Pattern) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1393">
                     <Axiom>Thyroid Gland Papillary Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Papillary Carcinoma EquivalentTo Papillary Adenocarcinoma and Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_May_Have_Molecular_Abnormality some TRK Rearrangement) and (Disease_Has_Finding only Ground Glass Nuclear Inclusion) and (Disease_Has_Finding only Nuclear Grooves) and (Disease_Has_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1394">
                     <Axiom>Thyroid Gland Mucoepidermoid Carcinoma SubClassOf Thyroid Gland Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Mucoepidermoid Carcinoma EquivalentTo Mucoepidermoid Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Circumscribed Lesion) and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Indolent Clinical Course)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1395">
                     <Axiom>Thyroid Gland Papillary Carcinoma SubClassOf Differentiated Thyroid Gland Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Papillary Carcinoma EquivalentTo Papillary Adenocarcinoma and Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_May_Have_Molecular_Abnormality some TRK Rearrangement) and (Disease_Has_Finding only Ground Glass Nuclear Inclusion) and (Disease_Has_Finding only Nuclear Grooves) and (Disease_Has_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1396">
                     <Axiom>C-Cell Hyperplasia SubClassOf Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle</Axiom>
                     <Source>
                        <Axiom>C-Cell Hyperplasia EquivalentTo Hyperplasia and Non-Neoplastic Endocrine Disorder and Thyroid Gland Disorder and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1397">
                     <Axiom>Thyroid Gland Papillary Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Papillary Carcinoma EquivalentTo Papillary Adenocarcinoma and Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_May_Have_Molecular_Abnormality some TRK Rearrangement) and (Disease_Has_Finding only Ground Glass Nuclear Inclusion) and (Disease_Has_Finding only Nuclear Grooves) and (Disease_Has_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1398">
                     <Axiom>Hereditary Thyroid Gland Medullary Carcinoma SubClassOf Disease_Has_Molecular_Abnormality only RET Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Hereditary Thyroid Gland Medullary Carcinoma EquivalentTo Hereditary Malignant Neoplasm and Thyroid Gland Medullary Carcinoma and (Disease_Has_Associated_Disease only Neoplastic C-Cell Hyperplasia) and (Disease_Has_Finding only Bilateral Mass) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1399">
                     <Axiom>Thyroid Gland Follicular Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Carcinoma EquivalentTo Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PPAR-gamma Rearrangement) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1400">
                     <Axiom>Thyroid Gland Follicular Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Carcinoma EquivalentTo Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PPAR-gamma Rearrangement) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1401">
                     <Axiom>Benign Thyroid Gland Neoplasm SubClassOf Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue</Axiom>
                     <Source>
                        <Axiom>Benign Thyroid Gland Neoplasm EquivalentTo Benign Neck Neoplasm and Thyroid Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1402">
                     <Axiom>Poorly Differentiated Thyroid Gland Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Poorly Differentiated Thyroid Gland Carcinoma EquivalentTo Thyroid Gland Adenocarcinoma and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Follicular Structures Present) and (Disease_Excludes_Finding only Papillary Pattern)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1403">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1404">
                     <Axiom>Thyroid Gland Carcinoma SubClassOf Neck Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Carcinoma EquivalentTo Malignant Thyroid Gland Neoplasm and Neck Carcinoma and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Epithelial Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1405">
                     <Axiom>Stage III Thyroid Gland Medullary Carcinoma SubClassOf Disease_is_Stage only Stage III</Axiom>
                     <Source>
                        <Axiom>Stage III Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage III)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1406">
                     <Axiom>Thyroid Gland Papillary Carcinoma SubClassOf Papillary Adenocarcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Papillary Carcinoma EquivalentTo Papillary Adenocarcinoma and Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_May_Have_Molecular_Abnormality some TRK Rearrangement) and (Disease_Has_Finding only Ground Glass Nuclear Inclusion) and (Disease_Has_Finding only Nuclear Grooves) and (Disease_Has_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1407">
                     <Axiom>Thyroid Gland Medullary Carcinoma SubClassOf Disease_Has_Normal_Cell_Origin only C-Cell</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Medullary Carcinoma EquivalentTo Medullary Carcinoma and Neuroendocrine Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Polygonal Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Round Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Spindle Cell) and (Disease_May_Have_Associated_Disease some Paraneoplastic Syndrome) and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Metastatic Neoplasm to the Lymph Node) and (Disease_May_Have_Finding some Organoid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Serum Calcitonin Level Increased) and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1408">
                     <Axiom>C-Cell Hyperplasia SubClassOf Disease_Has_Primary_Anatomic_Site only Thyroid Gland</Axiom>
                     <Source>
                        <Axiom>C-Cell Hyperplasia EquivalentTo Hyperplasia and Non-Neoplastic Endocrine Disorder and Thyroid Gland Disorder and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1409">
                     <Axiom>Stage I Thyroid Gland Papillary Carcinoma SubClassOf Disease_is_Stage only Stage I</Axiom>
                     <Source>
                        <Axiom>Stage I Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage I)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1410">
                     <Axiom>Thyroid Gland Mixed Medullary and Follicular Cell Carcinoma SubClassOf Thyroid Gland Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Mixed Medullary and Follicular Cell Carcinoma EquivalentTo Malignant Endocrine Neoplasm and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Metastatic Neoplasm to the Lymph Node) and (Disease_May_Have_Molecular_Abnormality some RET Gene Mutation) and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1411">
                     <Axiom>Malignant Thyroid Gland Neoplasm SubClassOf Thyroid Gland Neoplasm</Axiom>
                     <Source>
                        <Axiom>Malignant Thyroid Gland Neoplasm EquivalentTo Malignant Neck Neoplasm and Thyroid Gland Neoplasm</Axiom>
                     </Source>
                  </Change>
                  <Change id="1412">
                     <Axiom>Neoplastic C-Cell Hyperplasia SubClassOf Thyroid Gland Neoplasm</Axiom>
                     <Source>
                        <Axiom>Neoplastic C-Cell Hyperplasia EquivalentTo Atypical Hyperplasia and C-Cell Hyperplasia and Thyroid Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic C-Cell) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1413">
                     <Axiom>Thyroid Gland Follicular Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some PPAR-gamma Rearrangement</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Carcinoma EquivalentTo Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PPAR-gamma Rearrangement) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1414">
                     <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor SubClassOf Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor EquivalentTo Thyroid Gland Neoplasm and (Disease_May_Have_Associated_Disease some Thyroid Gland Papillary Carcinoma) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Finding only Hyalinized Stroma Formation) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Trabecular Pattern) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1415">
                     <Axiom>Thyroid Gland Medullary Carcinoma SubClassOf Thyroid Gland Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Medullary Carcinoma EquivalentTo Medullary Carcinoma and Neuroendocrine Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Polygonal Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Round Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Spindle Cell) and (Disease_May_Have_Associated_Disease some Paraneoplastic Syndrome) and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Metastatic Neoplasm to the Lymph Node) and (Disease_May_Have_Finding some Organoid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Serum Calcitonin Level Increased) and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1416">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1417">
                     <Axiom>Benign Thyroid Gland Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Thyroid Gland</Axiom>
                     <Source>
                        <Axiom>Benign Thyroid Gland Neoplasm EquivalentTo Benign Neck Neoplasm and Thyroid Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1418">
                     <Axiom>Stage IV Thyroid Gland Follicular Carcinoma SubClassOf Disease_is_Stage only Stage IV</Axiom>
                     <Source>
                        <Axiom>Stage IV Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage IV)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1419">
                     <Axiom>Stage III Thyroid Gland Follicular Carcinoma SubClassOf Thyroid Gland Follicular Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage III Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage III)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1420">
                     <Axiom>Differentiated Thyroid Gland Carcinoma SubClassOf Thyroid Gland Adenocarcinoma</Axiom>
                     <Source>
                        <Axiom>Differentiated Thyroid Gland Carcinoma EquivalentTo Thyroid Gland Adenocarcinoma and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Has_Finding only Follicular Cell Differentiation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1421">
                     <Axiom>Oncocytic Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Oncocytic Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Papillary Pattern) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Oxyphil Cell)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1422">
                     <Axiom>Thyroid Gland Mucinous Follicular Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Mucinous Follicular Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_May_Have_Abnormal_Cell some Neoplastic Thyroid Gland Follicular Signet Ring Cell) and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Honeycomb Pattern) and (Disease_Has_Finding only Mucoid Stroma Formation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1423">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Benign Thyroid Gland Neoplasm</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1424">
                     <Axiom>Thyroid Gland Squamous Cell Carcinoma SubClassOf Squamous Cell Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Squamous Cell Carcinoma EquivalentTo Squamous Cell Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1425">
                     <Axiom>C-Cell Hyperplasia SubClassOf Hyperplasia</Axiom>
                     <Source>
                        <Axiom>C-Cell Hyperplasia EquivalentTo Hyperplasia and Non-Neoplastic Endocrine Disorder and Thyroid Gland Disorder and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1426">
                     <Axiom>Thyroid Gland Clear Cell Follicular Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Clear Cell Follicular Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Clear Cell)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1427">
                     <Axiom>Thyroid Gland Paraganglioma SubClassOf Thyroid Gland Neoplasm</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Paraganglioma EquivalentTo Head and Neck Paraganglioma and Thyroid Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1428">
                     <Axiom>Thyroid Gland Papillary Microcarcinoma SubClassOf Disease_Has_Finding only Lesion with Diameter of 10mm or Less</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Papillary Microcarcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Papillary Pattern) and (Disease_Has_Finding only Lesion with Diameter of 10mm or Less)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1429">
                     <Axiom>Malignant Thyroid Gland Neoplasm SubClassOf Malignant Neck Neoplasm</Axiom>
                     <Source>
                        <Axiom>Malignant Thyroid Gland Neoplasm EquivalentTo Malignant Neck Neoplasm and Thyroid Gland Neoplasm</Axiom>
                     </Source>
                  </Change>
                  <Change id="1430">
                     <Axiom>Thyroid Gland Sarcoma SubClassOf Malignant Thyroid Gland Neoplasm</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Sarcoma EquivalentTo Malignant Thyroid Gland Neoplasm and Soft Tissue Sarcoma</Axiom>
                     </Source>
                  </Change>
                  <Change id="1431">
                     <Axiom>Thyroid Gland Squamous Cell Carcinoma SubClassOf Thyroid Gland Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Squamous Cell Carcinoma EquivalentTo Squamous Cell Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1432">
                     <Axiom>Thyroid Gland Angiosarcoma SubClassOf Disease_Has_Primary_Anatomic_Site only Thyroid Gland</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Angiosarcoma EquivalentTo Angiosarcoma and Thyroid Gland Sarcoma and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1433">
                     <Axiom>Stage I Thyroid Gland Medullary Carcinoma SubClassOf Thyroid Gland Medullary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage I Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage I)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1434">
                     <Axiom>Thyroid Gland Nodule SubClassOf Thyroid Gland Disorder</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Nodule EquivalentTo Thyroid Gland Disorder and (Disease_Has_Finding only Nodular Lesion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1435">
                     <Axiom>Tall Cell Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Tall Cell Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Finding only Trabecular Pattern)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1436">
                     <Axiom>Thyroid Gland Neoplasm SubClassOf Neck Neoplasm</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Neoplasm EquivalentTo Neck Neoplasm and Thyroid Gland Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="1437">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1438">
                     <Axiom>Thyroid Gland Mixed Medullary and Follicular Cell Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some RET Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Mixed Medullary and Follicular Cell Carcinoma EquivalentTo Malignant Endocrine Neoplasm and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Metastatic Neoplasm to the Lymph Node) and (Disease_May_Have_Molecular_Abnormality some RET Gene Mutation) and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1439">
                     <Axiom>Thyroid Gland Sarcoma SubClassOf Soft Tissue Sarcoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Sarcoma EquivalentTo Malignant Thyroid Gland Neoplasm and Soft Tissue Sarcoma</Axiom>
                     </Source>
                  </Change>
                  <Change id="1440">
                     <Axiom>Stage IV Thyroid Gland Medullary Carcinoma SubClassOf Thyroid Gland Medullary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage IV Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage IV)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1441">
                     <Axiom>Thyroid Gland Adenocarcinoma SubClassOf Thyroid Gland Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Adenocarcinoma EquivalentTo Adenocarcinoma and Common Carcinoma and Malignant Endocrine Neoplasm and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cold Nodule) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1442">
                     <Axiom>Benign Thyroid Gland Neoplasm SubClassOf Benign Neck Neoplasm</Axiom>
                     <Source>
                        <Axiom>Benign Thyroid Gland Neoplasm EquivalentTo Benign Neck Neoplasm and Thyroid Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1443">
                     <Axiom>Thyroid Gland Angiosarcoma SubClassOf Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Angiosarcoma EquivalentTo Angiosarcoma and Thyroid Gland Sarcoma and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1444">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1445">
                     <Axiom>Macrofollicular Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Macrofollicular Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_Excludes_Finding only Papillary Pattern) and (Disease_Has_Finding only Macrofollicular Structures Present) and (Disease_Has_Finding only Nuclear Clearing)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1446">
                     <Axiom>Poorly Differentiated Thyroid Gland Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Poorly Differentiated Thyroid Gland Carcinoma EquivalentTo Thyroid Gland Adenocarcinoma and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Follicular Structures Present) and (Disease_Excludes_Finding only Papillary Pattern)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1447">
                     <Axiom>Thyroid Gland Undifferentiated (Anaplastic) Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Undifferentiated (Anaplastic) Carcinoma EquivalentTo Thyroid Gland Carcinoma and Undifferentiated Carcinoma and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_May_Have_Finding some Coagulative Necrosis) and (Disease_May_Have_Finding some Dysphagia) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Hoarseness) and (Disease_May_Have_Finding some Vocal Cord Paralysis) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Abnormal_Cell only Anaplastic Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Giant Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelioid Cell) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Rapidly Enlarging Mass)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1448">
                     <Axiom>Recurrent Thyroid Gland Carcinoma SubClassOf Recurrent Head and Neck Cancer</Axiom>
                     <Source>
                        <Axiom>Recurrent Thyroid Gland Carcinoma EquivalentTo Recurrent Head and Neck Cancer and Thyroid Gland Carcinoma</Axiom>
                     </Source>
                  </Change>
                  <Change id="1449">
                     <Axiom>Thyroid Gland Follicular Adenoma with Bizarre Nuclei SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma with Bizarre Nuclei EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell with Large and Hyperchromatic Nucleus) and (Disease_Has_Finding only Nuclear Atypia)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1450">
                     <Axiom>Thyroid Gland Paraganglioma SubClassOf Head and Neck Paraganglioma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Paraganglioma EquivalentTo Head and Neck Paraganglioma and Thyroid Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1451">
                     <Axiom>Thyroid Gland Papillary Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some TRK Rearrangement</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Papillary Carcinoma EquivalentTo Papillary Adenocarcinoma and Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_May_Have_Molecular_Abnormality some TRK Rearrangement) and (Disease_Has_Finding only Ground Glass Nuclear Inclusion) and (Disease_Has_Finding only Nuclear Grooves) and (Disease_Has_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1452">
                     <Axiom>Stage I Thyroid Gland Medullary Carcinoma SubClassOf Disease_is_Stage only Stage I</Axiom>
                     <Source>
                        <Axiom>Stage I Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage I)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1453">
                     <Axiom>Thyroid Gland Adenocarcinoma SubClassOf Adenocarcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Adenocarcinoma EquivalentTo Adenocarcinoma and Common Carcinoma and Malignant Endocrine Neoplasm and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cold Nodule) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1454">
                     <Axiom>Thyroid Gland Medullary Carcinoma SubClassOf Medullary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Medullary Carcinoma EquivalentTo Medullary Carcinoma and Neuroendocrine Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Polygonal Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Round Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Spindle Cell) and (Disease_May_Have_Associated_Disease some Paraneoplastic Syndrome) and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Metastatic Neoplasm to the Lymph Node) and (Disease_May_Have_Finding some Organoid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Serum Calcitonin Level Increased) and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1455">
                     <Axiom>Stage II Thyroid Gland Follicular Carcinoma SubClassOf Disease_is_Stage only Stage II</Axiom>
                     <Source>
                        <Axiom>Stage II Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage II)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1456">
                     <Axiom>Sporadic Thyroid Gland Micromedullary Carcinoma SubClassOf Sporadic Thyroid Gland Medullary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Sporadic Thyroid Gland Micromedullary Carcinoma EquivalentTo Sporadic Thyroid Gland Medullary Carcinoma and (Disease_Has_Finding only Lesion with Diameter of 10mm or Less)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1457">
                     <Axiom>Multicentric Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Multicentric Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_Has_Finding only Multifocal Lesion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1458">
                     <Axiom>Thyroid Gland Teratoma SubClassOf Thyroid Gland Neoplasm</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Teratoma EquivalentTo Teratoma and Thyroid Gland Neoplasm and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Hoarseness) and (Disease_Has_Finding only Multicystic Lesion) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1459">
                     <Axiom>Thyroid Gland Medullary Carcinoma with Amyloid Stroma SubClassOf Thyroid Gland Medullary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Medullary Carcinoma with Amyloid Stroma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_Has_Finding only Amyloid Deposition)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1460">
                     <Axiom>Poorly Differentiated Thyroid Gland Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation</Axiom>
                     <Source>
                        <Axiom>Poorly Differentiated Thyroid Gland Carcinoma EquivalentTo Thyroid Gland Adenocarcinoma and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Follicular Structures Present) and (Disease_Excludes_Finding only Papillary Pattern)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1461">
                     <Axiom>Stage II Thyroid Gland Medullary Carcinoma SubClassOf Disease_is_Stage only Stage II</Axiom>
                     <Source>
                        <Axiom>Stage II Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage II)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1462">
                     <Axiom>C-Cell Hyperplasia SubClassOf Disease_Has_Normal_Cell_Origin only C-Cell</Axiom>
                     <Source>
                        <Axiom>C-Cell Hyperplasia EquivalentTo Hyperplasia and Non-Neoplastic Endocrine Disorder and Thyroid Gland Disorder and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1463">
                     <Axiom>Recurrent Thyroid Gland Carcinoma SubClassOf Thyroid Gland Carcinoma</Axiom>
                     <Source>
                        <Axiom>Recurrent Thyroid Gland Carcinoma EquivalentTo Recurrent Head and Neck Cancer and Thyroid Gland Carcinoma</Axiom>
                     </Source>
                  </Change>
                  <Change id="1464">
                     <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor SubClassOf Disease_Has_Primary_Anatomic_Site only Thyroid Gland</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Hyalinizing Trabecular Tumor EquivalentTo Thyroid Gland Neoplasm and (Disease_May_Have_Associated_Disease some Thyroid Gland Papillary Carcinoma) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Finding only Hyalinized Stroma Formation) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Trabecular Pattern) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1465">
                     <Axiom>Poorly Differentiated Thyroid Gland Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Poorly Differentiated Thyroid Gland Carcinoma EquivalentTo Thyroid Gland Adenocarcinoma and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Follicular Structures Present) and (Disease_Excludes_Finding only Papillary Pattern)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1466">
                     <Axiom>Thyroid Gland Papillary Microcarcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Papillary Microcarcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Papillary Pattern) and (Disease_Has_Finding only Lesion with Diameter of 10mm or Less)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1467">
                     <Axiom>Thyroid Gland Papillary Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Papillary Carcinoma EquivalentTo Papillary Adenocarcinoma and Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_May_Have_Molecular_Abnormality some TRK Rearrangement) and (Disease_Has_Finding only Ground Glass Nuclear Inclusion) and (Disease_Has_Finding only Nuclear Grooves) and (Disease_Has_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1468">
                     <Axiom>Sporadic Thyroid Gland Medullary Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some RET Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Sporadic Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_May_Have_Molecular_Abnormality some RET Gene Mutation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1469">
                     <Axiom>Thyroid Gland Undifferentiated (Anaplastic) Carcinoma SubClassOf Undifferentiated Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Undifferentiated (Anaplastic) Carcinoma EquivalentTo Thyroid Gland Carcinoma and Undifferentiated Carcinoma and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_May_Have_Finding some Coagulative Necrosis) and (Disease_May_Have_Finding some Dysphagia) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Hoarseness) and (Disease_May_Have_Finding some Vocal Cord Paralysis) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Abnormal_Cell only Anaplastic Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Giant Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelioid Cell) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Rapidly Enlarging Mass)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1470">
                     <Axiom>Stage II Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage II Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage II)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1471">
                     <Axiom>Thyroid Gland Carcinoma Showing Thymus-Like Differentiation SubClassOf Thyroid Gland Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Carcinoma Showing Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Epithelial Spindle Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Squamoid Cell) and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Metastatic Neoplasm to the Lymph Node) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Desmoplastic Stroma Formation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1472">
                     <Axiom>Stage IV Thyroid Gland Follicular Carcinoma SubClassOf Thyroid Gland Follicular Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage IV Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage IV)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1473">
                     <Axiom>Thyroid Gland Adenocarcinoma SubClassOf Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Cell</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Adenocarcinoma EquivalentTo Adenocarcinoma and Common Carcinoma and Malignant Endocrine Neoplasm and Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cold Nodule) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1474">
                     <Axiom>Stage I Thyroid Gland Follicular Carcinoma SubClassOf Disease_is_Stage only Stage I</Axiom>
                     <Source>
                        <Axiom>Stage I Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage I)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1475">
                     <Axiom>Thyroid Gland Angiosarcoma SubClassOf Angiosarcoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Angiosarcoma EquivalentTo Angiosarcoma and Thyroid Gland Sarcoma and (Disease_Has_Finding only Cold Nodule) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1476">
                     <Axiom>Stage II Thyroid Gland Papillary Carcinoma SubClassOf Disease_is_Stage only Stage II</Axiom>
                     <Source>
                        <Axiom>Stage II Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage II)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1477">
                     <Axiom>Thyroid Gland Macrofollicular Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Macrofollicular Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Finding only Macrofollicular Structures Present)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1478">
                     <Axiom>Stage III Thyroid Gland Papillary Carcinoma SubClassOf Disease_is_Stage only Stage III</Axiom>
                     <Source>
                        <Axiom>Stage III Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage III)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1479">
                     <Axiom>Stage IV Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage IV Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage IV)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1480">
                     <Axiom>Thyroid Gland Undifferentiated (Anaplastic) Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Undifferentiated (Anaplastic) Carcinoma EquivalentTo Thyroid Gland Carcinoma and Undifferentiated Carcinoma and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_May_Have_Finding some Coagulative Necrosis) and (Disease_May_Have_Finding some Dysphagia) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Hoarseness) and (Disease_May_Have_Finding some Vocal Cord Paralysis) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Abnormal_Cell only Anaplastic Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Giant Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelioid Cell) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Rapidly Enlarging Mass)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1481">
                     <Axiom>Poorly Differentiated Thyroid Gland Carcinoma SubClassOf Thyroid Gland Adenocarcinoma</Axiom>
                     <Source>
                        <Axiom>Poorly Differentiated Thyroid Gland Carcinoma EquivalentTo Thyroid Gland Adenocarcinoma and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Follicular Structures Present) and (Disease_Excludes_Finding only Papillary Pattern)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1482">
                     <Axiom>Stage II Thyroid Gland Follicular Carcinoma SubClassOf Thyroid Gland Follicular Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage II Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage II)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1483">
                     <Axiom>Hereditary Thyroid Gland Medullary Carcinoma SubClassOf Disease_Has_Associated_Disease only Neoplastic C-Cell Hyperplasia</Axiom>
                     <Source>
                        <Axiom>Hereditary Thyroid Gland Medullary Carcinoma EquivalentTo Hereditary Malignant Neoplasm and Thyroid Gland Medullary Carcinoma and (Disease_Has_Associated_Disease only Neoplastic C-Cell Hyperplasia) and (Disease_Has_Finding only Bilateral Mass) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1484">
                     <Axiom>Solid Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Solid Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_Has_Finding only Solid Pattern)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1485">
                     <Axiom>Thyroid Gland Neoplasm SubClassOf Thyroid Gland Disorder</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Neoplasm EquivalentTo Neck Neoplasm and Thyroid Gland Disorder</Axiom>
                     </Source>
                  </Change>
                  <Change id="1486">
                     <Axiom>Thyroid Gland Follicular Adenoma SubClassOf Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Adenoma EquivalentTo Adenoma and Benign Endocrine Neoplasm and Benign Thyroid Gland Neoplasm and Thyroid Gland Nodule and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Radiation Toxicity) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Thyroid Gland Follicular Cell) and (Disease_Has_Finding only Monoclonal Cellular Population Present) and (Disease_Has_Finding only Encapsulated Mass) and (Disease_Has_Finding only Follicular Structures Present) and (Disease_Has_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Normal_Cell_Origin only Thyroid Gland Follicular Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1487">
                     <Axiom>Thyroid Gland Papillary Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Papillary Carcinoma EquivalentTo Papillary Adenocarcinoma and Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Cystic Changes) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some RET/PTC Rearrangement) and (Disease_May_Have_Molecular_Abnormality some TRK Rearrangement) and (Disease_Has_Finding only Ground Glass Nuclear Inclusion) and (Disease_Has_Finding only Nuclear Grooves) and (Disease_Has_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1488">
                     <Axiom>Thyroid Gland Paraganglioma SubClassOf Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Paraganglioma EquivalentTo Head and Neck Paraganglioma and Thyroid Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1489">
                     <Axiom>Thyroid Gland Fetal Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Fetal Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_May_Have_Cytogenetic_Abnormality some Aneuploidy) and (Disease_Has_Finding only Edematous Stroma Formation) and (Disease_Has_Finding only Microfollicular Structures Present) and (Disease_Has_Finding only Trabecular Pattern)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1490">
                     <Axiom>Thyroid Gland Medullary Carcinoma SubClassOf Disease_Has_Finding only Circumscribed Lesion</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Medullary Carcinoma EquivalentTo Medullary Carcinoma and Neuroendocrine Carcinoma and Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Polygonal Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Round Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Neuroendocrine Spindle Cell) and (Disease_May_Have_Associated_Disease some Paraneoplastic Syndrome) and (Disease_May_Have_Finding some Cold Nodule) and (Disease_May_Have_Finding some Metastatic Neoplasm to the Lymph Node) and (Disease_May_Have_Finding some Organoid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Circumscribed Lesion) and (Disease_Has_Finding only Serum Calcitonin Level Increased) and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1491">
                     <Axiom>Thyroid Gland Toxic (Hyperfunctioning) Adenoma SubClassOf Thyroid Gland Follicular Adenoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Toxic (Hyperfunctioning) Adenoma EquivalentTo Thyroid Gland Follicular Adenoma and (Disease_Has_Associated_Disease only Hyperthyroidism) and (Disease_Has_Finding only Hot Nodule)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1492">
                     <Axiom>Stage II Thyroid Gland Medullary Carcinoma SubClassOf Thyroid Gland Medullary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage II Thyroid Gland Medullary Carcinoma EquivalentTo Thyroid Gland Medullary Carcinoma and (Disease_is_Stage only Stage II)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1493">
                     <Axiom>Thyroid Gland Carcinoma SubClassOf Malignant Thyroid Gland Neoplasm</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Carcinoma EquivalentTo Malignant Thyroid Gland Neoplasm and Neck Carcinoma and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Epithelial Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1494">
                     <Axiom>Reactive C-Cell Hyperplasia SubClassOf Non-Neoplastic Thyroid Gland Disorder</Axiom>
                     <Source>
                        <Axiom>Reactive C-Cell Hyperplasia EquivalentTo C-Cell Hyperplasia and Non-Neoplastic Endocrine Disorder and Non-Neoplastic Thyroid Gland Disorder and (Disease_Excludes_Abnormal_Cell only Neoplastic C-Cell)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1495">
                     <Axiom>Stage III Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Stage III Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage III)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1496">
                     <Axiom>Thyroid Gland Carcinoma SubClassOf Disease_Has_Primary_Anatomic_Site only Thyroid Gland</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Carcinoma EquivalentTo Malignant Thyroid Gland Neoplasm and Neck Carcinoma and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Epithelial Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1497">
                     <Axiom>Thyroid Gland Follicular Carcinoma SubClassOf Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Follicular Carcinoma EquivalentTo Differentiated Thyroid Gland Carcinoma and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Solid Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Molecular_Abnormality some HRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PPAR-gamma Rearrangement) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Excludes_Finding only Ground Glass Nuclear Inclusion) and (Disease_Excludes_Finding only Nuclear Clearing) and (Disease_Excludes_Finding only Nuclear Grooves) and (Disease_Excludes_Finding only Nuclear Pseudoinclusion)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1498">
                     <Axiom>Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia SubClassOf Thyroid Gland Mucoepidermoid Carcinoma</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia EquivalentTo Thyroid Gland Mucoepidermoid Carcinoma and (Disease_May_Have_Associated_Disease some Chronic Lymphocytic Thyroiditis) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1499">
                     <Axiom>Hereditary Thyroid Gland Medullary Carcinoma SubClassOf Thyroid Gland Medullary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Hereditary Thyroid Gland Medullary Carcinoma EquivalentTo Hereditary Malignant Neoplasm and Thyroid Gland Medullary Carcinoma and (Disease_Has_Associated_Disease only Neoplastic C-Cell Hyperplasia) and (Disease_Has_Finding only Bilateral Mass) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1500">
                     <Axiom>Clear Cell Variant Thyroid Gland Papillary Carcinoma SubClassOf Thyroid Gland Papillary Carcinoma</Axiom>
                     <Source>
                        <Axiom>Clear Cell Variant Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_May_Have_Finding some Follicular Structures Present) and (Disease_May_Have_Finding some Papillary Pattern) and (Disease_Has_Abnormal_Cell only Malignant Thyroid Gland Follicular Clear Cell)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1501">
                     <Axiom>Thyroid Gland Teratoma SubClassOf Disease_Has_Primary_Anatomic_Site only Thyroid Gland</Axiom>
                     <Source>
                        <Axiom>Thyroid Gland Teratoma EquivalentTo Teratoma and Thyroid Gland Neoplasm and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Hoarseness) and (Disease_Has_Finding only Multicystic Lesion) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1502">
                     <Axiom>C-Cell Hyperplasia SubClassOf Thyroid Gland Disorder</Axiom>
                     <Source>
                        <Axiom>C-Cell Hyperplasia EquivalentTo Hyperplasia and Non-Neoplastic Endocrine Disorder and Thyroid Gland Disorder and (Disease_Has_Normal_Cell_Origin only C-Cell) and (Disease_Has_Normal_Tissue_Origin only Thyroid Gland Follicle) and (Disease_Has_Primary_Anatomic_Site only Thyroid Gland)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1503">
                     <Axiom>Stage IV Thyroid Gland Papillary Carcinoma SubClassOf Disease_is_Stage only Stage IV</Axiom>
                     <Source>
                        <Axiom>Stage IV Thyroid Gland Papillary Carcinoma EquivalentTo Thyroid Gland Papillary Carcinoma and (Disease_is_Stage only Stage IV)</Axiom>
                     </Source>
                  </Change>
                  <Change id="1504">
                     <Axiom>Stage III Thyroid Gland Follicular Carcinoma SubClassOf Disease_is_Stage only Stage III</Axiom>
                     <Source>
                        <Axiom>Stage III Thyroid Gland Follicular Carcinoma EquivalentTo Thyroid Gland Follicular Carcinoma and (Disease_is_Stage only Stage III)</Axiom>
                     </Source>
                  </Change>
               </RemovedPseudoNovelProspectiveRedundancy>
            </RemovedNewProspectiveRedundancy>
         </RemovedProspectiveRedundancy>
      </Ineffectual>
   </Removals>
</root>
